10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

(Mark One)

x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2014, or

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from  to

Commission File No.: 001-16753

AMN HEALTHCARE SERVICES, INC.

(Exact Name of Registrant as Specified in Its Charter)

Delaware	06-1500476
(State or Other Jurisdiction of Incorporation or Organization)	(I.R.S. Employer Identification No.)
12400 High Bluff Drive, Suite 100 San Diego, California	92130
(Address of principal executive offices)	(Zip Code)

Registrant’s Telephone Number, Including Area Code: (866) 871-8519

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class	Name of each exchange on which registered
Common Stock, $0.01 par value	New York Stock Exchange

Securities registered pursuant to Section 12(g) of the Act:

None.

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  Yes  ¨  No  x

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act.  Yes  ¨  No  x

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes x No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes  x  No  ¨

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  x

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer  o Accelerated filer  x Non-accelerated filer  o Smaller reporting company o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes  ¨  No  x

The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of June 30, 2014, was $354,980,891 based on a closing sale price of $12.30 per share.

As of February 20, 2015, there were 47,110,127 shares of common stock, $0.01 par value, outstanding.

Documents Incorporated By Reference: Portions of the registrant’s definitive proxy statement for the annual meeting of stockholders scheduled to be held on April 22, 2015 have been incorporated by reference into Part III of this Form 10-K.

TABLE OF CONTENTS

Item		Page
	PART I
1.	Business	1
1A.	Risk Factors	8
1B.	Unresolved Staff Comments	14
2.	Properties	14
3.	Legal Proceedings	14
4.	Mine Safety Disclosures	14
	PART II
5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	15
6.	Selected Financial Data	17
7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	19
7A.	Quantitative and Qualitative Disclosures about Market Risk	28
8.	Financial Statements and Supplementary Data	29
9.	Changes In and Disagreements With Accountants on Accounting and Financial Disclosure	57
9A.	Controls and Procedures	57
9B.	Other Information	59
	PART III
10.	Directors, Executive Officers and Corporate Governance	59
11.	Executive Compensation	59
12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	59
13.	Certain Relationships and Related Transactions, and Director Independence	60
14.	Principal Accounting Fees and Services	60
	PART IV
15.	Exhibits and Financial Statement Schedules	61
	Signatures	65

References in this Annual Report on Form 10-K to “AMN Healthcare,” the “Company,” “we,” “us” and “our” refer to AMN Healthcare Services, Inc. and its wholly owned subsidiaries.

PART I

Item 1. Business

Our Company

We are the innovator in healthcare workforce solutions and staffing services to healthcare facilities across the nation. As an innovative workforce solutions partner, our managed services programs, or “MSP,” vendor management systems, or “VMS,” recruitment process outsourcing, or “RPO,” workforce consulting services, predictive modeling, staff scheduling and the placement of physicians, nurses and allied healthcare professionals into temporary and permanent positions enable our clients to successfully reduce staffing complexity, increase efficiency and improve patient outcomes within the rapidly evolving healthcare environment. Our clients include acute and sub-acute care hospitals, community health centers and clinics, physician practice groups, retail and urgent care centers, home health facilities, and several other healthcare settings.

Our clients utilize our workforce solutions and healthcare staffing services to manage their clinical workforce needs, both temporary and permanent, in an economically beneficial manner. Our managed services program and vendor management systems enable healthcare organizations to increase their efficiency by managing all of their supplemental workforce needs through one company or technology. Short- and long-term shortages in our clients’ workforce arise due to a variety of circumstances, including a lack of qualified, specialized local healthcare professionals, attrition, leave schedules, census fluctuations, electronic medical records, or “EMR,” conversions and new unit openings. Increasingly, our clients seek innovative, proven and capable partners that provide a strategic, sophisticated and integrated clinical workforce approach that enables them to achieve high quality patient outcomes more efficiently. We believe our clients contract with us based on our value proposition of quality and service excellence, our comprehensive suite of innovative workforce solutions that reduce complexity, drive efficiency, improve patient satisfaction and outcomes and provide an economic benefit, together with our execution capabilities, our national footprint and our access to a wide network of healthcare professionals. Our large number of hospital, healthcare facility and other clients provides us with the opportunity to offer positions to healthcare professionals typically in all 50 states and in a variety of work environments and clinical settings.

Healthcare professionals choose temporary assignments for a variety of reasons that include seeking flexible work opportunities, exploring different areas of the country and diverse practice settings, building clinical skills and experience by working at prestigious healthcare facilities, avoiding the demands and political environment of working as permanent staff, working through life and career transitions, and as a means of access into a permanent staff position. We provide our temporary healthcare professionals with a competitive compensation and benefit package that may include professional development opportunities, professional liability insurance, 401(k) plan and health insurance. In addition, we may provide reimbursements for meals and incidentals, travel and housing, or provide company housing if they elect not to receive reimbursement. We believe that we attract temporary healthcare professionals due to our long-standing reputation for providing a high level of service, our numerous employment opportunities, our benefit packages, our innovative marketing programs and word-of-mouth referrals from the thousands of current and former healthcare professionals who have worked with us.

We use distinct brands to market our different services to our two client bases: (1) healthcare organizations and (2) healthcare professionals. We market our managed services solutions, travel nurse and allied recruitment services to hospitals and healthcare facilities generally under one brand, AMN Healthcare^®, as a single managed services provider with access to healthcare professionals through multiple recruitment brands, including American Mobile^®, Nursefinders^®, NurseChoice^®, NursesRx^®, Med Travelers^®, Club Staffing^®, Rx Pro Health^®, Onward Healthcare^® and O’Grady Peyton International^®. For our other service offerings, we generally market using brand names, including ShiftWise^® and Medefis^TM for our VMS technology, Avantas^® for our clinical labor management services, Staff Care^®, Linde Healthcare^® and Locum Leaders^® for our locum tenens businesses, and Merritt Hawkins^® and Kendall & Davis^® for our physician permanent placement services. Each brand has a distinct clinician focus, market strength and brand reputation.

1

Competition

The healthcare recruitment and workforce solutions industry is highly competitive. We compete in national, regional and local markets for healthcare professionals, as well as healthcare facility clients. We believe that our value proposition is our quality and service excellence, our comprehensive suite of innovative workforce solutions that reduce complexity, drive efficiency, improve patient satisfaction and outcomes and provide an economic benefit, together with our execution capabilities, our national footprint and our access to a wide network of healthcare professionals. When recruiting for healthcare professionals, in addition to other recruitment and staffing firms, we also compete with hospital systems that have developed their own recruitment departments and interim staffing pools. We compete for healthcare professionals primarily based on customer service, recruitment and placement expertise, the quantity, diversity and quality of available assignments and placement opportunities, compensation packages and the benefits that we provide to them while they are on assignment.

We believe that our size, geographic scope and broad spectrum of workforce solutions give us distinct, scalable advantages over smaller, local and regional competitors and companies whose service offerings are not as robust. The breadth of our services allows us to provide even greater value through a more strategic, comprehensive and integrated approach to our clients. Larger firms also generally have a deeper, more comprehensive infrastructure with a more established operating model and processes that provide the long-term stability and foundation for quality standards recognition, such as the Joint Commission staffing agency certification and National Committee for Quality Assurance Credentials Verification Organization certification. We possess certifications from both Joint Commission and the National Committee for Quality Assurance. We believe a solid financial structure also provides us with an advantage as the provision of payroll and housing services are working capital intensive. With respect to our recruitment and placement businesses, we generally have access to a larger pool of available candidates than our competitors, substantial word-of-mouth referral networks and recognizable brand names, enabling us to attract a consistent flow of new applicants.

All of our business segments operate in highly competitive and fragmented markets. In the nurse and allied healthcare staffing business, we compete with a few national competitors together with numerous smaller, more regional and local companies, particularly in the per diem business. We believe we are one of the largest providers of nurse and allied healthcare staffing in the United States. Similarly, we believe we are one of the largest providers of locum tenens staffing services in the United States. The locum tenens staffing market consists of many small- to mid-sized companies with only a relatively small number of national competitors. The physician permanent placement services market is also highly fragmented and consists of many small- to mid-sized companies that do not have a national footprint. Our competitors vary by segment and include CHG Healthcare Services, Cross Country Healthcare, Maxim Healthcare, Jackson Healthcare, Parallon and MedAssets.

Demand and Supply Drivers

Demand Drivers

• Adoption of Outsourced Workforce Solutions. Healthcare organizations are increasingly seeking sophisticated, innovative and economically beneficial workforce solutions that improve patient outcomes. In 2014, approximately one-third of our consolidated revenues were generated through managed services provider relationships. We believe the prevalence of workforce solutions, such as MSP and VMS, in the healthcare industry is still underpenetrated in comparison with non-healthcare sectors, where average MSP and VMS penetration rates are greater than 60% according to the Staffing Industry Analysts 2014 Contingent Buyer Survey. The changes in reimbursement methodologies coupled with clinical labor representing a significant portion of a healthcare facility’s cost structure appear to be accelerating the adoption of strategic outsourced workforce solutions.

• Demographics and Advances in Medicine. We believe that the demand for both temporary and permanent healthcare professionals will increase as the United States population continues to age and medical technological advances result in longer life expectancy. According to the Bureau of Labor Statistics, the number of adults age 65 or older will grow an estimated 39% between 2010 and 2020. Adults age 65 or older are three times more likely to have a hospital stay, and visit physician offices twice as often, compared with the rest of the population.

• Physician and Nursing Shortage.While there are differing reports of the existence and extent of current and future healthcare professional shortages, many regions of the United States are experiencing a shortage of physicians and nurses that we believe will persist in the future. According to the Association of American Medical Colleges, the physician shortage is expected to grow to approximately 91,500 and 130,600 physicians in 2020 and 2025, respectively. In nursing, geographic and specialty-based shortages are also expected through 2025. The demand for our services is correlated with activity in the permanent labor market. When nurse vacancy rates increase, temporary nurse staffing

2

order levels typically increase as well. Factors that we believe are contributing to demand for our recruitment and placement services include:

— Aging of Physician and Nurse Population. According to the Association of American Medical Colleges, (1) in 2013 approximately 43% of active (i.e., licensed and working at least 20 hours per week) physicians in the United States were 55 years or older, and (2) nearly one-third of all physicians are expected to retire within the next ten years. The U.S. Department of Health and Human Services reported that nurses over the age of 50 comprised 45% of the total nurse population in 2008, compared with 33% in 2000. The National Council of State Boards of Nursing and The Forum of State Nursing Workforce Centers conducted a 2013 survey, which found that 55% of the registered nurse workforce was age 50 years or older.

— Shortage of Medical Schools. A shortage of qualified faculty and funding limits the availability of medical schools to prospective physicians. Some believe that the numbers of medical schools today may be insufficient to generate the number of physicians needed to address the current and projected shortage.

— Healthcare Professionals Leaving Patient Care Environments for Different Career Opportunities. Career opportunities for healthcare professionals have expanded beyond the traditional bedside role. Pharmaceutical companies, insurance companies, HMOs and hospital management, service and supply companies offer healthcare professionals attractive positions which involve work that may be perceived as more rewarding, and with increased compensation, less demanding work schedules and more varied career progression and opportunity.

— Physicians Leaving Private Practice Due to Burdens of Malpractice Insurance and Reimbursement. Physicians are concerned over reimbursement levels from insurance companies and government agencies and frustrated with claim billing requirements and paperwork. The cost of malpractice insurance is also considered a motivator for physicians to leave private practice.

• Increased Access to Healthcare Services. According to the Urban Institute, the number of uninsured adults decreased by 10.6 million between September 2013 and September 2014 due to uninsured citizens beginning to gain access to health insurance upon implementation of the Patient Protection and Affordable Care Act of 2010 (“PPACA”).

Supply Drivers

• Traditional Reasons for Healthcare Professionals to Work on a Temporary Assignment. Temporary assignments allow healthcare professionals to explore new areas of the United States, work at prestigious hospitals, learn new skills, manage work-life balance, earn supplemental income, build their resumes, try out different clinical settings, reduce administrative burdens, allow for a transitional period between permanent jobs and avoid unwanted workplace politics that may accompany a permanent position.

• Word-of-Mouth Referrals. New applicants are often referred to us by other healthcare professionals who have taken temporary assignments with or been placed in a permanent position by us or other staffing companies. The growth in the number of healthcare professionals who have worked on temporary assignments or have been placed in permanent positions, as well as growth in the number of hospital and healthcare facilities that have utilized our suite of solutions and services, creates more opportunities for referrals.

• Physicians May Choose Temporary Staffing Due to Increased Malpractice, Reimbursement and Collection Concerns. Locum tenens positions provide physicians the opportunity to practice medicine without undue concern for increased malpractice costs, government agency or private insurance reimbursement or collections administration.

3

• Nurses Choose Travel Staffing Due to the Nursing Shortage. In times of nursing shortages, permanent nurses are often required to assume greater responsibility and patient loads, work overtime and deal with increased pressures within the hospital. Many experienced nurses choose to leave their permanent employer and look for a more flexible and rewarding position. This may be offset in times of economic difficulties when general unemployment levels may reduce hospital attrition rates due to nurses or their spouses’ employment or job security concerns.

• Legislation Increasing Nurse Mobility. The Mutual Recognition Compact Legislation, promoted by the National Council of State Boards of Nursing, allows nurses to work more freely within states participating in the Compact Legislation without obtaining additional state licenses. As of December 31, 2014, twenty-four states had implemented the recognition legislation.

• Physicians Seeking Health System Employment. Physicians are increasingly seeking employment with health systems rather than their own practices to enhance their work-life balance and achieve a more consistent income level, which for some results in higher job satisfaction. Companies providing locum tenens and direct placement opportunities are an effective avenue for identifying compelling career options in health systems.

Business Strategy

The following components comprise the key elements of our business strategy to expand our position as the innovator in healthcare workforce solutions and staffing services in the United States.

• Deliver Differentiated Value and Innovation in Healthcare Workforce Solutions. We continually explore diversification into other healthcare workforce solutions, in addition to our current managed services programs, VMS, RPO, consulting, and staff scheduling services, so that we can better serve our clients’ workforce needs. We continue to look at expansion into other service offerings through both internal development and select acquisition opportunities. When considering any such expansion we analyze the following key criteria: (1) the needs of our clients; (2) alignment with our core expertise of recruitment, credentialing, and access to clinical labor; (3) strengthening and broadening of our client relationships; (4) reduction in exposure to economic cycles; (5) enhancement of our long-term sustainable, differentiated business model; and (6) return on invested capital.

• Strengthen and Expand Our Relationships with Hospitals and Healthcare Facilities. We continue to strengthen and expand our relationships with our current hospital and healthcare facility clients, while also developing new relationships. Many hospitals and healthcare facilities seek to fulfill their human capital needs through a strong business partner who can provide comprehensive workforce solutions, including the development of innovative strategies that are economically beneficial such as managed services programs, VMS and RPO. Over the past few years, hospitals and healthcare facilities have shown a preference for workforce solutions that provide efficiency by working with fewer vendors. For example, approximately one-third of our consolidated revenues flow through MSP relationships compared to approximately 1% in 2008. We believe that our execution capabilities and value proposition centered on quality, service excellence and a suite of solutions that reduce staffing complexity, drive efficiency and improve patient satisfaction and outcomes position us well to serve our clients’ needs today and in the future.

• Expand Our Network of Qualified Healthcare Professionals. Through our recruiting efforts, we continue to expand our network of qualified healthcare professionals and our breadth of specialties. We have made significant investments in innovative online recruitment, including social media and mobile technologies to increase the efficiency and effectiveness of our strategies to attract quality healthcare professionals. At the same time, we continue to build our supply of healthcare professionals through referrals from those who are currently working with, or have been placed by, us in the past.

• Leverage Our Business Model and Technology Infrastructure. We seek to increase our operational effectiveness, efficiency, scalability and agility through expansion of the service lines that we provide to each of our large base of hospital and healthcare facility clients, leveraging technology and innovative marketing and recruitment programs. We are making significant investments in our front and back office network applications as well as our technology infrastructure to help ensure we are able to achieve scale efficiencies, provide superior customer service and meet the current and future demands of our clients and our healthcare professionals.

• Connection through Innovative Technology. We continue to be an innovation leader in healthcare workforce solutions by providing online services and tools, including VMS and scheduling technology that utilizes predictive analysis, to our hospital and healthcare facility clients and our healthcare professionals. Through VMS, our hospital and healthcare facility clients streamline their communications and process flow to secure and

4

manage staffing services, access credential verification and schedule their workforce. Using our software as a service, or “SaaS” based scheduling technology, our clients can optimize and plan their clinical workforce to cost-effectively handle patient demand. Another online resource, The Service Connection, provides our healthcare professionals the ability to track assignment information and complete key forms electronically.

• Build the Strongest Team to Optimize Our Business Model. We continue to focus on training and professional development for all levels of management and staff and continue to hire skilled and experienced team members to deliver superior service to our hospital and healthcare facility clients and value to our shareholders. As an employer-of-choice, our differentiated employment value proposition is focused on fostering a values-driven culture, leader and co-worker quality, development and career opportunities, and a collegial work environment. During the first quarter of 2015 and for the third consecutive year, we were awarded a spot on Achievers’ 50 Most Engaged Workplaces™, which honors the top 50 employers in North America that are using leadership and innovation in engaging employees and making their workplaces more productive. We were also named one of the World’s Most Trustworthy Companies by Forbes magazine in 2014.

Business Overview

Services Provided

We conduct our business and provide our services through three reportable segments as set forth below.

Nurse and Allied Healthcare Staffing Segment

Through our nurse and allied healthcare staffing segment, we provide hospital and other healthcare facilities with a range of clinical workforce solutions, including (1) a comprehensive managed services workforce solution in which we can manage all of the contingent needs for a client; (2) a recruitment process outsourcing program that leverages our expertise and support systems to replace or complement a client’s existing internal recruitment function for permanent staffing needs; (3) a vendor management system delivered via a SaaS model; (4) traditional staffing service solutions of short- and long-term assignment lengths; and (5) clinical labor management services, including workforce consulting, data analytics, predictive modeling and SaaS-based scheduling technology through our newly acquired subsidiary, Avantas, LLC. We set forth our nurse and allied healthcare staffing segment’s revenue and operating income in “Item 8. Financial Statements and Supplementary Data—Notes to Consolidated Financial Statements—Note (1)(r).”

Nurses. We provide a wide range of nurse specialties and disciplines, most of whom are registered nurses, for temporary assignments throughout the United States. Assignments in acute-care hospitals, including teaching institutions, trauma centers and community hospitals comprise the majority of our assignments. The length of the assignment varies with a typical travel nurse assignment of 13 weeks. We also offer a shorter-term staffing solution of four to eight weeks under our NurseChoice^® brand to address hospitals’ urgent need for registered nurses. NurseChoice^® is targeted to recruit and staff nurses who can begin assignments within one to two weeks in acute-care facilities in contrast to the three to five week lead time that may be required for travel nurses. We also offer local staffing. Local staffing involves the placement of locally based healthcare professionals on daily shift work on an as-needed basis. Hospitals and healthcare facilities often give only a few hours notice of their local staffing assignments that require a turnaround from their staffing agencies of generally less than 24 hours. Nurses comprised approximately 85% of the total nurse and allied healthcare professionals working for us in 2014.

Allied Health Professionals. We provide allied health professionals under brands that include Med Travelers^®, Club Staffing^® and Rx Pro Health^® to acute-care hospitals and other healthcare facilities such as skilled nursing facilities, rehabilitation clinics, and retail and mail-order pharmacies. Allied health professionals include such disciplines as physical therapists, respiratory therapists, occupational therapists, medical and radiology technologists, speech pathologists, rehabilitation assistants, pharmacists and pharmacy technicians. Allied health professionals comprised approximately 15% of the total nurse and allied healthcare professionals working for us in 2014.

Locum Tenens Staffing Segment

Similar to our nurse and allied healthcare staffing segment, through our locum tenens staffing segment, we provide our clients with (1) managed services programs, (2) a VMS solution, and (3) traditional temporary staffing (“locum tenens”) services. We place as independent contractors physicians of all specialties, advanced practice clinicians and dentists on a locum tenens basis with all types of healthcare organizations throughout the United States, including hospitals, health systems, medical groups, occupational medical clinics, psychiatric facilities, government institutions and insurance companies. We recruit these professionals nationwide and typically place them on multi-week contracts with assignment lengths ranging from

5

a few days up to one year. We set forth our locum tenens staffing segment’s revenue and operating income in “Item 8. Financial Statements and Supplementary Data—Notes to Consolidated Financial Statements—Note (1)(r).”

Physician Permanent Placement Services Segment

We provide physician permanent placement services under our Merritt Hawkins^® and Kendall & Davis^® brands to hospitals, healthcare facilities and physician practice groups throughout the United States. Using a distinct consultative approach that we believe is more client-oriented, we perform the vast majority of our services on a retained basis through our Merritt Hawkins^® brand, for which we are generally paid through a blend of retained search fees and variable fees tied to work performed and successful placement. To a smaller degree, we also perform our services on a contingent basis exclusively through our Kendall & Davis^® brand, for which fees are paid once physician candidates are ultimately hired by our clients. Our broad specialty offerings include over 70 specialist and sub-specialist opportunities such as internal medicine, family practice and surgery. We set forth our physician permanent placement services segment’s revenue and operating income in “Item 8. Financial Statements and Supplementary Data—Notes to Consolidated Financial Statements—Note (1)(r).”

National Presence and Diversified Hospital and Healthcare Facility Client Base

We offer healthcare professionals placement opportunities and provide staffing solutions to our clients throughout the United States. During each of the past three years (1) we generated all of our revenue (other than a de minimus amount) in the United States and (2) all of our long-lived assets were located in the United States. We typically generate revenue in all 50 states. During 2014, the largest percentages of our revenue were concentrated in California, Texas and New York.

The majority of our temporary healthcare professional assignments are at acute-care hospitals. In addition to acute-care hospitals, we provide services to sub-acute healthcare facilities, physician groups, rehabilitation centers, dialysis clinics, pharmacies, home health service providers and ambulatory surgery centers. Our clients include Kaiser Foundation Hospitals, New York Presbyterian Health System, MedStar Health, HCA, NYU Medical Center, Stanford Hospital and Clinics, UCLA Medical Center and Johns Hopkins Health System. Kaiser Foundation Hospitals (and its affiliates) to whom we provide clinical and non-clinical managed services comprised approximately 10% of our consolidated revenue and 15% of our nursing and allied healthcare staffing segment’s revenue for the year ended December 31, 2014. No other client healthcare system comprised more than 10% of our consolidated revenue and no single client facility comprised more than 3% of our consolidated revenue for the year ended December 31, 2014. Our success in winning MSP contracts means some larger health systems have grown and may continue to grow substantially relative to our other revenue sources. The dynamics could lead to a greater client concentration than that which we have historically experienced.

Our Business Model

We have developed and continually refine our business model to achieve greater levels of productivity and service delivery efficiency. We seek to optimize the communication with, and service to, our healthcare professionals and entities in which these healthcare professionals are placed.

Marketing and Recruitment of New Healthcare Professionals

We believe that we attract healthcare professionals because of our customer service and relationship-oriented approach, our competitive compensation and benefits package, and our large and diverse offering of work assignments that provide the opportunity to work at numerous attractive locations throughout the United States. We believe that our multi-brand recruiting strategy makes us more effective at reaching a larger number of healthcare professionals, while still leveraging operational efficiencies.

In our effort to attract and retain highly qualified healthcare professionals, we offer an attractive package of benefits, which may include competitive compensation, professional development opportunities, professional liability insurance, 401(k) plan and health insurance. In addition, we may provide reimbursements for meals and incidentals, travel and housing, or we may provide company housing if they elect not to receive reimbursement.

Screening, Licensing and Quality Management

We design our internal processes to ensure that the healthcare professionals that we directly place with clients have the appropriate experience, credentials and skills. When placed on assignment, we continue to evaluate our healthcare professionals to ensure adequate performance and manage risk, as well as to determine feasibility for future placements. To a certain extent, we utilize subcontractors for placement of temporary healthcare professionals in our managed services programs, and the subcontractor agencies are responsible for the screening, licensing and privileging of these temporary healthcare professionals.

6

Our experience has shown us that well-matched placements result in more satisfied healthcare professionals, healthcare facility clients and patients.

Placement

Through our nurse and allied healthcare staffing segment, we provide acute-care systems as well as other healthcare facilities with a range of clinical workforce management and staffing solutions. These offerings include a comprehensive managed services workforce solution in which we can manage all of the temporary staffing needs for a client, a recruitment process outsourcing service that leverages our expertise and support systems to replace or complement our client’s existing internal recruitment function for permanent staffing needs, VMS technology delivered through a SaaS model, and more traditional staffing service solutions of short- and long-term assignment lengths. Under our national sales approach, staffing orders are available to the recruiters at all of our recruitment brands.

Our locum tenens staffing and physician permanent placement services segments generate nationwide orders for both temporary physicians and permanent physician placement. Our recruiters utilize our extensive database and our proven processes to fill permanent physician orders and schedule temporary physician assignments.

Client Billing

We bill our clients for the temporary healthcare professionals on assignment based on hours and days worked. The clinician is our employee for payroll and benefits purposes and the locum tenens provider is an independent contractor, typically paid directly by us on behalf of our clients. We bill our clients at an hourly or daily rate that effectively includes reimbursement for recruitment fees, compensation and, for our employed temporary healthcare professionals, any benefits and any applicable employer taxes. Housing, travel expenses, and meals and incidentals, if applicable, are either included in the hourly/daily rate or billed separately.

For our physician permanent placement services, we typically bill clients for a search initiation fee, hours worked and expenses on the search engagement and a non-refundable placement fee once the placement occurs.

Technology and Information Systems

Our technology infrastructure and systems are essential to the operation of our business and achievement of our strategic and financial goals. Over the past three years, we have invested in our digital presence on websites, social media and mobile applications focused on lead management and recruitment. In addition, we are in the third year of a multi-year investment in the modernization of our front office, back office and infrastructure domains primarily through the updating and expansion of our utilization of established commercially available platforms including PeopleSoft and Salesforce.com. We will continue to develop and maintain proprietary technology in areas in which we can differentiate our service offerings for our innovative workforce solutions such as VMS and workforce optimization platforms.

Risk Management

We have developed an integrated risk management program that focuses on loss analysis, education and assessment in an effort to reduce our operational costs and risk exposure. We regularly analyze our losses on professional liability claims and workers compensation claims to identify trends. This allows us to focus our resources on those areas that may have the greatest impact on us, price our services appropriately and adjust our sales and operational approach in these areas. We have also developed educational materials for distribution to our employed healthcare professionals to address specific work-injury risks and documentation of clinical events.

In addition to our proactive measures, we engage in a review process for incidents involving our healthcare professionals. Upon notification of a healthcare professional’s involvement in an incident that may result in liability for us, we review his or her actions and make a prompt determination regarding whether he or she will continue the assignment and whether we will place him or her on future assignments. We also rely on our hospital and healthcare facility clients’ assessments, national database information and the state professional associations’ investigations of incidents involving our healthcare professionals in determining continued and future assignments.

7

Regulation

The healthcare industry is subject to extensive and complex federal and state laws and regulations related to professional licensure, conduct of operations, payment for services and payment for referrals. We provide services to our clients on a contract basis and receive payment directly from them. Accordingly, Medicare, Medicaid and managed care reimbursement policies generally do not affect us directly, though reimbursement changes in government programs, particularly Medicare and Medicaid, can and do indirectly affect our business. We continuously monitor legislation and regulatory changes for their potential effect on our business and allocate or redirect resources accordingly.

Some states require state licensure for businesses that employ, assign and/or place healthcare personnel who provide healthcare services at hospitals and other healthcare facilities. We believe we are currently licensed in all states that require such licenses and take measures to ensure compliance with all material state licensure requirements. Our travel nurse and allied healthcare staffing divisions, as well as our largest locum tenens brand, Staff Care^®, and 25 of our local staffing offices have all received Joint Commission certification. AMN Healthcare has also obtained its Credentials Verification Organization certification from the National Committee for Quality Assurance.

Most of the healthcare professionals that we employ or independently contract with are required to be individually licensed or certified under applicable state laws. We believe we take appropriate and reasonable steps to validate that our healthcare professionals possess all necessary licenses and certifications.

Employees

As of December 31, 2014, we had approximately 1,800 corporate employees. During the fourth quarter of 2014, we had an average of 6,030 nurses, allied and other clinical healthcare professionals contracted to work for us. This does not include our locum tenens, all of whom are independent contractors and not employees.

Additional Information

We incorporated in the state of Delaware on November 10, 1997. We maintain a corporate website at www.amnhealthcare.com. We make available our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to these reports, as well as proxy statements and other information free of charge through our website as soon as reasonably practicable after being filed with or furnished to the Securities and Exchange Commission (“SEC”). The information found on our website is not part of this Annual Report on Form 10-K or any other report we file with or furnish to the SEC.

Special Note Regarding Forward-Looking Statements

This Annual Report on Form 10-K, including the section entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that are subject to safe harbors under the Securities Act and the Exchange Act. We base these forward-looking statements on our current expectations, estimates, forecasts and projections about future events and the industry in which we operate. Forward-looking statements are identified by words such as “believe,” “anticipate,” “expect,” “intend,” “plan,” “will,” “should,” “would,” “project,” “may,” variations of such words and other similar expressions. In addition, statements that refer to projections of financial items; anticipated growth; future growth and revenue; future economic conditions and performance; plans, objectives and strategies for future operations; and other characterizations of future events or circumstances, are forward-looking statements. Our actual results could differ materially from those discussed in, or implied by, these forward-looking statements. Factors that could cause actual results to differ from those implied by the forward-looking statements in this Annual Report on Form 10-K are described below, elsewhere in this Annual Report on Form 10-K and our other filings with the SEC.

Item 1A. Risk Factors

You should carefully read the following risk factors in connection with evaluating us and the forward-looking statements contained in this Annual Report on Form 10-K. Any of the following risks could materially adversely affect our business or our consolidated operating results, financial condition and cash flows, which, in turn, could cause the price of our common stock to decline. The risk factors described below and elsewhere in this Annual Report on Form 10-K are not the only risks we face. Factors we currently do not know, factors that we currently consider immaterial or factors that are not specific to us, such as general economic conditions, may also materially adversely affect our business or our consolidated operating results, financial

8

condition or cash flows. The risk factors described below qualify all forward-looking statements we make, including forward-looking statements within this section entitled “Risk Factors.”

Risk Factors that May Affect the Demand for Our Services

Economic downturns and slow recoveries could result in less demand from clients or otherwise negatively affect our clients, either of which could negatively impactour financial condition, results of operations and cash flows.

Demand for staffing services is sensitive to changes in economic activity. As economic activity slows, hospitals and other healthcare entities typically experience decreased attrition and reduce their use of temporary employees before undertaking layoffs of their regular employees, which results in decreased demand for our services. In times of economic downturn and high unemployment rates, permanent full time and part time healthcare facility staff are generally inclined to work more hours and overtime, resulting in fewer available vacancies and less demand for our services. Fewer placement opportunities for our temporary clinicians and physicians also impair our ability to recruit and place them both on a temporary and permanent basis.

Many healthcare facilities utilize temporary healthcare professionals to accommodate an increase in hospital admissions. Alternatively, when hospital admissions decrease, due to reduced consumer spending, general unemployment causing an increase in under- and uninsured patients and other factors, the demand for our temporary healthcare professionals typically declines. This may have an even greater negative impact on demand for physicians in certain specialties such as surgery, radiology and anesthesiology. In addition, we may experience more competitive pricing pressure during periods of decreased patient occupancy and hospital admissions, negatively affecting our revenue and profitability.

During challenging economic times, our clients, in particular our clients that rely on state government funding, may face issues gaining access to sufficient credit, which could result in an impairment of their ability to make payments to us, timely or otherwise, for services rendered. If that were to occur, we may increase our allowance for doubtful accounts and our days sales outstanding would be negatively affected.

Our business depends upon our ability to maintain existing and secure new contracts directly with our clients and through group purchasing organizations.

Outside of our managed services and VMS offerings, our hospital, healthcare facility and physician practice group clients are generally free to award contracts to and place orders and new searches with our competitors. Our clients may purchase these services directly or through group purchasing organizations with whom we must establish relationships in order to continue to provide our staffing services to our healthcare facility clients.

In addition, we provide services to some of our government clients through businesses such as small businesses or minority-owned contractors who have received set-aside awards. These intermediary organizations may negatively affect our ability to obtain new clients and maintain our existing client relationships by impeding our ability to access and contract directly with clients and may also negatively affect the profitability of these client relationships.

Consolidation and concentration in buyers of healthcare workforce solutions and staffing services could negatively affect pricing of our services and our ability to mitigate credit risk.

We extend credit and payment terms to our clients. In addition to ongoing credit evaluations of our clients’ financial condition, we traditionally seek to mitigate our credit risk by managing client concentration. We have seen an increase in our clients’ use of intermediaries such as vendor management service companies and group purchasing organizations as well as consolidation of healthcare systems, which may provide these organizations enhanced bargaining power. At the same time, our own success in winning managed services contracts means some larger health systems have grown and may continue to grow substantially relative to our other revenue sources. These dynamics could lead to a greater concentration of buyers of healthcare staffing services and less diversification of our customer base, which could negatively affect pricing for our services and our ability to mitigate credit risk.

One of our clients within our nurse and allied healthcare staffing segment comprised approximately 10% of our consolidated revenue in 2014. If we were to lose that client and were unable to provide a significant amount of services to that client, whether directly or as a subcontractor, such loss may have a material adverse effect on our revenue, results of operations and cash flows.

9

If we are unable to anticipate and quickly respond to changing marketplace conditions, such as alternative modes of healthcare delivery, reimbursement and client needs, we may not remain competitive.

The settings for the delivery of patient services continually evolve and implicate alternative modes of healthcare delivery, such as telemedicine. Government mandates, third-party reimbursements and the public’s adoption and demand for such new modes of healthcare delivery may negatively affect our clients’ demand for our services, which, in turn, could negatively affect our revenue, results of operations and cash flows.

Our success depends upon our ability to develop innovative workforce solutions and quickly adapt to changing marketplace conditions and client needs. The success of new service lines and business models will depend on many factors, including our ability to properly anticipate and satisfy client needs, quickly come into compliance with new federal or state regulations, and differentiate our services and abilities from those of our competitors. Moreover, our competition may respond more quickly to new or emerging client needs and marketplace conditions. The development of these service lines and business models requires close attention to emerging trends and proposed federal and state legislation related to the healthcare industry. If we are unable to anticipate changing marketplace conditions, adapt our current business model to adequately meet changing conditions in the healthcare industry and develop and successfully implement innovative services, we may not remain competitive.

The ability of our clients to retain and increase the productivity of their permanent staff or their ability to increase the efficiency and effectiveness of their internal recruiting efforts, through online recruiting or otherwise, may affect the demand for our services, which could negatively affect our revenue, results of operation and cash flows.

If our clients retain and increase the productivity of their permanent clinical staff, their need for our recruitment and placement services for temporary positions may decline. Higher permanent staff retention rates and increased productivity of permanent staff members could result in increased efficiencies, thereby reducing the demand for both our recruitment and placement services for temporary positions, which could negatively affect our revenue, results of operation and cash flows. Additionally, many of our clients maintain internal recruitment functions of various degrees of sophistication for their staffing needs, including utilization of online recruitment technologies. If such clients are able to successfully increase the efficiency and effectiveness of their internal recruiting efforts, through more effective internet- or social media-based recruiting or otherwise, it could reduce the demand for our permanent and temporary staffing services, which could negatively affect our revenue, results of operation and cash flows.

Regulatory and Legal Risk Factors

We are subject to federal and state healthcare industry regulation including conduct of operations, and costs and payment for services and payment for referrals as well as laws regarding employment practices and government contracting.

The healthcare industry is subject to extensive and complex federal and state laws and regulations related to conduct of operations, costs and payment for services and payment for referrals. We provide workforce solutions and services on a contract basis to our clients, who pay us directly. Accordingly, Medicare, Medicaid and insurance reimbursement policy changes generally do not directly impact us. Nevertheless, reimbursement changes in government programs, particularly Medicare and Medicaid, can and do indirectly affect the demand and the prices paid for our services. For example, our clients could receive reduced or no reimbursements because of a change in the rates or conditions set by federal or state governments, which would negatively affect the demand and the prices for our services. In addition, our hospital, healthcare facility and physician practice group clients could suffer civil and criminal penalties, and be excluded from participating in Medicare, Medicaid and other healthcare programs for failure to comply with applicable laws and regulations, which may negatively affect our profitability.

A significant portion of our hospital and healthcare facility clients are state and federal government agencies, where our ability to compete for new contracts and orders, and the profitability of these contracts and orders, may be affected by government legislation, regulation or policy. Additionally, in providing services to state and federal government clients and to clients who participate in state and federal programs, we are also subject to specific laws and regulations, which government agencies have broad latitude to enforce. If we were to be excluded from participation in these programs or should there be regulatory or policy changes or modification of application of existing regulations, it would likely materially adversely affect our business and our consolidated operating results, financial condition and cash flows.

The success of our business depends on our ability to quickly and efficiently assist in obtaining licenses and privileges for our healthcare professionals. The costs to provide these credentialing services impact the revenue and profitability of our business.

10

We are also subject to certain laws and regulations applicable to recruitment and placement agencies. Like all employers, we must also comply with various laws and regulations relating to employment and pay practices. There is a risk that we could be subject to payment of additional wages, insurance and employment and payroll-related taxes. Because of the nature of our business, the impact of these employment and payroll laws and regulations may have a more pronounced effect on our business. These laws and regulations may also impede our ability to grow the size and profitability of our operations.

Legislation regarding the current delivery and third-party payor system for healthcare may have significant and unforeseeable effects on our business.

The PPACA was signed into law on March 23, 2010. The PPACA was subsequently amended on March 30, 2010 by the Reconciliation Act. The PPACA and Reconciliation Act (collectively, the “Act”) entail sweeping health care reforms with staggered effective dates from 2010 through 2018, and many provisions in the Act require the issuance of additional guidance from the U.S. Department of Labor, the IRS, the U.S. Department of Health & Human Services, and the states. As the various provisions of the Act are implemented, the insurance market place and how employers provide insurance to employees is changing causing uncertainty for our clients and us. In addition, the shifting political landscape and commentary surrounding the Act provide increased uncertainty and the way in which the PPACA is ultimately implemented may have unforeseen effects on our clients and us.

The challenge to the classification of certain of our healthcare professionals as independent contractors could adversely affect our profitability.

We treat physicians and certain advanced practitioners, such as certified nurse anesthetists, nurse practitioners and physician assistants, as independent contractors. Federal or state taxing authorities may take the position that such professionals are employees exposing us to additional wage and insurance claims, and employment and payroll-related taxes. A reclassification of our locum tenens clinicians and physicians to employees from independent contractors could result in liability that would have a significant negative impact on the profitability of the period in which assessed, and would require changes to our payroll and related business processes, which could be costly. In addition, many states have laws that prohibit non-physician owned companies from employing physicians, referred to as the “corporate practice of medicine.” If our independent contractor physicians were classified as employees in states that prohibit the corporate practice of medicine, we may be prohibited from conducting our locum tenens staffing business in those states under our current business model, which may have a substantial negative effect on our revenue, results of operations and profitability.

Medical malpractice, violation of employment and wage regulations and other claims asserted against us could subject us to substantial liabilities.

We, along with our clients and healthcare professionals, are subject to investigations, claims and legal actions alleging malpractice or related legal theories. At times, plaintiffs name us in these lawsuits and actions regardless of our contractual obligations, the competency of the healthcare professionals, the standard of care provided by the healthcare professionals, the quality of service that we provided or our actions. In certain instances, we are contractually required to indemnify our clients against some or all of these potential legal actions. Additionally, we may be subject to various employment claims, including wage and hour claims, by our corporate employees and our employed healthcare professionals. We are also subject to possible claims alleging discrimination, sexual harassment and other similar activities in which we or our hospital and healthcare facility clients and their agents have allegedly engaged.

The nature of our business requires us to place our personnel in the workplaces of other businesses. Many of these individuals have access to client proprietary information systems and confidential information. An inherent risk of such activity includes possible claims of intentional misconduct, release, misuse or misappropriation of client intellectual property, confidential information, funds, or other property, cybersecurity breaches affecting our clients or us, criminal activity, torts or other claims. Such claims may result in negative publicity, injunctive relief, criminal investigations or charges, civil litigation, payment by us of monetary damages or fines, or other material adverse effects on our business.

We maintain various types of insurance coverage, including professional liability and employment practices, through commercial insurance carriers and a wholly-owned captive insurance company, and we self-insure for many of these types of claims through accruals for retention reserves. However, the cost of defending such claims, even if groundless, could be substantial and the associated negative publicity could adversely affect our ability to attract, retain and place qualified employees and healthcare professionals in the future. We may also experience increased insurance costs and reserve accruals and may not be able to pass on all or any portion of increased insurance costs to our clients, thereby reducing our profitability. Moreover, our insurance coverage and reserve accruals may not be sufficient to cover all claims against us.

11

We are also subject to exam from various federal and state taxation authorities from time to time and an unforeseen negative outcome from such an exam could have a negative impact on our financial position, results of operations and cash flow.

Our inability to safely secure private information could subject us to substantial liabilities.

We collect, retain and have access to personal information, personal health information and other protected information. The collection, use and maintenance of personal and health information is subject to numerous federal and state laws and regulations. We use software systems, security controls and business controls to limit access to the information and the inadvertent release of the information. However, private information may be accessed or released intentionally or unintentionally, resulting in a breach of privacy. A breach in privacy may require notifications and system changes and also subject us to certain fines, sanctions and legal actions, any or all of which may be costly. In addition, such a breach may cause reputational damage that could significantly impair our relationship with our clients and healthcare professionals.

Risk Factors Related to Our Operations, Personnel and Information Systems

Our inability to implement new infrastructure and technology systems may adversely affect our operating results and ability to manage our business effectively.

We have technology, operations and human capital infrastructures to support our existing business. We must continue to invest in these infrastructures including implementing new operating and front and back office technology systems to support our growth and improve our efficiency, and we have embarked on a multi-year plan to upgrade and convert our infrastructure, back office and front office network platforms. Implementing new systems is costly and involves risks inherent in the conversion to a new technology platform, including loss of information, disruption to our normal operations, changes in accounting procedures and internal control over financial reporting, as well as problems achieving accuracy in the conversion of electronic data. Failure to properly or adequately address these issues could result in increased costs, the diversion of management’s and employees’ attention and resources and could materially adversely affect our operating results, internal controls over financial reporting and ability to manage our business effectively.

Technology disruptions and obsolescence may negatively affect our business operations.

Our ability to deliver services to our clients and to manage our internal systems depends largely upon our access to and the performance of our management information and communications systems, including our VMS and other client/healthcare professional-facing self-service websites. These technology systems also maintain accounting and financial information upon which we depend to fulfill our financial reporting obligations. Although we have risk mitigation measures, these systems, and our access to these systems, are not impervious to floods, fire, storms, or other natural disasters, or service interruptions. There also is a potential for intentional and deliberate attacks to our systems, which may lead to service interruptions, data corruption or data theft. Additionally, these systems are subject to other non-environmental risks, including technological obsolescence and lack of strategic alignment with our evolving business. We have embarked on a multi-year plan to update and align our technology with our current and future business needs. If our current or planned systems do not adequately support our operations, are damaged or disrupted or if we are unable to replace, repair, maintain or expand them, it may adversely affect our business operations and our profitability.

If we do not continue to recruit and retain sufficient quality healthcare professionals at reasonable costs, it could increase our operating costs and negatively affect our business and our profitability.

We rely significantly on our ability to recruit and retain a sufficient number of healthcare professionals who possess the skills, experience and licenses necessary to meet the requirements of our clients. We compete with healthcare staffing companies, recruitment and placement agencies, including online staffing and recruitment agencies, and with hospitals, healthcare facilities and physician practice groups to attract healthcare professionals based on the quantity, diversity and quality of assignments offered, compensation packages and the benefits that we provide. We rely on our human capital intensive, relationship-oriented approach and national infrastructure to enable us to compete in all aspects of our business, but particularly in the physician permanent placement business. We must continually evaluate and expand our temporary and permanent healthcare professional network to serve the needs of our clients.

Our ability to recruit and retain temporary and permanent healthcare professionals depends on several factors, including our ability to provide our healthcare professionals with assignments and placements that they view as attractive and to provide competitive compensation packages. The costs of attracting healthcare professionals and providing them with attractive compensation packages may be higher than we anticipate, or we may be unable to pass these costs on to our hospital and

12

healthcare facility clients, which may reduce our profitability. Moreover, if we are unable to recruit temporary and permanent healthcare professionals, our service execution may deteriorate and, as a result, we could lose clients.

The inability to properly screen and match quality healthcare professionals with suitable placements may negatively affect demand for our services.

Our success depends on the quality of our healthcare professionals. A quality or licensure issue could adversely affect our business, client demand for our services, and potential for growth. Our ability to ensure the quality of our healthcare professionals relies heavily on the effectiveness of our data and communication systems as well as properly trained and competent operational employees that screen and match healthcare professionals in suitable placements. An inability to properly screen, match, and monitor healthcare professionals for acceptable credentials, experience, and performance may cause clients to lose confidence in our services, which may damage our reputation and result in clients opting to utilize competitors’ services or rely on their own internal resources.

Our operations may deteriorate if we are unable to continue to attract, develop and retain our sales and operations team members.

Our success depends heavily upon the performance of our sales and operations team members. The number of individuals who meet our qualifications for these positions is limited, and we may experience difficulty in attracting qualified candidates. In addition, we commit substantial resources to the training, development and support of our team members. Competition for qualified sales team members in the line of business in which we operate is strong, and we may not be able to retain some of our sales team members after we have expended the time and expense to recruit and train them.

The loss of key officers and management personnel could adversely affect our business and operating results.

We believe that the success of our business strategy and our ability to maintain our recent levels of profitability depends on the continued employment of our senior management team. We have an employment agreement with Susan R. Salka, our President and Chief Executive Officer, through May 4, 2016, which is renewable on an annual basis. Other senior members of the team are employees at will with standard severance agreements. If members of our senior management team become unable or unwilling to continue in their present positions, our business and financial results could be adversely affected.

Our inability to maintain our positive brand awareness and identity may adversely affect our results of operations.

We have invested substantial amounts in acquiring, developing and maintaining our brands, and our success depends substantially on our ability to maintain positive brand awareness identities for existing services and effectively building up brand awareness and image for new services. We cannot assure that additional expenditures and our continuing commitment to marketing and improving our brands will have the desired effect on our brands’ value, which may adversely affect our results of operations. In addition, our brands may suffer reputational damage that could negatively affect our short- and long-term financial results.

Our inability to effectively incorporate acquisitions into our business operations may adversely affect our results of operations.

We invest time and resources in carefully assessing opportunities for acquisitions, and made acquisitions in 2013, 2014 and early 2015 to broaden the scope and depth of our workforce solutions and bolster our staffing services. Despite diligence and integration planning, acquisitions still present certain risks, including the time and economic costs of integrating an acquisition’s technology, control and financial systems, unforeseen liabilities, and the difficulties in bringing together different work cultures and personnel. Difficulties in integrating our acquisitions may adversely affect our results of operations.

We maintain a substantial amount of goodwill and indefinite-lived intangibles on our balance sheet that may decrease our earnings or increase our losses if we recognize an impairment to goodwill or indefinite-lived intangibles.

We maintain goodwill on our balance sheet, which represents the excess of the total purchase price of our acquisitions over the fair value of the net assets and indefinite-lived intangibles we acquired. We evaluate goodwill and indefinite-lived intangibles for impairment annually, or when evidence of potential impairment exists. If we identify an impairment, we record a charge to earnings. An impairment charge to goodwill or indefinite-lived intangibles would decrease our earnings or increase our losses, as the case may be, which may adversely affect the price of our common stock.

13

Risk Factors Related to Our Indebtedness and Other Liabilities

We have substantial tax and insurance-related accruals on our balance sheet, and any significant adverse adjustments in these accruals may decrease our earnings or increase our losses and negatively impact our cash flow.

We maintain accruals related to our captive insurance company for professional liability and employment practices, and self-insured retention accruals for our health insurance, workers compensation and employment practices related matters on our balance sheet. A significant increase to these accruals may decrease our earnings. We determine the adequacy of our accruals by evaluating our historical experience and trends, related to both insurance claims and payments, information provided to us by our insurance brokers, attorneys, third-party administrators, actuarial firms and tax advisors as well as industry experience and trends. If such information collectively indicates that our accruals are overstated or understated, we reduce or provide for additional accruals, as appropriate.

In addition, we maintain an unrecognized tax benefits accrual related to certain income tax positions that we have taken. As of December 31, 2014, the unrecognized tax benefits including interest and penalties was $28.7 million. Adjustments in the amount or nature of accruals for tax matters may negatively impact our financial results and our cash flow, if there are payments to governmental agencies associated with these tax positions.

Our level of indebtedness could adversely affect our future financial condition.

We are party to a credit agreement, which contains various financial covenants, restricts the payment of dividends, and limits the amount of repurchases of our common stock. As of December 31, 2014, our total debt outstanding equaled $162.4 million.

Our indebtedness could have a material adverse effect on our financial condition by, among other things:

• increasing our vulnerability to a downturn in general economic conditions or to increases in interest rates, particularly with respect to the portion of our outstanding debt that is subject to variable interest rates;

• potentially limiting our ability to obtain additional financing or to obtain such financing on favorable terms;

• causing us to dedicate a portion of future cash flow from operations to service or pay down our debt, which reduces the cash available for other purposes, such as operations, capital expenditures, and future business opportunities; and

• possibly limiting our ability to adjust to changing market conditions and placing us at a competitive disadvantage compared to our competitors who may be less leveraged.

Our ability to service our indebtedness will depend on our ability to generate cash in the future. We cannot assure you that our business will generate sufficient cash flow from operations or that future borrowings will be available in an amount sufficient to enable us to service our indebtedness or to fund other liquidity needs. Additionally, if we are not in compliance with the covenants in our credit agreement, we would be in default, and the lenders could call the debt, which would have a material adverse effect on our business.

Item 1B. Unresolved Staff Comments

None.

Item 2.    Properties

We lease all of our properties, which consist of office-type facilities. We believe that our leased space is adequate for our current needs and that we can obtain adequate space to meet our foreseeable business needs. We have pledged substantially all of our leasehold interests to our lenders under our credit agreement to secure our obligations thereunder. We set forth below our principal leased office spaces as of December 31, 2014 together with our business segments that utilize them:

Location	Square Feet
San Diego, California (corporate headquarters and all segments)	175,672
Irving, Texas (all segments)	93,400

Item 3. Legal Proceedings

We are subject to various claims and legal actions in the ordinary course of our business. Some of these matters relate to professional liability, tax, payroll, contract and employee-related matters and include individual and collective lawsuits, as well as inquiries and investigations by governmental agencies regarding our employment practices. We currently are not aware of any pending or threatened litigation that we believe is reasonably possible to have a material adverse effect on our results of operations, financial position or liquidity.

Additionally, some of our clients may also become subject to claims, governmental inquiries and investigations and legal actions relating to services provided by our healthcare professionals. From time to time, and depending upon the particular facts and circumstances, we may be subject to indemnification claims under our contracts with such clients relating to these matters.

Item 4. Mine Safety Disclosures

Not applicable.

14

PART II

Item 5. Market For Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Our common stock trades on the New York Stock Exchange under the symbol “AHS.” The last reported sale of our common stock on February 20, 2015 on the New York Stock Exchange was $22.51 per share. The following table sets forth, for the periods indicated, the high and low sales prices reported by the New York Stock Exchange.

	Sales Price
	High		Low
Year Ended December 31, 2013
First Quarter	$	15.94	$	10.34
Second Quarter	$	15.91	$	12.29
Third Quarter	$	16.20	$	13.50
Fourth Quarter	$	14.88	$	11.30
Year Ended December 31, 2014
First Quarter	$	15.45	$	13.30
Second Quarter	$	14.36	$	10.35
Third Quarter	$	16.31	$	11.96
Fourth Quarter	$	20.33	$	15.04

During the quarter ended December 31, 2014, neither we nor any “affiliated purchaser” on our behalf repurchased any shares of our common stock. During the fiscal year ended December 31, 2014, we did not sell any equity securities that were not registered under the Securities Act.

As of February 20, 2015, there were 25 stockholders of record of our common stock, one of which was Cede & Co., a nominee for The Depository Trust Company. All of our common stock held by brokerage firms, banks and other financial institutions as nominees for beneficial owners are considered to be held of record by Cede & Co., which is considered to be one stockholder of record. A substantially greater number of holders of our common stock are “street name” or beneficial holders, whose shares are held of record by banks, brokers and other financial institutions. Because such shares are held on behalf of stockholders, and not by the stockholders directly, and because a stockholder can have multiple positions with different brokerage firms, banks and other financial institutions, we are unable to determine the total number of stockholders we have without undue burden and expense.

We have not paid any dividends on our common stock in the past and currently do not expect to pay cash dividends or make any other distributions on common stock in the future. We expect to retain our future earnings, if any, for use in the operation and expansion of our business and to pay down debt. Any future determination to pay dividends on common stock will be at the discretion of our board of directors and will depend upon our financial condition, results of operations, capital requirements and such other factors as the board deems relevant. In addition, our ability to declare and pay dividends on our common stock is subject to covenants restricting such actions in our credit agreement. See “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources.”

The information required by Item 201(d) of Regulation S-K is incorporated by reference to the table set forth in Part III, Item 12 entitled “Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters” below.

15

Performance Graph

This performance graph shall not be deemed “filed” with the SEC or subject to Section 18 of the Exchange Act, nor shall it be deemed incorporated by reference in any of our filings under the Exchange Act or the Securities Act.

The graph below compares the total stockholder return on our common stock with the total stockholder return of (i) the NYSE Composite Index, and (ii) the Dow Jones US Business Training & Employment Agencies Index (“BTEA”), assuming an investment of $100 on December 31, 2009 in our common stock, the stocks comprising the NYSE Composite Index, and the stocks comprising the BTEA.

	12/31/09	12/31/10	12/31/11	12/31/12	12/31/13	12/31/14
AMN Healthcare Services, Inc.	100.00	67.77	48.90	127.48	162.25	216.34
NYSE Composite	100.00	113.39	109.04	126.47	159.71	170.49
BTEA	100.00	120.44	79.24	89.57	150.44	158.06

16

Item 6. Selected Financial Data

You should read the selected financial and operating data presented below in conjunction with “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Item 8. Financial Statements and Supplementary Data” below. We derive our statements of operations data for the years ended December 31, 2014, 2013 and 2012, and the balance sheet data at December 31, 2014 and 2013 from the audited financial statements included elsewhere in this Annual Report on Form 10-K. We derive the statements of operations data for the years ended December 31, 2011 and 2010 and the balance sheet data at December 31, 2012, 2011 and 2010 from audited financial statements of ours that do not appear herein.

We completed our acquisition of NF Investors, Inc., a Delaware corporation (“NFI”), on September 1, 2010. Accordingly, the consolidated statement of operations for the year ended December 31, 2010 includes the result of operations of NFI since the date of acquisition. Our acquisition of NFI in September 2010 affects the comparability of the selected financial data of the pre-acquisition time period and post-acquisition time period.

During the fourth quarter of 2011, we decided to divest our home healthcare services segment. Accordingly, we classify the home healthcare services segment as a disposal group held for sale as of December 31, 2011 and its results of operations as discontinued operations for the years ended December 31, 2012, 2011 and 2010, the only three years in which we maintained a home healthcare services segment. We completed the sale of this segment in January 2012.

We completed our acquisition of ShiftWise on November 20, 2013. Accordingly, the consolidated statement of operations for the year ended December 31, 2013 includes the result of operations of ShiftWise since the date of acquisition. Our acquisition of ShiftWise in November 2013 affects the comparability of the selected financial data of the pre-acquisition time period and post-acquisition time period.

We completed our acquisition of Avantas on December 22, 2014. Accordingly, the consolidated statement of operations for the year ended December 31, 2014 includes the result of operations of Avantas since the date of acquisition.

We have not paid any cash dividends during the past five fiscal years.

17

	Fiscal Years Ended December 31,
	2014		2013		2012		2011			2010
	( in thousands, except per share data)
Consolidated Statements of Operations:
Revenue	$	1,036,027	$	1,011,816	$	953,951	$	887,466		$	669,912
Cost of revenue	719,910		714,536		683,554		638,147			485,550
Gross profit	316,117		297,280		270,397		249,319			184,362
Operating expenses:
Selling, general and administrative	232,221		218,233		202,904		195,348			162,543
Depreciation and amortization	15,993		13,545		14,151		16,324			14,764
Impairment charges	—		—		—		—			50,832
Total operating expenses	248,214		231,778		217,055		211,672			228,139
Income (loss) from operations	67,903		65,502		53,342		37,647			(43,777		)
Interest expense, net, and other	9,237		9,665		26,019		23,727			19,762
Income (loss) from continuing operations before income taxes	58,666		55,837		27,323		13,920			(63,539		)
Income tax expense (benefit)	25,449		22,904		11,010		8,904			(10,787		)
Income (loss) from continuing operations	33,217		32,933		16,313		5,016			(52,752		)
Income (loss) from discontinued operations, net of tax	—		—		823		(31,281		)	761
Net income (loss)	$	33,217	$	32,933	$	17,136	$	(26,265	)	$	(51,991	)
Basic income (loss) per common share from:
Continuing operations	$	0.71	$	0.72	$	0.36	$	0.12		$	(1.51	)
Discontinued operations	—		—		0.02		(0.78		)	0.02
Net income (loss)	$	0.71	$	0.72	$	0.38	$	(0.66	)	$	(1.49	)
Diluted income (loss) per common share from:
Continuing operations	$	0.69	$	0.69	$	0.35	$	0.11		$	(1.51	)
Discontinued operations	—		—		0.02		(0.68		)	0.02
Net income (loss)	$	0.69	$	0.69	$	0.37	$	(0.57	)	$	(1.49	)
Weighted average common shares outstanding:
Basic	46,504		45,963		41,632		39,913			34,840
Diluted	48,086		47,787		46,709		45,951			34,840

	As of December 31,
	2014		2013		2012		2011		2010
	(in thousands)
Consolidated Balance Sheet Data:
Cash and cash equivalents	$	13,073	$	15,580	$	5,681	$	3,962	$	1,883
Total assets	681,916		604,288		517,386		535,631		562,110
Total notes payable, including current portion and discount	144,375		148,672		158,178		202,323		214,686
Total stockholders’ equity	256,581		217,742		182,111		135,659		153,455

18

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

You should read the following discussion in conjunction with our consolidated financial statements and the notes thereto and other financial information included elsewhere in this Annual Report on Form 10-K. Certain statements in this “Management’s Discussion and Analysis (“MD&A”) of Financial Condition and Results of Operations” are “forward-looking statements.” See “Special Note Regarding Forward-Looking Statements” under Item 1, “Business.” We intend this MD&A section to provide you with a narrative from the perspective of our management on our financial condition, results of operations, liquidity and certain other factors that may affect our future results. The following sections comprise this MD&A:

• Overview

• Management Initiatives

• Recent Trends

• Critical Accounting Policies and Estimates

• Results of Operations

• Liquidity and Capital Resources

• Off-Balance Sheet and Other Financing Arrangements

• Contractual Obligations

• Potential Fluctuations in Quarterly Results and Seasonality

• Inflation

• Recent Accounting Pronouncements

Overview

We conduct business through three reportable segments: nurse and allied healthcare staffing, locum tenens staffing and physician permanent placement services. For the year ended December 31, 2014, we recorded revenue of $1,036.0 million, as compared to revenue of $1,011.8 million for 2013. We recorded net income of $33.2 million for 2014, as compared to $32.9 million for 2013.

Nurse and allied healthcare staffing segment revenue comprised 67% and 68% of total consolidated revenue for the years ended December 31, 2014 and 2013, respectively. Through our nurse and allied healthcare staffing segment, we provide hospital and other healthcare facilities with a range of clinical workforce solutions, including: (1) a comprehensive managed services solution in which we manage all of the temporary nursing and allied staffing needs of a client; (2) a software as a service, or “SaaS,” VMS through which our clients can manage all of their temporary nursing and allied staffing needs; (3) traditional clinical staffing solutions of variable assignment lengths; (4) a recruitment process outsourcing program that leverages our expertise and support systems to replace or complement a client’s existing internal recruitment function for permanent placement needs; and (5) clinical labor consulting management services.

Locum tenens staffing segment revenue comprised 29% and 28% of total consolidated revenue for the years ended December 31, 2014 and 2013, respectively. Through our locum tenens staffing segment, we provide (1) a comprehensive managed services solution in which we manage all of the locum tenens needs of a client; (2) a SaaS VMS through which our clients can manage all of their locum tenens needs; and (3) placement of physicians of all specialties, as well as dentists and other advanced practice providers, with clients on a temporary basis as independent contractors. These locum tenens providers are used by our healthcare facility and physician practice group clients to fill temporary vacancies created by vacation and leave schedules and to bridge the gap while they seek permanent candidates or explore expansion. Our locum tenens clients represent a diverse group of healthcare organizations throughout the United States, including hospitals, health systems, medical groups, occupational medical clinics, psychiatric facilities, government institutions and insurance entities. The professionals we place are recruited nationwide and are typically placed on multi-week contracts with assignment lengths ranging from a few days up to one year.

Physician permanent placement services segment revenue comprised 4% of total consolidated revenue for each of the years ended December 31, 2014 and 2013. Through our physician permanent placement services segment, we assist hospitals, healthcare facilities and physician practice groups throughout the United States in identifying and recruiting physicians for

19

permanent placement. We perform the vast majority of our services on a retained basis through our Merritt Hawkins^® brand, for which we are generally paid through a blend of retained search fees and variable fees tied to work performed and successful placement. To a smaller degree, we also perform our services on a contingent basis, exclusively through our Kendall & Davis^® brand, for which fees are paid once physician candidates are ultimately hired by our clients. Our broad specialty offerings include over 70 specialist and sub-specialist opportunities such as internal medicine, family practice and orthopedic surgery.

Management Initiatives

Our growth strategy focuses on providing an innovative and differentiated value and experience to our clients and healthcare professionals. To accomplish this, we have broadened our service offerings beyond our traditional travel nurse and allied temporary staffing, locum tenens staffing, and physician permanent placement services, to include more strategic and recurring revenue sources from innovative workforce solutions offerings such as managed services programs, VMS, RPO and clinical labor management consulting. Through these differentiated services, we have built strategic relationships with our clients to assist them in improving their financial, operational and patient care results through enhanced productivity, labor optimization and candidate quality enhancement. We continually seek strategic opportunities to expand into complementary service offerings that leverage our core capabilities of recruiting and credentialing healthcare professionals, while providing a more recurring stream of revenue that reduces our exposure to economic cycle risk. At the same time, we continue to invest in our innovative workforce solutions, new candidate recruitment initiatives and technology infrastructure to capitalize on the demand growth we are experiencing and expect to continue in the future due to the impact of healthcare reform, the aging population and shortages within certain regions and disciplines.

Recent Trends

The healthcare staffing environment improved throughout the second half of 2014 and into the first quarter of 2015. Demand in our travel nurse and allied healthcare staffing businesses is significantly above prior-year levels. This demand growth has translated into increased booking levels for future assignments as well as healthcare professionals currently on assignment. Our locum tenens business has also experienced increased demand over the same period with significant increases in the majority of specialties.

We continue to see clients migrate to managed services program relationships, and during the year ended December 31, 2014, revenue from these contracts represented approximately 45% of our nurse and allied healthcare staffing segment revenue. With the inclusion of ShiftWise and the newly acquired Avantas and Medefis entities and continued penetration of managed services programs, we expect that revenue attributable to our suite of workforce solutions offerings will continue to grow. Through our managed services program relationships, we have an improved ability to fill more of the demand and create operational efficiencies. Although our gross margins have improved compared to 2013, we are experiencing an increase in housing-related costs as a constrained rental market continues to drive rental rates higher. We have partially mitigated this impact by contracting with new lower cost rental properties and through bill rate increases. In addition, with the significant demand increases, we have recently experienced some compression in our pay to bill spread as we have increased pay rates to attract more nursing professionals into our industry. This competitive market for supply has allowed us to negotiate increased bill rates with our clients to mitigate the gross margin impact.

In our locum tenens staffing segment, our managed services program offering is growing as we add new clients and increase penetration with existing clients. Revenue from MSP contracts increased from 5% in 2013 to 12% in 2014.

Throughout 2014 and into 2015, we have experienced strong demand for our services within our physician permanent placement services segment. We have also seen an increase in our recruiter productivity completing searches, which has translated into improved profitability.

Critical Accounting Policies and Estimates

Our critical accounting policies are described in Note (1) to our Consolidated Financial Statements contained in Item 8 of this Annual Report on Form 10-K. Critical accounting policies are those that we believe are both important to the portrayal of our financial condition and results and require our most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. The preparation of our consolidated financial statements in conformity with United States generally accepted accounting principles requires us to make estimates and judgments that affect our reported amounts of assets and liabilities, revenue and expenses, and related disclosures of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates and base them on the information that is currently available to us and on various other assumptions that we believe are reasonable under the circumstances. Actual results could

20

vary from these estimates under different assumptions or conditions. We believe that the following critical accounting policies affect the more significant judgments and estimates used in the preparation of our consolidated financial statements:

Goodwill and Indefinite-lived Intangible Assets

Our business acquisitions typically result in the recording of goodwill and other intangible assets, and the recorded values of those assets may become impaired in the future. The determination of the value of such intangible assets requires management to make estimates and assumptions that affect our consolidated financial statements. For intangible assets purchased in a business combination, the estimated fair values of the assets received are used to establish their recorded values. In accordance with accounting guidance on goodwill and other intangible assets, we perform annual impairment analysis to assess the recoverability of the goodwill and indefinite-lived intangible assets. We assess the impairment of goodwill of our reporting units and indefinite-lived intangible assets annually, or more often if events or changes in circumstances indicate that the carrying value may not be recoverable. We may first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, after assessing the totality of events and circumstances, we determine that it is more likely than not that the fair value of the reporting unit is greater than its carrying amount, the quantitative impairment test is unnecessary. If the reporting unit does not pass the qualitative assessment, then the reporting unit’s carrying value is compared to its fair value. The fair values of the reporting units are estimated using market and discounted cash flow approaches. Goodwill is considered impaired if the carrying value of the reporting unit exceeds its fair value. Application of the goodwill impairment test requires judgment, including the identification of reporting units, assignment of assets and liabilities to reporting units, assignment of goodwill to reporting units, and determination of the fair value of each reporting unit. Valuation techniques consistent with the market approach and income approach are used to measure the fair value of each reporting unit. Significant judgments are required to estimate the fair value of reporting units including estimating future cash flows, and determining appropriate discount rates, growth rates, company control premium and other assumptions. Changes in these estimates and assumptions could materially affect the determination of fair value for each reporting unit. We perform our annual impairment test on October 31 of each year.

Intangible assets with estimable useful lives are required to be amortized over their respective estimated useful lives and reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. An impairment evaluation is based on an undiscounted cash flow analysis at the lowest level at which cash flows of the long-lived assets are largely independent of other groups of assets and liabilities. We assess potential impairments to intangible assets when there is evidence that events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recovered. Our judgments regarding the existence of impairment indicators and future cash flows related to intangible assets are based on operational performance of our businesses, market conditions and other factors. Although there are inherent uncertainties in this assessment process, the estimates and assumptions we use, including estimates of future cash flows, volumes, market penetration and discount rates, are consistent with our internal planning. If these estimates or their related assumptions change in the future, we may be required to record an impairment charge on all or a portion of our long-lived intangible assets. Furthermore, we cannot predict the occurrence of future impairment-triggering events nor the impact such events might have on our reported asset values. Future events could cause us to conclude that impairment indicators exist and that long-lived intangible assets associated with our acquired businesses are impaired.

Professional Liability Reserve

We maintain an accrual for professional liability that we include in accounts payable and accrued expenses and other long-term liabilities in our consolidated balance sheets. We determine the adequacy of this accrual by evaluating our historical experience and trends, loss reserves established by our insurance carriers, management and third-party administrators, and our independent actuarial studies. We obtain actuarial studies on a semi-annual basis that use our historical claims data and industry data to assist us in determining the adequacy of our reserves each year. For periods between the actuarial studies, we record our accruals based on loss rates provided in the most recent actuarial study and management's review of loss history. In November 2012, we established a captive insurance subsidiary, which provides coverage, on an occurrence basis, for professional liability within our nurse and allied healthcare staffing segment. Liabilities include provisions for estimated losses incurred but not yet reported (“IBNR”), as well as provisions for known claims. IBNR reserve estimates involve the use of assumptions and are primarily based upon historical loss experience, industry data and other actuarial assumptions. We maintain excess insurance coverage through a commercial carrier for losses above the per occurrence retention.

Workers Compensation Reserve

We maintain an accrual for workers compensation, which we include in accrued compensation and benefits and other long-term liabilities in our consolidated balance sheets. We determine the adequacy of these accruals by evaluating our historical experience and trends, loss reserves established by our insurance carriers and third-party administrators, and our independent actuarial studies. We obtain updated actuarial studies on a semi-annual basis that use our payroll and historical c

21

laims data, as well as industry data, to determine the appropriate reserves for each policy year. For periods between the actuarial studies, we record our accruals based on loss rates provided in the most recent actuarial study.

Accounts Receivable

We record accounts receivable at the invoiced amount. Accounts receivable are non-interest bearing. We maintain an allowance for doubtful accounts for estimated credit losses resulting from collection risk, including the inability of our customers to make required payments under contractual agreements. We report the allowance for doubtful accounts as a reduction of accounts receivable in our consolidated balance sheets. We determine the adequacy of this allowance by evaluating historical delinquency and write-off trends, the financial condition and credit risk and history of each customer, historical payment trends as well as the current economic conditions and the impact of such conditions on our customers’ liquidity and overall financial condition. If the financial condition of our customers deteriorates, affecting their ability to make payments, additional allowances would be provided. We also maintain a sales allowance to reserve for potential credits issued to customers. We determine the amount of the reserve based on historical credits issued.

Contingent Liabilities

From time to time, we are involved in various lawsuits, claims, investigations, and proceedings that arise in the ordinary course of business. Additionally, some of our clients may also become subject to claims, governmental inquiries and investigations and legal actions relating to services provided by our healthcare professionals. From time to time, and depending upon the particular facts and circumstances, we may be subject to indemnification obligations under our contracts with such clients relating to these matters. Certain of the above-referenced matters may include speculative claims for substantial or indeterminate amounts of damages. We record a liability when we believe that it is both probable that a loss has been incurred and the amount can be reasonably estimated. Significant judgment is required to determine both probability and the estimated amount. We review these provisions at least quarterly and adjust these provisions accordingly to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, and updated information. We believe that the amount or estimable range of reasonably possible loss, will not, either individually or in the aggregate, have a material adverse effect on our business, consolidated financial position, results of operations, or cash flows with respect to loss contingencies for legal and other contingencies as of December 31, 2014. However, the outcome of litigation is inherently uncertain. Therefore, if one or more of these legal matters were resolved against us for amounts in excess of management’s expectations, our results of operations and financial condition, including in a particular reporting period, could be materially adversely affected.

Income Taxes

We evaluate our unrecognized tax benefits in accordance with the guidance for accounting for uncertainty in income taxes. We recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement.

22

Results of Operations

The following table sets forth, for the periods indicated, certain statements of operations data as a percentage of revenue. Our results of operations include three reportable segments: (1) nurse and allied healthcare staffing; (2) locum tenens staffing; and (3) physician permanent placement services. Our historical results are not necessarily indicative of our results of operations to be expected in the future.

	Years Ended December 31,
	2014		2013		2012
Consolidated Statements of Operations:
Revenue	100.0	%	100.0	%	100.0	%
Cost of revenue	69.5		70.6		71.7
Gross profit	30.5		29.4		28.3
Selling, general and administrative	22.4		21.6		21.3
Depreciation and amortization	1.5		1.3		1.5
Income from operations	6.6		6.5		5.5
Interest expense, net, and other	0.9		1.0		2.7
Income from continuing operations before income taxes	5.7		5.5		2.8
Income tax expense	2.5		2.3		1.2
Income from continuing operations	3.2		3.2		1.6
Income from discontinued operations, net of tax	—		—		0.1
Net income	3.2	%	3.2	%	1.7	%

Comparison of Results for the Year Ended December 31, 2014 to the Year Ended December 31, 2013

Revenue.    Revenue increased 2% to $1,036.0 million for 2014 from $1,011.8 million for 2013, as a result of higher revenue in all three of our reportable segments.

Nurse and allied healthcare staffing segment revenue increased 2% to $695.2 million for 2014 from $682.0 million for 2013. The increase was primarily due to the addition of ShiftWise revenue and an increase in bill rates during the year ended December 31, 2014. The increase was partially offset by a 3% decrease in the average number of healthcare professionals on assignment, which partially resulted from decreased volume of electronic medical record staffing engagements during the year ended December 31, 2014.

Locum tenens staffing segment revenue increased 3% to $296.2 million for 2014 from $287.5 million for 2013. The increase was primarily attributable to a 6% increase in revenue per day filled, partially offset by a 2% decrease in the number of days filled during the year ended December 31, 2014.

Physician permanent placement services segment revenue increased 5% to $44.7 million for 2014 from $42.4 million for 2013. The increase was primarily due to the increase in billable active searches and placements during the year ended December 31, 2014.

Gross Profit.    Gross profit increased 6% to $316.1 million for 2014 from $297.3 million for 2013, representing gross margins of 30.5% and 29.4%, respectively. The increase in consolidated gross margin was primarily due to an increase in gross margin in all three of our reportable segments. The nurse and allied healthcare staffing segment increase was primarily due to higher bill to pay spreads during the year ended December 31, 2014 and the addition of the higher margin ShiftWise business, which we acquired in November 2013. The locum tenens staffing segment increase was primarily due to higher bill to pay spreads during the year ended December 31, 2014. The physician permanent placement services segment increase was primarily due to a decrease in recruiter compensation as a percentage of revenue during the year ended December 31, 2014. Gross margin rate by reportable segment for 2014 and 2013 was 28.8% and 27.4%, respectively, for nurse and allied healthcare staffing, 29.3% and 29.1%, respectively, for locum tenens staffing, and 64.4% and 62.7%, respectively, for physician permanent placement services.

Selling, General and Administrative Expenses.    Selling, general and administrative (“SG&A”) expenses were $232.2 million, representing 22.4% of revenue, for 2014, as compared to $218.2 million, representing 21.6% of revenue, for 2013. The increase in SG&A expenses was due primarily to the addition of a full year of our ShiftWise business in 2014, a $3.0 million

23

gain on the holdback settlement in connection with the NFI acquisition, which was recorded in unallocated corporate overhead during the year ended December 31, 2013, and higher expenses during 2014 associated with our information technology initiatives to support our current demand and future growth initiatives. For more information on the holdback settlement, see “Item 8. Financial Statements and Supplementary Data—Notes to Consolidated Financial Statements—Note (10)(b), Treasury Stock.” The increase was partially offset by $2.7 million and $2.1 million favorable actuarial-based decreases in our professional liability reserves in our locum tenens staffing segment and nurse and allied healthcare staffing segment, respectively, during the year ended December 31, 2014, as compared to a $0.8 million unfavorable actuarial-based increase in our professional liability reserves (which was comprised of a $2.2 million unfavorable actuarial-based increase in our locum tenens staffing segment, partially offset by a $1.4 million favorable actuarial-based decrease in our nurse and allied healthcare staffing segment) during the year ended December 31, 2013. SG&A expenses broken down among the reportable segments, unallocated corporate overhead and share-based compensation are as follows:

	(In Thousands) Years Ended December 31,
	2014		2013
Nurse and allied healthcare staffing	$	113,233	$	104,642
Locum tenens staffing	55,876		58,909
Physician permanent placement services	18,959		17,630
Unallocated corporate overhead	36,996		30,927
Share-based compensation	7,157		6,125
	$	232,221	$	218,233

Depreciation and Amortization Expenses.    Amortization expense increased 17% to $7.6 million for 2014 from $6.5 million for 2013, attributable to additional amortization expense related to the intangibles assets resulting from the ShiftWise acquisition in November 2013. Depreciation expense increased 20% to $8.4 million for 2014 from $7.0 million for 2013, primarily attributable to fixed assets acquired as part of the ShiftWise acquisition and an increase in purchased and developed hardware and software.

Interest Expense, Net, and Other.    Interest expense, net, and other, was $9.2 million for 2014 as compared to $9.7 million for 2013. Interest expense for the year ended December 31, 2014 included a $3.1 million write-off of unamortized deferred financing fees and original issue discount in connection with the refinancing of our credit facilities. Excluding the impact of refinancing, the lower interest expense for the year ended December 31, 2014 as compared to 2013 was due to lower average debt outstanding balances and lower interest rates.

Income Tax Expense.    We recorded an income tax expense of $25.4 million for 2014 from continuing operations as compared to $22.9 million for 2013, reflecting effective income tax rates of 43.4% and 41.0% for these periods, respectively. The difference in the effective income tax rate was primarily attributable to an increase in non-deductible expenses in 2014. See additional information in “Item 8. Financial Statements and Supplementary Data—Notes to Consolidated Financial Statements—Note (7), Income Taxes.”

Comparison of Results for the Year Ended December 31, 2013 to the Year Ended December 31, 2012

Revenue.    Revenue increased 6% to $1,011.8 million for 2013 from $954.0 million for 2012, as a result of higher revenue in all three of our reportable segments.

Nurse and allied healthcare staffing segment revenue increased 4% to $682.0 million for 2013 from $653.8 million for 2012. The increase was primarily attributable to a 2% increase in the average number of healthcare professionals on assignment, which was driven by increased travel nurse volume and increased volume of electronic medical record staffing engagements during 2013, with the remainder of the increase due primarily to a combination of an increase in bill rates, and mix shift to higher bill rate specialties during the year ended December 31, 2013.

Locum tenens staffing segment revenue increased 10% to $287.5 million for 2013 from $261.4 million for 2012. The increase was primarily attributable to an 8% increase in the number of days filled and a 2% increase in the revenue per day filled resulting from bill rate increases across most specialties during the year ended December 31, 2013.

Physician permanent placement services segment revenue increased 9% to $42.4 million for 2013 from $38.7 million for 2012. The increase was primarily due to the increase in billable active searches and placements during the year ended December 31, 2013.

24

Gross Profit.    Gross profit increased 10% to $297.3 million for 2013 from $270.4 million for 2012, representing gross margins of 29.4% and 28.3%, respectively. The increase in consolidated gross margin was primarily due to an increase in gross margin in all three of our reportable segments. The nurse and allied healthcare staffing segment increase was primarily due to favorable insurance claims experience, the locum tenens staffing segment increase was primarily due to higher bill to pay spreads and the physician permanent placement services segment increase was primarily due to an increase in recruiter productivity during the year ended December 31, 2013. Gross margin rate by reportable segment for 2013 and 2012 was 27.4% and 26.5%, respectively, for nurse and allied healthcare staffing, 29.1% and 27.9%, respectively, for locum tenens staffing, and 62.7% and 62.3%, respectively, for physician permanent placement services.

Selling, General and Administrative Expenses.    SG&A expenses were $218.2 million, representing 21.6% of revenue, for 2013, as compared to $202.9 million, representing 21.3% of revenue, for 2012. The increase in SG&A expenses was due primarily to increased employee headcount, sales commissions and other costs related to supporting growth in the business during 2013 and a $2.0 million refund received from the EDD in 2012 in connection with the settlement of a prior period assessment. The increase was partially offset by a $3.0 million gain on the holdback settlement in connection with the NFI acquisition during the year ended December 31, 2013. For more information on the holdback settlement, see “Item 8. Financial Statements and Supplementary Data—Notes to Consolidated Financial Statements—Note (10)(b), Treasury Stock.” SG&A expenses broken down among the reportable segments, unallocated corporate overhead and share-based compensation are as follows:

	(In Thousands) Years Ended December 31,
	2013		2012
Nurse and allied healthcare staffing	$	104,642	$	97,584
Locum tenens staffing	58,909		51,202
Physician permanent placement services	17,630		16,223
Unallocated corporate overhead	30,927		31,674
Share-based compensation	6,125		6,221
	$	218,233	$	202,904

Depreciation and Amortization Expenses.    Amortization expense decreased 3% to $6.5 million for 2013 from $6.7 million for 2012, with the decrease primarily attributable to having more intangible assets fully amortized during the year ended December 31, 2013. Depreciation expense decreased 7% to $7.0 million for 2013 from $7.5 million for 2012, with the decrease primarily attributable to having more fixed assets fully depreciated for the year ended December 31, 2013.

Interest Expense, Net, and Other.    Interest expense, net, and other, was $9.7 million for 2013 as compared to $26.0 million for 2012. The decrease was primarily attributable to a $9.8 million loss on debt extinguishment recorded during the year ended December 31, 2012 and a lower average debt outstanding balance and lower interest rate for the year ended December 31, 2013.

Income Tax Expense.    We recorded an income tax expense of $22.9 million for 2013 from continuing operations as compared to $11.0 million for 2012, reflecting effective income tax rates of 41.0% and 40.3% for these periods, respectively. The difference in the effective income tax rate was primarily attributable to the relationship of pre-tax income to permanent differences. See additional information in “Item 8. Financial Statements and Supplementary Data—Notes to Consolidated Financial Statements—Note (7), Income Taxes.”

Income From Discontinued Operations.    We recorded no income from discontinued operations for the year ended December 31, 2013. For the year ended December 31, 2012, income from discontinued operations of $0.8 million was comprised of a $1.2 million gain on sale, net of tax, and a $0.4 million loss from discontinued operations, net of tax. See additional information in “Item 8. Financial Statements and Supplementary Data—Notes to Consolidated Financial Statements—Note (2), Discontinued Operations.”

25

Liquidity and Capital Resources

In summary, our cash flows were:

	Year Ended December 31,
	2014			2013			2012
	(in thousands)
Net cash provided by operating activities	$	27,678		$	60,169		$	58,380
Net cash provided by (used in) investing activities	(28,228		)	(49,198		)	1,578
Net cash used in financing activities	(2,099		)	(1,017		)	(58,169		)

Historically, our primary liquidity requirements have been for acquisitions, working capital requirements and debt service under our credit facilities. We have funded these requirements through internally generated cash flow and funds borrowed under our credit facilities. At December 31, 2014, $162.4 million was outstanding under the New Credit Facilities (as defined below) with $197.6 million of available credit under our $225 million secured revolving credit facility (the “Revolver”).

We believe that cash generated from operations and available borrowings under our Revolver will be sufficient to fund our operations for the next 12 months and beyond. We intend to finance potential future acquisitions with cash provided from operations, borrowings under our Revolver, bank loans, debt or equity offerings, or some combination of the foregoing. The following discussion provides further details of our liquidity and capital resources.

Operating Activities

Net cash provided by operations for 2014 was $27.7 million, compared to $60.2 million for 2013 and $58.4 million for 2012. The decrease in net cash provided by operating activities for 2014 from 2013 was primarily attributable to an increase in accounts receivable and accounts receivable for subcontractors due to an increase in both revenues and our Days Sales Outstanding (“DSO”). Our DSO was 61 days and 55 days at December 31, 2014 and 2013, respectively. The increase in DSO is attributable to several factors including slower than normal payment by a few larger customers, extended billing processes for clients utilizing third-party VMS technologies, and unique billing requirements for several staffing projects, which delay payments. However, we have not noted any deterioration of the credit quality of our overall client base. The decrease in cash provided by operations was also due to an increase in restricted cash, cash equivalents and investments attributable to cash payments made to our captive insurance entity, which are restricted for use by the captive for future claim payments and, to a lesser extent, its working capital needs.

Investing Activities

Net cash used in investing activities for 2014 and 2013 were $28.2 million and $49.2 million, respectively, as compared to $1.6 million net cash provided by investing activities for 2012. Capital expenditures were $19.1 million, $9.0 million and $5.5 million for the years ended December 31, 2014, 2013 and 2012, respectively. The increase in capital expenditures during 2014 was to support the growth in the business and for investments made in conjunction with management initiatives to update our front and back office information technology platforms. We intend to continue our investment in these information technology initiatives, including investments of $10.0 to $15.0 million in each of the next two years, to standardize our staffing operations on PeopleSoft and Salesforce. We believe these investments will further differentiate our ability to deliver innovative workforce solutions in addition to delivering improved operating efficiency. The increase in capital expenditures was partially offset by the decrease in restricted cash, cash equivalents and investments balance resulting from the reduction of standby letters of credit.

We paid cash of $14.5 million and $39.5 million in conjunction with our acquisitions of Avantas and Shiftwise in 2014 and 2013, respectively, as compared to $0 paid for acquisitions in 2012.

Financing Activities

Net cash used in financing activities during the year ended December 31, 2014 was $2.1 million, primarily attributable to paying down our Term Loan (as defined below) offset by borrowings under the Revolver. Net cash used in financing activities during the year ended December 31, 2013 was $1.0 million. Net cash used in financing activities during the year ended December 31, 2012 was $58.2 million, primarily due to paying off debt.

26

Credit Agreement

On April 18, 2014, we entered into a Credit Agreement (the “Credit Agreement”) with several lenders to provide for two credit facilities (the “New Credit Facilities”) to replace our prior credit facilities, including (A) the $225 million Revolver that includes a $40 million sublimit for the issuance of letters of credit and a $20 million sublimit for swingline loans and (B) a $150 million secured term loan credit facility (the “Term Loan”). For more detail regarding the terms of the Credit Agreement, please see “Item 8. Financial Statements and Supplementary Data—Notes to Consolidated Financial Statements—Note (8), Notes Payable and Related Credit Agreement.”

Borrowings Under Credit Facilities

As of December 31, 2014 and 2013, the total of our Term Loan outstanding (including both the current and long-term portions), net of discount, was $144.4 million and $148.7 million, respectively. There was $18.0 million and $10.0 million outstanding under the Revolver at December 31, 2014 and 2013, respectively.

Letters of Credit

At December 31, 2014, we maintained outstanding standby letters of credit totaling $15.0 million as collateral in relation to our professional liability insurance agreements, workers compensation insurance agreements, and a corporate office lease agreement. Of the $15.0 million outstanding letters of credit, we have collateralized $5.6 million in cash, cash equivalents and investments and the remaining amount has been collateralized by the Revolver. Outstanding standby letters of credit at December 31, 2013 totaled $27.7 million.

Off-Balance Sheet and Other Financing Arrangements

At December 31, 2014 and 2013, we did not have any off-balance sheet arrangement that has or is reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources that is material to investors.

Contractual Obligations

The following table summarizes our contractual obligations as of December 31, 2014 (in thousands):

	Fiscal Year
	2015		2016		2017		2018		2019		Thereafter		Total
Notes payable (1)	$	10,189	$	10,047	$	9,904	$	9,762	$	115,087	$	—	$	154,989
Operating lease obligations (2)	13,215		13,786		12,271		11,662		11,783		92,949		155,666
Cash holdback (3)	—		825		—		—		—		—		825
Total contractual obligations	$	23,404	$	24,658	$	22,175	$	21,424	$	126,870	$	92,949	$	311,480

(1) Amounts represent contractual amounts due under the Term Loan, including interest calculated on rate in effect at December 31, 2014.

(2) Amounts represent minimum contractual amounts, with initial or remaining lease terms in excess of one year. We have assumed no escalations in rent or changes in variable expenses other than as stipulated in lease contracts. The amounts also include rent payments relating to the new lease agreement entered in January 2015 as described immediately below.

(3) Amounts represent the long-term portion of the cash holdback payable in cash in connection with the Avantas acquisition, subject to our claims against the holdback under the acquisition agreement.

On January 26, 2015, we entered into a ten-year operating lease agreement for office space in Dallas, Texas that will replace our current operating lease agreement for our Irving, Texas offices, which expires in August 2015. Base rent payments under the new lease agreement will begin in September 2015 and the total estimated base rent payments will be approximately $24.0 million over the life of the lease and have been included in the table immediately above.

27

In addition to the above disclosed contractual obligations, the unrecognized income tax benefits, including interest and penalties, was $28.7 million at December 31, 2014. See additional information in “Item 8. Financial Statements and Supplementary Data—Notes to Consolidated Financial Statements—Note (7), Income Taxes.”

Potential Fluctuations in Quarterly Results and Seasonality

Due to the regional and seasonal fluctuations in the hospital patient census and staffing needs of our hospital and healthcare facility and other clients and due to the seasonal preferences for destinations of our healthcare professionals, revenue, earnings and the number of healthcare professionals on assignment are subject to moderate seasonal fluctuations.

Inflation

Although inflation has remained relatively stable during the last several years, the rate of inflation in healthcare-related services continues to exceed the rate experienced by the economy as a whole. Our contracts typically provide for an annual increase in the fees paid to us by our clients based on increases in various inflation indices, which provides us the opportunity to pass on inflation costs to our clients.

Recent Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board issued new accounting guidance related to revenue recognition. This new standard will replace all current U.S. GAAP guidance on this topic and eliminate all industry-specific guidance. The new revenue recognition standard provides a unified model to determine when and how revenue is recognized. The core principle is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration for which the entity expects to be entitled in exchange for those goods or services. This guidance will be effective for us beginning January 1, 2017 and can be applied either retrospectively to each period presented or as a cumulative-effect adjustment as of the date of adoption. We are evaluating the impact of adopting this new accounting standard on our consolidated financial statements. We have not yet selected a transition method nor have we determined the effect of the standard on our ongoing financial reporting.

There have been no other new accounting pronouncements issued but not yet adopted that are expected to materially affect our consolidated financial condition or results of operations.

Item 7A. Quantitative and Qualitative Disclosures about Market Risk

Market risk is the risk of loss arising from adverse changes in market rates and prices, such as interest rates, foreign currency exchange rates and commodity prices.

During 2014, our primary exposure to market risk was interest rate risk associated with our variable interest debt instruments. A 100 basis point increase in interest rates on our variable rate debt would not have resulted in a material effect on our consolidated financial statements for 2014.

We conduct a de minimus amount of international operations. Accordingly, we believe that our foreign currency risk is immaterial.

28

Item 8. Financial Statements and Supplementary Data

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

	Page
Report of Independent Registered Public Accounting Firm	30
Consolidated Balance Sheets as of December 31, 2014 and 2013	31
Consolidated Statements of Comprehensive Income for the years ended December 31, 2014, 2013 and 2012	32
Consolidated Statements of Stockholders’ Equity for the years ended December 31, 2014, 2013 and 2012	33
Consolidated Statements of Cash Flows for the years ended December 31, 2014, 2013 and 2012	34
Notes to Consolidated Financial Statements	36

29

Report of Independent Registered Public Accounting Firm

The Board of Directors and Stockholders

AMN Healthcare Services, Inc.:

We have audited the accompanying consolidated balance sheets of AMN Healthcare Services, Inc. and subsidiaries (the Company) as of December 31, 2014 and 2013, and the related consolidated statements of comprehensive income, stockholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2014. These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of AMN Healthcare Services, Inc. and subsidiaries as of December 31, 2014 and 2013, and the results of their operations and their cash flows for each of the years in the three-year period ended December 31, 2014, in conformity with U.S. generally accepted accounting principles.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), AMN Healthcare Services, Inc. and subsidiaries’ internal control over financial reporting as of December 31, 2014, based on criteria established in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO), and our report dated February 24, 2015 expressed an unqualified opinion on the effectiveness of the Company’s internal control over financial reporting.

/s/ KPMG LLP

San Diego, California

February 24, 2015

30

AMN HEALTHCARE SERVICES, INC.

CONSOLIDATED BALANCE SHEETS

(in thousands, except par value)

	December 31, 2014			December 31, 2013
ASSETS
Current assets:
Cash and cash equivalents	$	13,073		$	15,580
Accounts receivable, net of allowances of $4,515 and $5,118 at December 31, 2014 and 2013, respectively	186,274			147,477
Accounts receivable, subcontractor	28,443			18,271
Deferred income taxes, net	27,330			24,938
Prepaid and other current assets	27,550			26,631
Total current assets	282,670			232,897
Restricted cash, cash equivalents and investments	19,567			23,115
Fixed assets, net of accumulated depreciation of $68,814 and $63,031 at December 31, 2014 and 2013, respectively	32,880			21,158
Other assets	39,895			32,279
Goodwill	154,387			144,642
Intangible assets, net of accumulated amortization of $41,963 and $42,439 at December 31, 2014 and 2013, respectively	152,517			150,197
Total assets	$	681,916		$	604,288
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable and accrued expenses	$	78,993		$	71,314
Accrued compensation and benefits	67,995			55,949
Revolving credit facility	18,000			10,000
Current portion of notes payable	7,500			—
Deferred revenue	3,177			1,373
Other current liabilities	2,630			4,454
Total current liabilities	178,295			143,090
Notes payable, net of discount	136,875			148,672
Deferred income taxes, net	32,491			17,764
Other long-term liabilities	77,674			77,020
Total liabilities	425,335			386,546
Commitments and contingencies and subsequent events
Stockholders’ equity:
Preferred stock, $0.01 par value; 10,000 shares authorized; none issued and outstanding at December 31, 2014 and 2013	—			—
Common stock, $0.01 par value; 200,000 shares authorized; 46,639 and 46,011 shares issued and outstanding at December 31, 2014 and 2013, respectively	466			460
Additional paid-in capital	434,529			429,055
Accumulated deficit	(178,058		)	(211,275		)
Accumulated other comprehensive loss	(356		)	(498		)
Total stockholders’ equity	256,581			217,742
Total liabilities and stockholders’ equity	$	681,916		$	604,288

See accompanying notes to consolidated financial statements.

31

AMN HEALTHCARE SERVICES, INC.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(in thousands, except per share amounts)

	Years Ended December 31,
	2014		2013			2012
Revenue	$	1,036,027	$	1,011,816		$	953,951
Cost of revenue	719,910		714,536			683,554
Gross profit	316,117		297,280			270,397
Operating expenses:
Selling, general and administrative	232,221		218,233			202,904
Depreciation and amortization	15,993		13,545			14,151
Total operating expenses	248,214		231,778			217,055
Income from operations	67,903		65,502			53,342
Interest expense, net (including loss on debt extinguishment of $3,113, $434, and $9,815 for the years ended December 31, 2014, 2013, and 2012, respectively), and other	9,237		9,665			26,019
Income from continuing operations before income taxes	58,666		55,837			27,323
Income tax expense	25,449		22,904			11,010
Income from continuing operations	33,217		32,933			16,313
Income from discontinued operations, net of tax	—		—			823
Net income	$	33,217	$	32,933		$	17,136
Other comprehensive income (loss) - foreign currency translation	142		(55		)	(70		)
Comprehensive income	$	33,359	$	32,878		$	17,066
Basic income per common share from:
Continuing operations	$	0.71	$	0.72		$	0.36
Discontinued operations	—		—			0.02
Net income	$	0.71	$	0.72		$	0.38
Diluted income per common share from:
Continuing operations	$	0.69	$	0.69		$	0.35
Discontinued operations	—		—			0.02
Net income	$	0.69	$	0.69		$	0.37
Weighted average common shares outstanding:
Basic	46,504		45,963			41,632
Diluted	48,086		47,787			46,709

See accompanying notes to consolidated financial statements.

32

AMN HEALTHCARE SERVICES, INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

Years Ended December 31, 2014, 2013 and 2012

(in thousands)

	Common Stock					Additional Paid-in Capital			Treasury Stock				Accumulated Deficit			Accumulated Other Comprehensive Gain (Loss)			Total
	Shares		Amount						Shares	Amount
Balance, December 31, 2011	40,454		$	405		$	394,958		—	$	—		$	(259,331	)	$	(373	)	$	135,659
Equity awards vested and issued and exercised, net of shares withheld for payroll taxes	486		5			(550		)	—	—			—			—			(545		)
Preferred Stock converted to common stock	4,751		47			23,992			—	—			—			—			24,039
Preferred Stock retirement	—		—			37			—	—			—			—			37
Income tax shortfall from equity awards vested and exercised	—		—			(369		)	—	—			—			—			(369		)
Share-based compensation	—		—			6,224			—	—			—			—			6,224
Comprehensive income (loss)	—		—						—	—			17,136			(70		)	17,066
Balance, December 31, 2012	45,691		$	457		$	424,292		—	$	—		$	(242,195	)	$	(443	)	$	182,111
Settlement of acquisition share holdback	—		—			—			—	(3,046		)	—			—			(3,046		)
Treasury stock retirement	(204	)	(2		)	(1,031		)	—	3,046			(2,013		)	—			—
Equity awards vested and issued and exercised, net of shares withheld for payroll taxes	524		5			(1,498		)	—	—			—			—			(1,493		)
Income tax benefit from equity awards vested and exercised	—		—			1,167			—	—			—			—			1,167
Share-based compensation	—		—			6,125			—	—			—			—			6,125
Comprehensive income (loss)	—		—			—			—	—			32,933			(55		)	32,878
Balance, December 31, 2013	46,011		$	460		$	429,055		—	$	—		$	(211,275	)	$	(498	)	$	217,742
Equity awards vested and issued and exercised, net of shares withheld for payroll taxes	628		6			(2,661		)	—	—			—			—			(2,655		)
Income tax benefit from equity awards vested and exercised	—		—			978			—	—			—			—			978
Share-based compensation	—		—			7,157			—	—			—			—			7,157
Comprehensive income	—		—			—			—	—			33,217			142			33,359
Balance, December 31, 2014	46,639		$	466		$	434,529		—	$	—		$	(178,058	)	$	(356	)	$	256,581

See accompanying notes to consolidated financial statements.

33

AMN HEALTHCARE SERVICES, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

	Years Ended December 31,
	2014			2013			2012
Cash flows from operating activities:
Net income	$	33,217		$	32,933		$	17,136
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	15,993			13,545			14,151
Non-cash interest expense and other	1,392			1,336			2,921
Increase in allowances for doubtful accounts and sales credits	4,393			4,628			6,786
Provision for deferred income taxes	11,779			3,031			6,951
Share-based compensation	7,157			6,125			6,224
Excess tax benefit from share-based compensation	(1,819		)	(1,521		)	(44		)
Holdback settlement in equity from prior acquisition	—			(3,046		)	—
Gain on sale of discontinued operations	—			—			(1,187		)
Loss on disposal or sale of fixed assets	60			14			32
Loss on debt extinguishment	3,113			434			9,815
Changes in assets and liabilities, net of effects from acquisition and divestiture:
Accounts receivable	(41,958		)	(8,644		)	(2,642		)
Accounts receivable, subcontractor	(10,172		)	196			4,030
Income taxes receivable	768			(1,572		)	3,035
Prepaid expenses and other current assets	(13		)	3,226			(8,684		)
Other assets	(268		)	(11,865		)	(1,537		)
Accounts payable and accrued expenses	6,125			6,244			(680		)
Accrued compensation and benefits	11,515			6,367			5,794
Other liabilities	(4,488		)	13,129			(3,029		)
Deferred Revenue	(114		)	(90		)	(692		)
Restricted cash, cash equivalents and investments balance	(9,002		)	(4,301		)	—
Net cash provided by operating activities	27,678			60,169			58,380
Cash flows from investing activities:
Purchase and development of fixed assets	(19,134		)	(9,047		)	(5,472		)
Change in restricted cash, cash equivalents and investments balance	12,550			47			(617		)
Equity method investment	(5,000		)	—			—
Payments to fund deferred compensation plan	(2,174		)	(1,298		)	(1,383		)
Cash paid for acquisitions, net of cash received	(14,470		)	(39,500		)	—
Proceeds from sales of assets held for sale	—			600			9,050
Net cash provided by (used in) investing activities	(28,228		)	(49,198		)	1,578
Cash flows from financing activities:
Capital lease repayments	(529		)	(681		)	(650		)
Payments on term loan	(155,245		)	(10,000		)	(246,880		)
Proceeds from term loan	150,000			—			198,000
Payments on revolving credit facility	(39,500		)	(16,000		)	(3,000		)
Proceeds from revolving credit facility	47,500			26,000			—
Prepayment penalty associated with the prior credit facilities	—			—			(1,200		)
Payment of financing costs	(3,488		)	(364		)	(3,938		)
Proceeds from exercise of equity awards	1,792			1,177			530
Cash paid for shares withheld for taxes	(4,448		)	(2,670		)	(1,075		)
Excess tax benefit from share-based compensation	1,819			1,521			44
Net cash used in financing activities	(2,099		)	(1,017		)	(58,169		)
Effect of exchange rate changes on cash	142			(55		)	(70		)
Net change in cash and cash equivalents	(2,507		)	9,899			1,719

34

Cash and cash equivalents at beginning of year	15,580			5,681			3,962
Cash and cash equivalents at end of year	$	13,073		$	15,580		$	5,681
Supplemental disclosures of cash flow information:
Cash paid for interest (net of $123, $63 and $27 capitalized in 2014, 2013 and 2012, respectively)	$	4,599		$	7,405		$	13,698
Cash paid for income taxes	$	17,880		$	18,865		$	1,860
Acquisitions:
Fair value of tangible assets acquired in acquisitions, net of cash received	$	1,631		$	9,899		$	—
Goodwill	9,750			21,318			—
Intangible assets	9,960			19,790			—
Liabilities and deferred revenue assumed	(3,821		)	(11,507		)	—
Holdback provision	(1,650		)	—			—
Earn-out liabilities	(1,400		)	—			—
Net cash paid for acquisitions	$	14,470		$	39,500		$	—
Supplemental disclosures of non-cash investing and financing activities:
Purchase of fixed assets recorded in accounts payable and accrued expenses	$	4,618		$	3,727		$	282

See accompanying notes to consolidated financial statements.

35

AMN HEALTHCARE SERVICES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2014, 2013 and 2012

(in thousands, except per share amounts)

(1) Summary of Significant Accounting Policies

(a) General

AMN Healthcare Services, Inc. was incorporated in Delaware on November 10, 1997. AMN Healthcare Services, Inc. and its subsidiaries (collectively, the “Company”) provide healthcare workforce solutions and staffing services at acute and sub-acute care hospitals and other healthcare facilities throughout the United States.

(b) Principles of Consolidation

The accompanying consolidated financial statements include the accounts of AMN Healthcare Services, Inc. and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

(c) Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. On an ongoing basis, the Company evaluates its estimates, including those related to asset impairment, accruals for self-insurance and compensation and related benefits, accounts receivable, contingencies and litigation, and income taxes. The Company bases these estimates on the information that is currently available and on various other assumptions that it believes are reasonable under the circumstances. Actual results could differ from those estimates under different assumptions or conditions.

(d) Cash and Cash Equivalents

The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents include currency on hand, deposits with financial institutions and highly liquid investments.

(e) Restricted Cash, Cash Equivalents and Investments

Restricted cash, cash equivalents and investments primarily represent the cash and U.S. Treasury securities on deposit with financial institutions that serve as collateral for the Company’s outstanding letters of credit and captive insurance subsidiary claim payments. The original maturity terms for the U.S. Treasury securities were between 3-months and 12-months. See Note (4), “Fair Value Measurement” and Note (8), “Notes Payable and Credit Agreement” for additional information.

(f) Fixed Assets

The Company records furniture, equipment, leasehold improvements and internal-use software at cost less accumulated amortization and depreciation. The Company records equipment acquired under capital leases at the present value of the future minimum lease payments. The Company capitalizes major additions and improvements, and expenses maintenance and repairs when incurred. The Company calculates depreciation on furniture, equipment and software using the straight-line method based on the estimated useful lives of the related assets (three to seven years). The Company amortizes leasehold improvements and equipment obtained under capital leases over the shorter of the term of the lease or their estimated useful lives. The Company includes amortization of equipment obtained under capital leases with depreciation expense in the accompanying consolidated financial statements.

The Company capitalizes costs it incurs to develop internal-use software during the application development stage. Application development stage costs generally include costs associated with internal-use software configuration, coding, installation and testing. The Company also capitalizes costs of significant upgrades and enhancements that result in additional functionality, whereas it expenses as incurred costs for maintenance and minor upgrades and enhancements. The Company amortizes capitalized costs using the straight-line method over three to seven years once the software is ready for its intended use.

36

The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset group to the future undiscounted net cash flows that are expected to be generated by the asset group. If such asset group is considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset group exceeds the fair value of the asset group. The Company reports assets to be disposed of at the lower of the carrying amount or fair value less costs to sell.

(g) Goodwill

The Company records as goodwill the portion of the purchase price that exceeds the fair value of net assets of entities acquired. The Company evaluates goodwill annually for impairment at the reporting unit level and whenever circumstances occur indicating that goodwill may be impaired. The Company may first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, after assessing the totality of events and circumstances, the Company determines that it is more likely than not that the fair value of the reporting unit is greater than its carrying amount, the quantitative impairment test is unnecessary. The performance of the quantitative impairment test involves a two-step process. The first step of the test involves comparing the fair value of the Company’s reporting units with the reporting unit’s carrying amount, including goodwill. The Company generally determines the fair value of its reporting units using a combination of the income approach (using discounted future cash flows) and the market valuation approach. If the carrying amount of the Company’s reporting units exceeds the reporting unit’s fair value, the Company performs the second step of the test to determine the amount of impairment loss. The second step of the test involves comparing the implied fair value of the Company’s reporting unit’s goodwill with the carrying amount of that goodwill. The amount by which the carrying value of the goodwill exceeds its implied fair value, if any, is recognized as an impairment loss.

(h) Intangible Assets

Intangible assets consist of identifiable intangible assets acquired through acquisitions. Identifiable intangible assets include tradenames and trademarks, customer relationships, non-compete agreements, staffing databases, acquired technology and online courses. The Company amortizes intangible assets, other than tradenames and trademarks with an indefinite life, using the straight-line method over their useful lives. The Company amortizes non-compete covenants using the straight-line method over the lives of the related agreements. The Company reviews for impairment intangible assets with estimable useful lives whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.

The Company does not amortize indefinite-lived tradenames and trademarks and instead reviews them for impairment annually. The Company may first perform a qualitative assessment to determine whether it is more likely than not that an indefinite-lived intangible asset is impaired. If, after assessing the totality of events and circumstances, the Company determines that it is more likely than not that the indefinite-lived intangible asset is not impaired, no quantitative fair value measurement is necessary. If a quantitative fair value measurement calculation is required for the indefinite-lived intangible assets, the Company compares the fair value of the Company’s indefinite-lived intangibles with their carrying amount. If the carrying amount exceeds the fair value, the Company records the excess as an impairment loss.

(i) Insurance Reserves

The Company maintains an accrual for professional liability that is included in accounts payable and accrued expenses and other long-term liabilities in the consolidated balance sheets. The expense is included in the selling, general and administrative expenses in the consolidated statement of comprehensive income. The Company determines the adequacy of this accrual by evaluating its historical experience and trends, loss reserves established by the Company’s insurance carriers, management and third-party administrators, and its independent actuarial studies. The Company obtains actuarial studies on a semi-annual basis that use the Company’s actual claims data and industry data to assist the Company in determining the adequacy of its reserves each year. For periods between the actuarial studies, the Company records its accruals based on loss rates provided in the most recent actuarial study and management's review of loss history. In November 2012, the Company established a captive insurance subsidiary, which provides coverage, on an occurrence basis, for professional liability within its nurse and allied healthcare staffing segment. Liabilities include provisions for estimated losses incurred but not yet reported (“IBNR”), as well as provisions for known claims. IBNR reserve estimates involve the use of assumptions and are primarily based upon historical loss experience, industry data and other actuarial assumptions. The Company maintains excess insurance coverage through a commercial carrier for losses above the per occurrence retention.

The Company maintains an accrual for workers compensation, which is included in accrued compensation and benefits and other long-term liabilities in the consolidated balance sheets. The Company determines the adequacy of this accrual by evaluating its historical experience and trends, loss reserves established by the Company’s insurance carriers and third-party administrators, and its independent actuarial studies. The Company obtains actuarial studies on a semi-annual basis that use the

37

Company’s payroll and historical claims data, as well as industry data, to determine the appropriate reserve for both reported claims and IBNR claims for each policy year. For periods between the actuarial studies, the Company records its accruals based on loss rates provided in the most recent actuarial study.

(j) Revenue Recognition

Revenue consists of fees earned from the permanent and temporary placement of healthcare professionals. Revenue is recognized when earned and realizable. The Company has entered into certain contracts with healthcare organizations to provide managed services programs. Under these contract arrangements, the Company uses its healthcare professionals along with those of third-party subcontractors to fulfill client orders. If the Company uses subcontractors, it records revenue net of related subcontractors expense. The resulting net revenue represents the administrative fee the Company charges for its vendor management services. The Company is liable to the subcontractor after it receives payment from the client. The Company includes payables to subcontractors in accounts payable and accrued expenses in the consolidated balance sheets.

(k) Accounts Receivable

The Company records accounts receivable at the invoiced amount. Accounts receivable are non-interest bearing. The Company maintains an allowance for doubtful accounts for estimated credit losses resulting from collection risk, including the inability of customers to make required payments under contractual agreements. The allowance for doubtful accounts is reported as a reduction of accounts receivable in the consolidated balance sheets. The Company determines the adequacy of this allowance by evaluating historical delinquency and write-off trends, the financial condition and credit risk and history of each customer, historical payment trends as well as current economic conditions and the impact of such conditions on the customers’ liquidity and overall financial condition. The Company also maintains a sales allowance to reserve for potential credits issued to customers. The Company determines the amount of the reserve based on historical credits issued.

(l) Concentration of Credit Risk

The majority of the Company’s business activity is with hospitals located throughout the United States. Credit is extended based on the evaluation of each entity’s financial condition, and collateral is generally not required. Credit losses have been within management’s expectations. Other than one healthcare system, which comprised approximately 10% of the consolidated revenue of the Company for the fiscal year ended December 31, 2014, no client healthcare system exceeded 10% of consolidated revenue for the years ended December 31, 2014, 2013 or 2012. As of each of December 31, 2014 and 2013, accounts receivable from the Company’s top five clients represented approximately 12% of the net accounts receivable balance, excluding amounts due to subcontractors.

The Company’s cash and cash equivalents and restricted cash, cash equivalents and investments accounts are also financial instruments that are exposed to concentration of credit risk. The Company maintains its cash balances with high-credit quality and federally insured institutions. Cash balances may be invested in a non-federally insured money market account. As of December 31, 2014 and 2013, there were $19,567 and $23,115, respectively, of restricted cash, cash equivalents and investments primarily invested in a non-federally insured U.S. Treasury security account.

(m) Income Taxes

The Company records income taxes using the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period the changes are enacted. In assessing the realizability of deferred tax assets, the Company considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. The Company considers the scheduled reversal of deferred tax liabilities (including the impact of available carryback and carryforward periods), projected future taxable income, and tax-planning strategies in making this assessment. The Company recognizes the effect of income tax positions only if it is more likely than not that such positions will be sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company records interest and penalties related to unrecognized tax benefits in income tax expense.

38

(n) Fair Value of Financial Instruments

The carrying amounts of the Company’s cash equivalents and restricted cash equivalents approximate their respective fair values due to the short-term nature and liquidity of these financial instruments. The carrying amount of the Company’s notes payable approximates its fair value as the Company refinanced its credit facilities in 2014 and the instrument’s interest rates are variable (significant other observable inputs - level 2). See Note (8), “Notes Payable and Credit Agreement,” for additional information. The fair value of the long-term portion of the Company’s insurance accruals cannot be estimated as the Company cannot reasonably determine the timing of future payments.

(o) Share-Based Compensation

The Company accounts for its share-based employee compensation plans by expensing the estimated fair value of share-based awards on a straight-line basis over the requisite employee service period, which is the vesting period. Restricted stock units (“RSUs”) granted under the Equity Plan (as defined in Note (11), “Share-Based Compensation”) typically vest at the end of a three-year vesting period, however, 33% of the awards may vest on the 13th month anniversary of the grant date, and 34% on the second anniversary of the grant date, if certain performance targets are met. Share-based compensation cost of RSUs is measured by the market value of the Company’s common stock on the date of grant. Performance restricted stock units (“PRSUs”) granted under the Equity Plan typically consist of 1) PRSUs that contain a market condition with the ultimate realizable number of PRSUs dependent on relative and absolute total shareholder return over a three-year period, up to a maximum amount to be issued under the award of 175% of the original grant (“TSR PRSUs”), the fair values of which are estimated using the Monte-Carlo simulation valuation model and will not be adjusted for the achievement, or lack thereof, of the performance conditions; and 2) PRSUs that contain a performance condition, with the ultimate realizable number of PRSUs dependent on the adjusted EBITDA margin performance of the Company during a certain annual performance period, with a range of 0% to 175% of the target amount granted to be issued under the award. Share-based compensation cost for EBITDA margin PRSUs is measured by the market value of the Company’s common stock on the date of grant, and will be adjusted for estimated achievement of the performance conditions. Stock options and stock appreciation rights granted are measured on the date of grant using the Black-Scholes valuation model, which includes assumptions such as expected term of the award, stock price volatility, dividend rate and risk free interest rate. The Company also estimates the forfeiture rate and records share-based compensation expense only for those awards that are expected to vest.

(p) Net Income per Common Share

Securities that are entitled to participate in dividends with common stock, such as the Company’s Series A Conditional Convertible Preferred Stock (the “Preferred Stock”), are considered to be participating securities and the two-class method is used for purposes of calculating basic net income per share. Under the two-class method, a portion of net income is allocated to participating securities and excluded from the calculation of basic net income per common share. On December 21, 2012, all outstanding shares of Preferred Stock were converted into common stock; accordingly, for the two-class method calculation, the net income was allocated between common stock and Preferred Stock on a proportionate basis using a systematic and reasonable basis (based on number of days outstanding) for purpose of calculating the basic net income per share for the year ended December 31, 2012.

Share-based awards to purchase 298, 308 and 1,902 shares of common stock for the years ended December 31, 2014, 2013 and 2012, respectively, were not included in the calculation of diluted net income per common share because the effect of these instruments was anti-dilutive.

39

The following table sets forth the computation of basic and diluted net income per common share for the years ended December 31, 2014, 2013 and 2012, respectively:

	Years Ended December 31,
	2014		2013		2012
Income from continuing operations	$	33,217	$	32,933	$	16,313
Income from discontinued operations, net of tax	—		—		823
Net income	$	33,217	$	32,933	$	17,136
Less: Allocation to participating securities from continuing operations	—		—		(1,249		)
Allocation to participating securities from discontinued operations	—		—		(65		)
Total allocation to participating securities	—		—		(1,314		)
Net income attributable to common stockholders - basic	$	33,217	$	32,933	$	15,822
Basic income per common share from:
Continuing operations	$	0.71	$	0.72	$	0.36
Discontinued operations	—		—		0.02
Net income	$	0.71	$	0.72	$	0.38
Diluted income per common share from:
Continuing operations	$	0.69	$	0.69	$	0.35
Discontinued operations	—		—		0.02
Net income	$	0.69	$	0.69	$	0.37
Weighted average common shares outstanding—basic	46,504		45,963		41,632
Plus dilutive effect of potential common shares	1,582		1,824		5,077
Weighted average common shares outstanding—diluted	48,086		47,787		46,709

(q) Discontinued Operations

The results of operations of a disposal group held for sale or disposed is presented as discontinued operations when the underlying operations and cash flows of the disposal group will be, or have been, eliminated from the Company’s continuing operations and the Company no longer has the ability to influence the operating and/or financial policies of the disposal group. This assessment is made at the time the disposal group is classified as held for sale and for a one-year period after the sale of the disposal group. See Note (2), “Discontinued Operations,” for further information regarding the Company’s discontinued operations.

(r) Segment Information

Historically, the Company had four reportable segments: nurse and allied healthcare staffing, locum tenens staffing, physician permanent placement services and home healthcare services. During the fourth quarter of 2011, the Company announced the expected divestiture of its home healthcare services segment, which was completed in January 2012. As a result, the home healthcare services segment was classified as disposal group held for sale as of December 31, 2011, and its results of operations have been classified as discontinued operations for the year ended December 31, 2012.

The Company’s management relies on internal management reporting processes that provide revenue and operating income by reportable segment for making financial decisions and allocating resources. Segment operating income represents income before income taxes plus depreciation, amortization of intangible assets, share-based compensation expense, interest expense (net) and other, and unallocated corporate overhead. The Company’s management does not evaluate, manage or measure performance of segments using asset information; accordingly, asset information by segment is not prepared or disclosed.

40

The following table provides a reconciliation of revenue and segment operating income by reportable segment to consolidated results and was derived from each segment’s internal financial information as used for corporate management purposes:

	Years Ended December 31,
	2014		2013		2012
Revenue
Nurse and allied healthcare staffing	$	695,206	$	681,979	$	653,829
Locum tenens staffing	296,166		287,484		261,431
Physician permanent placement services	44,655		42,353		38,691
	$	1,036,027	$	1,011,816	$	953,951
Segment operating income
Nurse and allied healthcare staffing	$	87,246	$	82,458	$	75,907
Locum tenens staffing	30,985		24,712		21,613
Physician permanent placement services	9,818		8,929		7,868
	128,049		116,099		105,388
Unallocated corporate overhead	36,996		30,927		31,674
Depreciation and amortization	15,993		13,545		14,151
Share-based compensation	7,157		6,125		6,221
Interest expense, net (including loss on debt extinguishment of $3,113, $434, and $9,815 for the years ended December 31, 2014, 2013 and 2012, respectively), and other	9,237		9,665		26,019
Income from continuing operations before income taxes	$	58,666	$	55,837	$	27,323

(s) Reclassifications

Certain reclassifications have been made to certain of the prior years’ consolidated financial statements to conform to the current year presentation. Specifically, 1) payments made into the Company’s life insurance policies to assist in funding the deferred compensation plan were reclassified from cash flows from operating activities to cash flows from investing activities; and 2) changes in book overdraft were reclassified from cash flows from financing activities to changes in accounts payable and accrued expenses within cash flows from operating activities in the consolidated statement of cash flows for both the year ended December 31, 2013 and 2012. In addition, the Company reclassified expected insurance recoveries under its professional liability and workers compensation policies in the consolidated balance sheet for the year ended December 31, 2013 to conform to the current year presentation. Professional liability and workers compensation liabilities were previously presented net of insurance recoveries. For the fiscal year ended December 31, 2014, expected insurance recoveries are presented on a gross basis, with the short-term insurance receivable portion included within “Prepaid and other current assets” and the long-term portion included within “Other assets” on the consolidated balance sheet.

(2) Discontinued Operations

In January 2012, the Company completed the sale of its home healthcare services segment and the related results of operations have been classified as discontinued operations for the year ended December 31, 2012.

41

The following table represents the revenue and the components of discontinued operations, net of tax:

	Year Ended December 31, 2012
Revenue	$	3,885
Loss before income taxes	$	(547	)
Income tax benefit	183
Loss from discontinued operations	$	(364	)
Gain on sale of discontinued operations, before income taxes	$	3,825
Income tax expense	(2,638		)
Gain on sale of discontinued operations	$	1,187
Total income from discontinued operations	$	823

(3) Business Combinations and Equity Investment

Avantas Acquisition

On December 22, 2014, the Company completed its acquisition of Avantas, a leading provider of clinical labor management services, including workforce consulting, data analytics, predictive modeling and SaaS-based scheduling technology. The acquisition is intended to help enable the Company to provide a level of workforce predictability to clients that can be integrated with its workforce and staffing solutions. The acquisition is not considered a material business combination and, accordingly, pro forma information is not provided. The acquisition was funded through cash-on-hand and borrowings under the Company’s Revolver (as defined in Note (8), “Notes Payable and Credit Agreement”). The Company did not incur any material acquisition-related costs.

The Company accounted for the acquisition using the acquisition method of accounting and, accordingly, it recorded the tangible and intangible assets acquired and liabilities assumed at their estimated fair values as of the date of the acquisition. The total purchase price of $17,520 included $14,470 cash consideration paid, $1,650 cash holdback for potential claims indemnified by the Avantas shareholders and contingent earn-out with a fair value of $1,400. The acquisition agreement provides for a contingent earn-out payment of up to $8,500 to be paid in 2016 based on future operating performance. As of the date of this Annual Report on Form 10-K, the Company is still finalizing the allocation of the purchase price. The provisional items pending finalization are primarily related to tax matters, which the Company expects to complete during 2015.

The preliminary allocation of the purchase price consisted of $1,631 of fair value of tangible assets acquired, $3,821 of liabilities and deferred revenue assumed, $9,750 of goodwill and $9,960 of identified intangible assets. The intangible assets include the fair value of tradenames and trademarks, customer relationships and acquired technologies. The weighted average useful life of the acquired intangible assets subject to amortization is approximately 14 years. All goodwill recognized from this acquisition is deductible for tax purposes.

The results of operations of Avantas are included in the nurse and allied healthcare staffing segment in the Company’s consolidated financial statements since the date of acquisition.

42

ShiftWise Acquisition

On November 20, 2013, the Company completed its acquisition of ShiftWise, a leading national provider of web-based healthcare workforce solutions, including its VMS technology utilized by hospitals and other healthcare systems. The acquisition is not considered a material business combination and, accordingly, pro forma information is not provided. The acquisition was funded through cash-on-hand and the Company did not incur any material acquisition-related costs.

The Company accounted for the acquisition using the acquisition method of accounting and, accordingly, it recorded the tangible and intangible assets acquired and liabilities assumed at their estimated fair values as of the date of the acquisition. The purchase price of the acquisition totaled $39,500, of which $6,000 was deposited in escrow to satisfy any indemnification claims by the Company with respect to, among other customary items, breaches of representations, warranties and covenants by ShiftWise and post-closing purchase price adjustments. The $6,000 deposited in escrow is scheduled to be disbursed to the selling shareholders in three years following the closing date at $2,000 per annum minus any indemnification claims. In November 2014, $132 cash was released from escrow to the Company, and $1,568 cash was released from escrow to the former Shiftwise shareholders, under the terms of the acquisition agreement.

The allocation of the purchase price consisted of $9,899 of fair value of tangible assets acquired, $11,502 of liabilities assumed (including $2,701 of deferred tax liabilities), $21,313 of goodwill and $19,790 of identified intangible assets. The intangible assets include the fair value of tradenames and trademarks, customer relationships, non-compete agreements and acquired technologies. The weighted average useful life of the acquired intangible assets subject to amortization is approximately 8 years. There is no goodwill recognized as part of this acquisition that is deductible for tax purposes.

The results of operations of ShiftWise are included in the nurse and allied healthcare staffing segment in the Company’s consolidated financial statements since the date of acquisition.

Pipeline Equity Investment

In March 2014, the Company entered into an agreement (the “Pipeline Agreement”) under which it made an initial $2,000 investment in Pipeline Health Holdings LLC (“Pipeline”), a telepharmacy and pharmacy technology solutions provider. The Company’s ownership percentage in Pipeline at March 31, 2014 was approximately 9%. Under the Pipeline Agreement, the Company committed to invest up to an additional $3,000 contingent upon Pipeline reaching two milestone commitments within a year. In April and September 2014, the Company made the milestone investments of $1,000 and $2,000, respectively, which together with the initial investment represents an ownership percentage in Pipeline of approximately 18% as of December 31, 2014. The investment is accounted for under the equity method of accounting. The Company’s share of Pipeline’s results is included within “Interest expense, net, and other” in the accompanying audited consolidated statement of comprehensive income for the year ended December 31, 2014.

(4) Fair Value Measurement

Fair value represents the price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. When determining fair value, the Company considers the principal or most advantageous market in which the Company would conduct a transaction, in addition to the assumptions that market participants would use when pricing the related assets or liabilities, including non-performance risk.

A three-level hierarchy prioritizes the inputs to valuation techniques used to measure fair value and requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The three levels of the fair value hierarchy are as follows:

Level 1—Quoted prices in active markets for identical assets or liabilities.

Level 2—Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

Assets and Liabilities Measured on a Recurring Basis

43

The Company’s assets that are measured at fair value on a recurring basis include restricted cash equivalents and investments.

In addition, with the recent acquisition of Avantas, the Company has an obligation to pay earn-out consideration of up to $8,500 in cash, to the former selling shareholders, if certain future financial metrics are met by Avantas. The earn-out payment is expected to be determined in the second half of 2016. Expected cash flows are determined using the probability-weighted average of possible outcomes that would occur should certain financial metrics be reached. There is no market data available to use in valuing the contingent consideration, therefore, the Company developed its own assumptions related to the future financial performance of Avantas to evaluate the fair value of this liability. As such, the contingent consideration is classified within Level 3.

In connection with estimating the fair value of the contingent consideration, the Company estimates the weighted probability of Avantas earningeach of the five specified tiered earn-out amountsof $0, $1,500, $3,500, $5,500 and $8,500, whichareeach tied to the financial performance of Avantasduring the year ending June 30, 2016. An increase or decrease in the probability of achievement of an earn-out tierwill result in an increase or decrease to the estimated fair value of the contingent consideration.The Company will reassess the fair value each reporting period and adjust the liability to its then fair value.

The following tables present information about these assets and liabilities and indicate the fair value hierarchy of the valuation techniques utilized to determine such fair value:

	Fair Value Measurements as of December 31, 2014
	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
U.S. Treasury securities	$	5,291	$	5,291	$	—	$	—
Money market funds	335		335		—		—
Acquisition contingent consideration earn-out liability	1,400		—		—		1,400
Total financial assets measured at fair value	$	7,026	$	5,626	$	—	$	1,400

	Fair Value Measurements as of December 31, 2013
	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
U.S. Treasury securities	$	17,817	$	17,817	$	—	$	—
Money market funds	359		359		—		—
Total financial assets measured at fair value	$	18,176	$	18,176	$	—	$	—

The Company’s restricted cash equivalents and investments typically consist of U.S. Treasury securities and money market funds on deposit with financial institutions that serve as collateral for the Company’s outstanding letters of credit.

Assets Measured on a Non-Recurring Basis

The Company applies fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to its goodwill, indefinite-lived intangible assets, long-lived assets and equity method investment.

The Company evaluates goodwill at the reporting unit level and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. The Company determines the fair value of its reporting units based on a combination of inputs including the market capitalization of the Company as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. The Company determined the fair value of its indefinite-lived intangible assets using the income approach (relief-from-royalty method) based on Level 3 inputs.

44

The Company performed its annual impairment testing at each of October 31, 2014, 2013 and 2012, and determined there was no impairment of goodwill or its indefinite-lived intangibles. See Note (5), “Goodwill and Identifiable Intangible Assets” for additional information.

(5) Goodwill and Identifiable Intangible Assets

As of December 31, 2014 and 2013, the Company had the following acquired intangible assets:

	As of December 31, 2014							As of December 31, 2013
	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount
Intangible assets subject to amortization:
Staffing databases	$	3,020	$	(2,618	)	$	402	$	5,450	$	(4,444	)	$	1,006
Customer relationships	77,300		(32,971		)	44,329		72,990		(29,363		)	43,627
Tradenames and trademarks	17,540		(5,436		)	12,104		16,871		(6,203		)	10,668
Non-compete agreements	190		(72		)	118		1,666		(1,484		)	182
Acquired technology	7,030		(866		)	6,164		6,200		(886		)	5,314
Online courses	—		—			—		59		(59		)	—
	$	105,080	$	(41,963	)	$	63,117	$	103,236	$	(42,439	)	$	60,797
Intangible assets not subject to amortization: tradenames and trademarks						$	89,400						$	89,400
						$	152,517						$	150,197

Aggregate amortization expense for intangible assets was $7,639 and $6,503 for the years ended December 31, 2014 and 2013, respectively. Based on the current amount of intangibles subject to amortization, the estimated amortization expense as of December 31, 2014 is as follows:

	Amount
Year ending December 31, 2015	$	8,202
Year ending December 31, 2016	7,734
Year ending December 31, 2017	7,517
Year ending December 31, 2018	7,315
Year ending December 31, 2019	6,911
Thereafter	25,438
	$	63,117

The following table summarizes the activity related to the carrying value of goodwill by reportable segment:

	Nurse and Allied Healthcare Staffing			Locum Tenens Staffing		Physician Permanent Placement Services		Total
Balance, January 1, 2013	$	76,493		$	14,502	$	32,329	$	123,324
Goodwill acquired from ShiftWise acquisition	21,318			—		—		21,318
Balance, December 31, 2013	97,811			14,502		32,329		144,642
Goodwill adjustment for ShiftWise acquisition	(5		)	—		—		(5		)
Goodwill acquired from Avantas acquisition	9,750			—		—		9,750
Balance, December 31, 2014	$	107,556		$	14,502	$	32,329	$	154,387
Accumulated impairment loss as of December 31, 2013 and 2014	$	154,444		$	53,940	$	6,555	$	214,939

45

46

(6) Balance Sheet Details

The consolidated balance sheets detail is as follows as of December 31, 2014 and 2013:

	As of December 31,
	2014			2013
Prepaids and other current assets:
Prepaid expenses	$	10,350		$	8,128
Restricted cash	9,054			8,325
Income taxes receivable	3,503			3,084
Other current assets	4,643			7,094
Prepaids and other current assets	$	27,550		$	26,631
Fixed assets:
Furniture and equipment	$	17,761		$	16,413
Software	78,593			62,471
Leasehold improvements	5,340			5,305
	101,694			84,189
Accumulated depreciation and amortization	(68,814		)	(63,031		)
Fixed assets, net	$	32,880		$	21,158
Accounts payable and accrued expenses:
Trade accounts payable	$	30,039		$	37,288
Subcontractor payable	33,474			22,051
Professional liability reserve	7,380			10,158
Overdraft	6,338			233
Other	1,762			1,584
Accounts payable and accrued expenses	$	78,993		$	71,314
Accrued compensation and benefits:
Accrued payroll	$	21,857		$	17,216
Accrued bonuses	15,196			11,359
Accrued travel expense	2,413			2,203
Accrued health insurance reserve	1,871			2,021
Accrued workers compensation reserve	5,830			5,313
Deferred compensation	20,729			17,731
Other	99			106
Accrued compensation and benefits	$	67,995		$	55,949
Other long-term liabilities:
Workers compensation reserve	$	13,855		$	13,086
Professional liability reserve	30,722			27,414
Deferred rent	8,122			6,625
Unrecognized tax benefits	21,706			27,178
Other	3,269			2,717
Other long-term liabilities	$	77,674		$	77,020

47

(7) Income Taxes

The provision for income taxes from continuing operations for the years ended December 31, 2014, 2013 and 2012 consists of the following:

	Years Ended December 31,
	2014		2013		2012
Current income taxes:
Federal	$	10,787	$	17,268	$	3,334
State	2,883		2,605		727
Foreign	—		—		(2		)
Total	13,670		19,873		4,059
Deferred income taxes:
Federal	10,430		1,693		5,663
State	1,349		1,338		1,288
Total	11,779		3,031		6,951
Provision for income taxes from continuing operations	$	25,449	$	22,904	$	11,010

The Company’s income tax expense differs from the amount that would have resulted from applying the federal statutory rate of 35% to pretax income from continuing operations because of the effect of the following items during the years ended December 31, 2014, 2013 and 2012:

	Years Ended December 31,
	2014			2013			2012
Tax expense at federal statutory rate	$	20,533		$	19,543		$	9,563
State taxes, net of federal benefit	2,551			2,302			1,263
Non-deductible expenses	1,816			—			—
Unrecognized tax benefit	971			1,952			742
Other, net	(422		)	(893		)	(558		)
Income tax expense from continuing operations	$	25,449		$	22,904		$	11,010

48

The tax effects of temporary differences that give rise to significant portions of deferred tax assets and deferred tax liabilities are presented below as of December 31, 2014 and 2013:

	Years Ended December 31,
	2014			2013
Deferred tax assets:
Stock compensation	$	11,217		$	11,998
Deferred revenue	573			1,003
Allowance for doubtful accounts	1,467			1,552
Deferred compensation	8,142			7,116
Accrued expenses, net	20,475			23,078
Deferred rent	3,420			3,209
Net operating losses	14,354			19,841
State taxes	1,346			446
Other	2,265			1,803
Total deferred tax assets	$	63,259		$	70,046
Deferred tax liabilities:
Intangibles	$	(57,316	)	$	(56,121	)
Fixed assets	(8,453		)	(4,289		)
Prepaid expenses	(1,427		)	(1,259		)
Total deferred tax liabilities	$	(67,196	)	$	(61,669	)
Valuation allowance	$	(1,224	)	$	(1,205	)
Net deferred tax assets (liabilities)	$	(5,161	)	$	7,172

In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. Management believes it is more likely than not that the Company will realize the benefits of its deferred tax assets, net of the recorded valuation allowance.

The deferred tax assets related to net operating losses (“NOLs”) include NOLs from the 2010 NFI and 2013 ShiftWise acquisitions. The amount of NOL from acquired companies has been the subject of an evaluation under the NOL limitation rules of Internal Revenue Code (“IRC”) Section 382 and corresponding state authorities and the balances reflect these limitations.

The amount of federal NOL carryforward that is available for use in years subsequent to December 31, 2014 is $31,364, which is set to expire by 2029. The amount of state NOL carryforward that is available for use in years subsequent to December 31, 2014 is $47,688, which is set to expire at various dates between 2015 and 2032.

A summary of the changes in the amount of unrecognized tax benefits (excluding interest and penalties) for 2014, 2013 and 2012 is as follows:

	2014		2013		2012
Beginning balance of unrecognized tax benefits	$	22,573	$	21,415	$	21,221
Additions based on tax positions related to the current year	—		809		1,096
Additions based on tax positions of prior years	317		349		—
Reductions due to lapse of applicable statute of limitation	—		—		(902		)
Ending balance of unrecognized tax benefits	$	22,890	$	22,573	$	21,415

At December 31, 2014, if recognized, approximately $25,056 would affect the effective tax rate (including interest and penalties).

The Company recognizes interest and penalties related to unrecognized tax benefits in income tax expense. The Company has approximately $5,815, $4,605 and $3,178 of accrued interest and penalties related to unrecognized tax benefits at

49

December 31, 2014, 2013 and 2012, respectively. The amount of interest and penalties recognized in 2014, 2013 and 2012 were $1,211, $1,427 and $468, respectively.

The Company is subject to taxation in the U.S. and various states and foreign jurisdictions. With few exceptions, as of December 31, 2014, the Company is no longer subject to U.S. federal, state, local or foreign examinations by tax authorities for years before 2005. The Internal Revenue Service (“IRS”) completed its tax audit of the Company for the years 2007, 2008, 2009 and 2010, and issued a Revenue Agent Report (“RAR”) to the Company related to its completed tax examination. The RAR seeks adjustments to the Company’s taxable income for 2007-2010 and net operating loss carryforwards from 2005-2006. The adjustments to the Company’s taxable income relate to the proposed disallowance of certain per diems paid to our healthcare professionals. Concurrent with the RAR, the Company received an Employment Tax Examination Report (“ETER”) for 2009 and 2010. The ETER adjustments propose additional Company payroll tax liabilities and penalties related to the treatment of certain non-taxable per diem allowances and travel benefits. The positions in the RAR and ETER are mutually exclusive. The RAR and ETER contain multiple tax positions, some of which are contrary to each other. The Company has filed a Protest Letter for both the RAR and ETER and intends to defend its position. The Company has held several meetings with the IRS Appeals office throughout 2014. The Company does expect resolution of these matters within the next twelve months but cannot predict with certainty the timing of such resolution or an estimated settlement amount. However, the Company believes its reserves will be adequate to cover the anticipated settlement. Notwithstanding, the Company could adjust its provision for income taxes and/or contingent tax liability based on future developments.

The IRS began a separate 2011-2012 income and payroll tax audit during November 2013 and has recently completed its field work. We are awaiting the IRS exam report but do not expect the issues to be different than the issues raised in the last exam. The Company believes its reserve for unrecognized tax benefits and contingent tax issues is adequate with respect to all open years.

(8) Notes Payable and Credit Agreement

On April 18, 2014, the Company entered into a Credit Agreement (the “Credit Agreement”) with several lenders to provide for two credit facilities (the “New Credit Facilities”) to replace its prior credit facilities, including (A) a $225,000 secured revolving credit facility (the “Revolver”) that includes a $40,000 sublimit for the issuance of letters of credit and a $20,000 sublimit for swingline loans and (B) a $150,000 secured term loan credit facility (the “Term Loan”). In addition, the Credit Agreement provides that the Company may from time to time obtain an increase in the Revolver or the Term Loan or both in an aggregate principal amount not to exceed $125,000 subject to, among other conditions, the arrangement of additional commitments with financial institutions reasonably acceptable to the Company and the administrative agent.

The Revolver carries an unused fee of 0.25% to 0.35% per annum and each standby letter of credit issued under the Revolver is subject to a letter of credit fee ranging from 1.50% to 2.25% per annum of the average daily maximum amount available to be drawn under the standby letter of credit, in each case, depending on the Company’s consolidated leverage ratio, as calculated quarterly in accordance with the Credit Agreement. The Term Loan is subject to amortization of principal of 5.00% per year of the original Term Loan amount, which is $7,500 per annum, and payable in equal quarterly installments. Borrowings under the Term Loan and Revolver bear interest at floating rates, at the Company’s option, based upon either LIBOR plus a spread of 1.50% to 2.25% or a base rate plus a spread of 0.50% to 1.25%. The applicable spread is determined quarterly based upon the Company’s consolidated leverage ratio, as calculated quarterly in accordance with the Credit Agreement. The interest rate for the outstanding Term Loan was 1.9% on a LIBOR basis and the interest rate for the outstanding Revolver was 4.0% on a base rate basis as of December 31, 2014.

The Company used the proceeds from the New Credit Facilities to repay in full all outstanding indebtedness under its prior credit facilities and to pay related transaction costs.

In connection with obtaining the New Credit Facilities, the Company incurred $3,488 in fees paid to lenders and other third parties, which were capitalized and are amortized to interest expense over the term of the New Credit Facilities. In addition, the Company wrote off $3,113 of unamortized financing fees and original issue discount, which was recorded as loss on debt extinguishment in the accompanying consolidated statement of comprehensive income for the year ended December 31, 2014.

The New Credit Facilities are available for working capital, capital expenditures, permitted acquisitions and general corporate purposes of the Company. The maturity date of the New Credit Facilities is April 18, 2019. At December 31, 2014, the outstanding balance of the Term Loan was $144,375, of which $7,500 is due in the next 12 months, and there was $18,000 outstanding under the Revolver. At December 31, 2014, with $9,380 of outstanding letters of credit collaterialized by the Revolver, there was $197,620 of available credit under the Revolver.

50

Annual principal maturities of the Term Loan are as follows:

Year ending December 31, 2015	$	7,500
Year ending December 31, 2016	7,500
Year ending December 31, 2017	7,500
Year ending December 31, 2018	7,500
Thereafter	114,375
	$	144,375

The Company’s outstanding debt instruments at December 31, 2014 and 2013 were secured by substantially all of the assets of the Company and the common stock or equity interests of its domestic subsidiaries.

The Credit Agreement contains various customary affirmative and negative covenants, including restrictions on assumption of additional indebtedness, declaration and payment of dividends, dispositions of assets, consolidation into another entity and allowable investments. It also contains financial covenants that require the Company (1) not to exceed a certain maximum consolidated leverage ratio, as calculated in accordance with the Credit Agreement, which is initially set at 4.00 to 1.00 but ultimately steps down to 3.50 to 1.00 beginning with the fiscal quarter ending June 30, 2016, and (2) to maintain a minimum consolidated interest coverage ratio of 2.50 to 1.00, as calculated in accordance with the Credit Agreement.

Letters of Credit

At December 31, 2014, the Company maintained outstanding standby letters of credit totaling $15,006 as collateral in relation to its professional liability insurance agreements, workers compensation insurance agreements, and a corporate office lease agreement. Of the $15,006 outstanding letters of credit, the Company has collateralized $5,626 in cash, cash equivalents and investments and the remaining amount has been collateralized by the Revolver. Outstanding standby letters of credit at December 31, 2013 totaled $27,691.

(9) Retirement Plans

The Company maintains the AMN Services 401(k) Retirement Savings Plan (the “AMN Plan”), which the Company believes complies with the IRC Section 401(k) provisions. The AMN Plan covers all employees that meet certain age and other eligibility requirements. An annual discretionary matching contribution is determined by the Compensation and Stock Plan Committee of the Board of Directors each year. Employer contributions under the AMN Plan were $553, $165 and $0 for the years ended December 31, 2014, 2013 and 2012, respectively.

The Company has a deferred compensation plan for certain executives and key employees (the “Plan”). The Plan is not intended to be tax qualified and is an unfunded plan. The Plan is composed of deferred compensation and all related income and losses attributable thereto. Discretionary matching contributions to the Plan are made that vest incrementally so that the employee is fully vested in the match following five years of employment with the Company. Under the Plan, participants can defer up to 80% of their base salary, 90% of their bonus and 100% of their vested RSUs or vested PRSUs. An annual discretionary matching contribution is determined by the Compensation and Stock Plan Committee of the Board of Directors each year. Employer contributions under the Plan were $595, $384 and $343 for the years ended December 31, 2014, 2013 and 2012, respectively.

(10) Capital Stock

(a) Preferred Stock

The Company has 10,000 shares of preferred stock authorized for issuance in one or more series (including preferred stock designated as Series A Conditional Convertible Preferred Stock), at a par value of $0.01 per share.At December 31, 2014 and 2013, no shares of preferred stock were outstanding.

(b) Treasury Stock

In connection with the 2010 acquisition of NFI, 457 shares of the Company’s common stock remained in escrow as of December 31, 2012 for potential Company indemnification claims. During the second quarter of 2013, the Company and former NFI selling shareholders agreed to release all 457 shares in escrow as follows: 1) 204 shares were returned to the Company for settlement of certain indemnification claims, which were recorded as treasury stock and a $3,046 reduction to selling, general and administrative expenses for the year ended December 31, 2013; and 2) the remaining 253 shares were

51

released from escrow to the former NFI selling shareholders. During 2013, the Company cancelled and retired all 204 shares of treasury stock. Upon cancellation and retirement, these shares were returned to the status of authorized and unissued.

(11) Share-Based Compensation

(a) Equity Award Plans

Stock Option Plan

The Company established a stock option plan (the “Stock Option Plan”) to provide a means to attract and retain employees. 4,178 options were authorized for issuance to be granted under the Stock Option Plan. Unless otherwise provided at the time of the grant, the options vest and become exercisable in increments of 25% on each of the first four anniversaries of the date of grant. Options granted under the Stock Option Plan expire on the tenth anniversary of the grant date. On April 12, 2006, 371 shares of common stock reserved for future issuance under The Stock Option Plan were rolled into the Equity Plan, which is discussed below. There will be no further equity awards granted from the Stock Option Plan.

Equity Plan

The Company established the AMN Healthcare Equity Plan (as amended or amended and restated from time to time, the “Equity Plan”), which has been approved by the Company’s stockholders. At the time of the Equity Plan’s adoption in 2006, equity awards, based on the Company’s common stock, could be issued for a maximum of 723 shares plus the number of shares of common stock underlying any grants under the Stock Option Plan that are forfeited, canceled or terminated (other than by exercise) from and after the effective date of the Equity Plan. Pursuant to the Equity Plan, stock options and stock appreciation rights (“SARs”) granted have a maximum contractual life of ten years and exercise prices will be determined at the time of grant and will be no less than fair market value of the underlying common stock on the date of grant. Any shares to be issued under the Equity Plan will be issued by the Company from authorized but unissued common stock or shares of common stock reacquired by the Company. On April 18, 2007, April 9, 2009 and April 18, 2012, the Company amended the Equity Plan, with stockholder approval, to increase the number of shares authorized under the Equity Plan by 3,000, 1,850 and 2,400, respectively. At December 31, 2014 and 2013, respectively, 2,421 and 2,173 shares of common stock were reserved for future grants under the Equity Plan.

Other Plans

From time to time, we grant, and have granted, key employees inducement awards outside of the Equity Plan (collectively, “Other Plans”), which have consisted of SARs,options orRSUs, which generally have three-year cliff vesting with a potential for accelerated vesting based on the Company’s achievement of selected targeted financial performance. Although these awards are not made under the Equity Plan, the key terms and conditions of the grant are typically the same as equity awards made under the Equity Plan.

Additionally, in February 2014, the Company established the 2014 Employment Inducement Plan, which reserves for issuance 200 shares of common stock for prospective employees of the Company. As of December 31, 2014, 200 shares of common stock remained available for future grants under the 2014 Employment Inducement Plan.

(b) Share-Based Compensation

Restricted Stock Units

RSUs granted under the Equity Plan generally entitle the holder to receive, at the end of a vesting period, a specified number of shares of the Company’s common stock.

52

The following table summarizes RSU and PRSU activity for non-vested awards for the years ended December 31, 2014, 2013 and 2012:

	Number of Shares		Weighted Average Grant Date Fair Value per Share
Unvested at January 1, 2012	1,529		$	7.74
Granted—RSUs	459		$	6.70
Granted—PRSUs	465		$	8.15
Vested	(716	)	$	7.95
Canceled/forfeited/expired	(78	)	$	6.66
Unvested at December 31, 2012	1,659		$	7.53
Granted—RSUs	285		$	12.86
Granted—PRSUs	291		$	13.86
Vested	(588	)	$	7.02
Canceled/forfeited/expired	(10	)	$	13.06
Unvested at December 31, 2013	1,637		$	9.73
Granted—RSUs	361		$	13.76
Granted—PRSUs	535		$	14.97
Vested	(838	)	$	8.63
Canceled/forfeited/expired	(120	)	$	12.16
Unvested at December 31, 2014	1,575		$	11.95

As of December 31, 2014, there was $7,742 unrecognized compensation cost related to non-vested RSUs and PRSUs. The Company expects to recognize such cost over a period of 1.8 years. As of December 31, 2014 and 2013, the aggregate intrinsic value of the RSUs and PRSUs outstanding was $30,876 and $24,070, respectively.

Stock Options and SARs

Stock options entitle the holder to purchase, at the end of a vesting period, a specified number of shares of the Company’s common stock at a price per share set at the date of grant. SARs entitle the holder to receive, at the end of a vesting period, shares of the Company’s common stock equal in value to the difference between the exercise price of the SAR, which is set at the date of grant, and the fair market value of the Company’s common stock on the date of exercise.

53

A summary of stock option and SAR activity under the Stock Option Plan and the Equity Plan and Other Plans are as follows:

	Stock Option Plan				Equity Plan and Other Plans
	Number Outstanding		Weighted- Average Exercise Price per Share		Number Outstanding		Weighted- Average Exercise Price per Share
Outstanding at December 31, 2011	781		$	14.06	1,500		$	10.10
Granted	—		$	—	—		$	—
Exercised	(55	)	$	9.68	(143	)	$	8.10
Canceled/forfeited/expired	(28	)	$	15.63	(116	)	$	7.55
Outstanding at December 31, 2012	698		$	14.34	1,241		$	10.57
Granted	—		$	—	—		$	—
Exercised	(109	)	$	11.23	(132	)	$	8.31
Canceled/forfeited/expired	—		$	—	(13	)	$	15.19
Outstanding at December 31, 2013	589		$	14.92	1,096		$	10.78
Granted	—		$	—	—		$	—
Exercised	(117	)	$	14.86	(142	)	$	11.53
Canceled/forfeited/expired	(227	)	$	14.94	(6	)	$	19.69
Outstanding at December 31, 2014	245		$	14.93	948		$	10.61
Vested and expected to vest at December 31, 2014	245		$	14.93	948		$	10.61
Exercisable at December 31, 2014	245		$	14.93	948		$	10.61

As of December 31, 2014, all stock options and SARs were fully vested. The total intrinsic value of stock options and SARs exercised was $770, $980 and $453 for 2014, 2013 and 2012, respectively. At December 31, 2014 and 2013, the total intrinsic value of stock options and SARs outstanding and exercisable was $10,142 and $5,146, respectively.

Share-Based Compensation

Total share-based compensation expense for the years ended December 31, 2014, 2013 and 2012 was as follows:

	Years Ended December 31,
	2014			2013			2012
Share-based employee compensation, before tax	$	7,157		$	6,125		$	6,224
Related income tax benefits	(2,783		)	(2,383		)	(2,403		)
Share-based employee compensation, net of tax	$	4,374		$	3,742		$	3,821

(12) Commitments and Contingencies

(a) Legal

From time to time, the Company is involved in various lawsuits, claims, investigations, and proceedings that arise in the ordinary course of business. Additionally, some of its clients may also become subject to claims, governmental inquiries and investigations and legal actions relating to services provided by the Company’s healthcare professionals. From time to time, and depending upon the particular facts and circumstances, the Company may be subject to indemnification obligations under its contracts with such clients relating to these matters. Certain of above-referenced matters may include speculative claims for substantial or indeterminate amounts of damages. The Company records a liability when management believes that it is both probable that a loss has been incurred and the amount can be reasonably estimated. Significant judgment is required to determine both probability and the estimated amount. The Company reviews these provisions at least quarterly and adjusts them accordingly to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, and updated information. During the first quarter of 2014, the Company completed the settlement of a wage and hour class action (and a related action) for an immaterial amount. With regards to outstanding loss contingencies as of December 31, 2014, the Company believes that the amount or estimable range of reasonably possible loss, will not, either individually or in the aggregate, have a material a

54

dverse effect on its business, consolidated financial position, results of operations or cash flows. However, the outcome of litigation is inherently uncertain, and therefore, if one or more of these legal matters were resolved against the Company for amounts in excess of management’s expectations, the Company’s results of operations and financial condition, including in a particular reporting period, could be materially adversely affected.

(b) Leases

The Company leases certain office facilities and equipment under various operating leases. The Company recognizes rent expense on a straight-line basis over the lease term. Future minimum lease payments under noncancelable operating leases (with initial or remaining lease terms in excess of one year) as of December 31, 2014 are as follows:

	Operating Leases
Years ending December 31,
2015	$	13,215
2016	13,786
2017	12,271
2018	11,662
2019	11,783
Thereafter	92,949
Total minimum lease payments	$	155,666

On January 26, 2015, the Company entered into a 10-year operating lease agreement for office space in Dallas, Texas that will replace its current operating lease agreement for its Irving, Texas offices, which expires in August 2015. Base rent payments under the new lease agreement will begin in September 2015 and the total estimated base rent payments will be approximately $23,956 over the life of the lease, which has been included in the above total minimum lease payments table.

Rent expense under operating leases for continuing operations was $14,136, $14,205, and $15,187 for the years ended December 31, 2014, 2013 and 2012, respectively.

(13) Quarterly Financial Data (Unaudited)

	Year Ended December 31, 2014
	First Quarter		Second Quarter		Third Quarter		Fourth Quarter		Total Year
	(In thousands, except per share data)
Revenue	$	240,881	$	250,913	$	264,584	$	279,649	$	1,036,027
Gross profit	$	73,956	$	77,159	$	80,306	$	84,696	$	316,117
Net income	$	7,630	$	7,193	$	8,499	$	9,895	$	33,217
Net income per share from:
Basic	$	0.16	$	0.15	$	0.18	$	0.21	$	0.71
Diluted	$	0.16	$	0.15	$	0.18	$	0.20	$	0.69

55

	Year Ended December 31, 2013
	First Quarter		Second Quarter		Third Quarter		Fourth Quarter		Total Year
	(In thousands, except per share data)
Revenue	$	252,120	$	253,943	$	257,095	$	248,658	$	1,011,816
Gross profit	$	73,007	$	74,413	$	75,667	$	74,193	$	297,280
Net income	$	7,563	$	8,399	$	8,615	$	8,356	$	32,933
Net income per share from:
Basic	$	0.17	$	0.18	$	0.19	$	0.18	$	0.72
Diluted	$	0.16	$	0.18	$	0.18	$	0.17	$	0.69

(14) Subsequent Events

Onward Healthcare, Locum Leaders and Medefis Acquisition

On January 7, 2015, the Company completed its acquisition of Onward Healthcare, Locum Leaders and Medefis from OGH, LLC for $82,500 in cash. Onward Healthcare is a national nurse and allied healthcare staffing firm, Locum Leaders is a national locum tenens provider, and Medefis is a leading provider of a SaaS-based vendor management system for healthcare facilities.

56

Item 9. Changes In and Disagreements With Accountants on Accounting and Financial Disclosure

None.

Item 9A. Controls and Procedures

(1) Evaluation of Disclosure Controls and Procedures

We carried out an evaluation, under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures as of December 31, 2014 were effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms.

(2) Management’s Annual Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rule 13a-15(f) of the Exchange Act. Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. Based on our evaluation under the framework set forth in Internal Control—Integrated Framework (2013), management concluded that our internal control over financial reporting was effective as of December 31, 2014.

The effectiveness of our internal control over financial reporting as of December 31, 2014 has been audited by KPMG LLP, an independent registered public accounting firm, as stated in its report, which we include herein.

(3) Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during the quarter ended December 31, 2014 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

57

(4) Report of Independent Registered Public Accounting Firm

The Board of Directors and Stockholders

AMN Healthcare Services, Inc.:

We have audited AMN Healthcare Services, Inc. and subsidiaries’ (the Company) internal control over financial reporting as of December 31, 2014, based on criteria established in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Annual Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit.

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

In our opinion, AMN Healthcare Services, Inc. and subsidiaries maintained, in all material respects, effective internal control over financial reporting as of December 31, 2014, based on criteria established in InternalControl—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheets of AMN Healthcare Services, Inc. and subsidiaries as of December 31, 2014 and 2013, and the related consolidated statements of comprehensive income, stockholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2014, and our report dated February 24, 2015 expressed an unqualified opinion on those consolidated financial statements.

/s/ KPMG LLP

San Diego, California

February 24, 2015

58

Item 9B. Other Information

None.

PART III

Item 10. Directors, Executive Officers and Corporate Governance

Information required by this item, other than the information below concerning our Code of Ethics for Senior Financial Officers and stockholder recommended nominations, is incorporated by reference to the Proxy Statement to be distributed in connection with our Annual Meeting of Stockholders currently scheduled to be held on April 22, 2015 (the “2015 Annual Meeting Proxy Statement”) under the headings “Election of Directors – Nominees for the Board of Directors,” “Executive Compensation Disclosure – Non-Director Executive Officers,” “Security Ownership and Other Matters – Section 16(a) Beneficial Ownership Reporting Compliance,” the table set forth in “Corporate Governance – Committees of the Board” identifying, among other things, members of our Board committees, and “Corporate Governance – Committees of the Board – Audit Committee.”

We have adopted a Code of Ethics for Senior Financial Officers that applies to our principal executive officer, principal financial officer, and principal accounting officer or any person performing similar functions, which we post on our website in the “Corporate Governance” link located at www.amnhealthcare.com/investors. We intend to publish any amendment to, or waiver from, the Code of Ethics for Senior Financial Officers on our website. We will provide any person, without charge, a copy of such Code of Ethics upon written request, which may be mailed to 12400 High Bluff Drive, Suite 100, San Diego, California 92130, Attn: Corporate Secretary.

There have been no material changes to the procedures by which stockholders may recommend nominees to our Board since we last disclosed information related to such procedures.

Item 11. Executive Compensation

Information required by this item is incorporated by reference to the 2015 Annual Meeting Proxy Statement under the headings “Compensation, Discussion and Analysis,” “Executive Compensation Disclosure,” “Director Compensation and Stock Ownership Guidelines – Director Compensation Table,” “Corporate Governance – Board Role In Risk Oversight,” “Corporate Governance – Committees of the Board – Compensation Committee – Compensation Committee Interlocks and Insider Participation,” and “Compensation Committee Report.”

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Information required by this item, other than the information below concerning our equity compensation plans, is incorporated by reference to the 2015 Annual Meeting Proxy Statement under the heading “Security Ownership and Other Matters – Security Ownership of Certain Beneficial Owners and Management.”

59

The following table sets forth information as of December 31, 2014 regarding compensation plans under which our equity securities are authorized for issuance.

	(a)	(b)		(c)
	Number of Securities to be Issued upon Exercise of Outstanding Options, Warrants and Rights(1)	Weighted-Average Exercise Price  of Outstanding Options, Warrants and Rights ($)		Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected in Column (a))(2)
Plan Category
Equity compensation plans approved by security holders	2,673,682	$	12.01	2,420,588
Equity compensation plans not approved by security holders(3)	94,205	$	4.55	200,000
Total	2,767,887	$	11.50	2,620,588

(1) Includes stock options, SARs, RSUs and PRSUs. For purposes of this table, we set forth one share of common stock to be issued under the exercise of each SAR. Because of the nature of a SAR, the number of shares that are actually issued upon exercise of a SAR may be more or less than one share of common stock. The weighted-average exercise price set forth in this table excludes the effect of 573,113 shares of RSUs and 987,948 shares of PRSUs, which have no exercise price.

(2) We no longer issue awards under our Stock Option Plan. Under the Equity Plan, however, we may re-award shares that are forfeited, expired or settled for cash under our Stock Option Plan. Additionally, under the Equity Plan, each share (a) tendered or held back upon exercise of an option or settlement of an award to cover the exercise price or tax withholding with respect to an award, or (b) subject to SARs that are not issued in connection with the settlement of the SARs on exercise thereof, is made available to be re-awarded. This figure does not include shares underlying our Stock Option Plan or the Equity Plan that are forfeited, canceled or terminated after December 31, 2014. See “Item 8. Financial Statements and Supplementary Data—Notes to Consolidated Financial Statements—Note (11), Share-Based Compensation.”

(3) On occasion, we have made employee award inducement equity grants to key employees outside of the Equity Plan. Although these awards were made outside of the Equity Plan, the key terms and conditions of each grant are the same in all material respects as equity awards made under the Equity Plan. See additional information in “Item 8. Financial Statements and Supplementary Data—Notes to Consolidated Financial Statements—Note (11), Share-Based Compensation.” Additionally, in 2014, the Board adopted the Company’s 2014 Employment Inducement Plan under which we may issue up to 200,000 shares of our common stock to prospective employees. As of December 31, 2014, no equity awards had been made under the 2014 Employment Inducement Plan.

Item 13. Certain Relationships and Related Transactions, and Director Independence

Information required by this item is incorporated by reference to the 2015 Annual Meeting Proxy Statement under the headings “Corporate Governance – Board Policy on Conflicts of Interest and Related Party Transactions,” “Corporate Governance – Director Independence,” and “Corporate Governance – Committees of the Board.”

Item 14. Principal Accounting Fees and Services

Information required by this item is incorporated by reference to the 2015 Annual Meeting Proxy Statement under the heading “Ratification of the Selection of Independent Registered Public Accounting Firm.”

60

PART IV

Item 15. Exhibits and Financial Statement Schedules

(a) Documents filed as part of the report.

(1) Consolidated Financial Statements

Report of Independent Registered Public Accounting Firm

Consolidated Balance Sheets as of December 31, 2014 and 2013

Consolidated Statements of Comprehensive Income for the years ended December 31, 2014, 2013

and 2012

Consolidated Statements of Stockholders’ Equity for the years ended December 31, 2014, 2013 and 2012

Consolidated Statements of Cash Flows for the years ended December 31, 2014, 2013 and 2012

Notes to Consolidated Financial Statements

(2) Financial Statement Schedules

All schedules have been omitted because the required information is presented in the financial statements or notes thereto, the amounts involved are not significant or the schedules are not applicable.

(3) Exhibits

61

Exhibit Number	Description
2.1	Agreement and Plan of Merger dated as of December 16, 2014 by and among Onward Healthcare, Inc., AMN Healthcare, Inc., Terrell Acquisition Corp., and OGH, LLC (Incorporated by reference to Exhibit 2.1 of the Registrant’s Current Report on Form 8-K dated January 7, 2015, filed with the SEC on January 9, 2015).
3.1	Amended and Restated Certificate of Incorporation of AMN Healthcare Services, Inc. (Incorporated by reference to Exhibit 3.1 of the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2001, filed with the SEC on March 18, 2002).
3.2	Seventh Amended and Restated By-laws of AMN Healthcare Services, Inc., effective July 27, 2010 (Incorporated by reference to Exhibit 3.1 of the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2010, filed with the SEC on July 30, 2010).
3.3	Certificate of Designations of Series A Conditional Convertible Preferred Stock (Incorporated by reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K dated August 29, 2010, filed with the SEC on September 1, 2010).
4.1	Specimen Stock Certificate (Incorporated by reference to Exhibit 4.1 of the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2001, filed with the SEC on March 18, 2002).
4.2	Credit Agreement, dated as of April 18, 2014, by and among AMN Healthcare, Inc., as borrower, AMN Healthcare Services, Inc., AMN Services, LLC, O’Grady-Peyton International (USA), Inc., AMN Staffing Services, LLC, Merritt, Hawkins & Associates, LLC, AMN Healthcare Allied, Inc., Staff Care, Inc., AMN Allied Services, LLC, Rx Pro Health, LLC, Nursefinders, LLC, Linde Health Care Staffing, Inc., and Shiftwise, Inc., as guarantors, the lenders identified on the signature pages thereto, as lenders, and SunTrust Bank, as administrative agent (Incorporated by reference to Exhibit 4.1 filed with the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2014, filed with the SEC on August 1, 2014).
10.1	Office Lease, dated as of April 2, 2002, between Kilroy Realty, L.P. and AMN Healthcare, Inc. (Incorporated by reference to Exhibit 10.45 of the Registrant’s Registration Statement on Form S-1 (File No. 333-86952), filed with the SEC on April 25, 2002).
10.2	Third Amendment to Office Lease, dated as of June 30, 2014, between Kilroy Realty, L.P. and AMN Healthcare, Inc. (Incorporated by reference to Exhibit 10.1 filed with the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2014, filed with the SEC on August 1, 2014).
10.3	Stock Option Plan (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Appendix 2 of the Registrant’s Definitive Proxy Statement on Schedule 14A, filed with the SEC on April 14, 2004).
10.4	Form of Stock Option Plan Stock Option Agreement (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.6 filed with the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2005, filed with the SEC on May 9, 2005).
10.5	Stock Option Plan Stock Option Agreement, dated as of September 28, 2005, between AMN Healthcare Services, Inc. and Douglas D. Wheat (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.3 of the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2005, filed with the SEC on November 7, 2005).
10.6	Stock Option Plan Stock Option Agreement, dated as of September 28, 2005, between AMN Healthcare Services, Inc. and R. Jeffrey Harris (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.4 of the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2005, filed with the SEC on November 7, 2005).
10.7	AMN Healthcare Equity Plan, as Amended and Restated (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.1 filed with the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2014, filed with the SEC on May 2, 2014).
10.8	Form of AMN Healthcare Equity Plan Stock Appreciation Right Agreement—Director (Management Contract or Compensatory Plan or Arrangement).**
10.9	Form of AMN Healthcare Equity Plan Restricted Stock Unit Agreement—Director (Management Contract or Compensatory Plan or Arrangement).**
10.10	Form of AMN Healthcare Equity Plan Stock Appreciation Right Agreement—Officer (Management Contract or Compensatory Plan or Arrangement).**
10.11	Form of AMN Healthcare Equity Plan Restricted Stock Unit Agreement—Officer (Management Contract or Compensatory Plan or Arrangement).**

62

Exhibit Number	Description
10.12	Form of AMN Healthcare Equity Plan Restricted Stock Unit Agreement—Officer (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.1 of the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2010, filed with the SEC on May 7, 2010).
10.13	Form of AMN Healthcare Equity Plan Performance Restricted Stock Unit Agreement—Officer (TSR) (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.1 of the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2011, filed with the SEC on May 6, 2011).
10.14	Form of AMN Healthcare Equity Plan Restricted Stock Unit Agreement—Director (One Year Vesting and Settlement) (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.2 of the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2012, filed with the SEC on August 7, 2012).
10.15	Form of AMN Healthcare Equity Plan Performance Restricted Stock Unit Agreement—Officer (Adjusted EBITDA Margin) (Management Contract or Compensation Plan or Arrangement) (Incorporated by reference to Exhibit 10.1 of the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2013, filed with the SEC on May 3, 2013).
10.16	Form of AMN Healthcare Equity Plan Restricted Stock Unit Agreement—Officer (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.2 of the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2014, filed with the SEC on May 2, 2014).
10.17	Form of AMN Healthcare Equity Plan Performance Restricted Stock Unit Agreement—Officer (TSR) (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.3 of the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2014, filed with the SEC on May 2, 2014).
10.18	Form of AMN Healthcare Equity Plan Restricted Stock Unit Agreement—Director (One Year Vesting with Deferral) (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.4 of the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2014, filed with the SEC on May 2, 2014).
10.19	AMN Healthcare Services, Inc. Senior Management Bonus Plan, as Amended and Restated (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Appendix A of the Registrant’s Definitive Proxy Statement on Schedule 14A, filed on March 9, 2012).
10.20	The 2005 Amended and Restated Executive Nonqualified Excess Plan of AMN Healthcare, Inc., effective January 1, 2009 (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.2 of the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2008, filed with the SEC on November 7, 2008).
10.21	Employment Agreement, dated as of May 4, 2005, between AMN Healthcare, Inc. and Susan R. Nowakowski (aka Susan R. Salka) (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.3 of the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2005, filed with the SEC on May 9, 2005).
10.22	First Amendment to Employment Agreement, dated as of February 6, 2008, between AMN Healthcare, Inc. and Susan R. Nowakowski (aka Susan R. Salka) (Management Contract or Compensatory Plan or Arrangement).***
10.23	Executive Severance Agreement between AMN Healthcare, Inc. and Denise L. Jackson, dated February 6, 2008 (Management Contract or Compensatory Plan or Arrangement).***
10.24	Executive Severance Agreement between AMN Healthcare, Inc. and Ralph Henderson, dated February 6, 2008 (Management Contract or Compensatory Plan or Arrangement).***
10.25	Executive Severance Agreement between AMN Healthcare, Inc. and Brian M. Scott, effective as of January 24, 2011 (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 99.3 of the Registrant’s Current Report on Form 8-K dated January 3, 2011, filed with the SEC on January 5, 2011).
10.26	Form of Indemnification Agreement—Officer and Director (Incorporated by reference to Exhibit 10.14 of the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009, filed with the SEC on March 5, 2010).

63

Exhibit Number	Description
10.27	Stockholders Agreement between AMN Healthcare Services, Inc. and the Persons Listed on Schedule 1, dated July 28, 2010 (Incorporated by reference to Exhibit 10.1 of the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2010, filed with the SEC on July 30, 2010).
21.1	Subsidiaries of the Registrant.*
23.1	Consent of Independent Registered Public Accounting Firm.*
31.1	Certification by Susan R. Salka pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934.*
31.2	Certification by Brian M. Scott pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934.*
32.1	Certification by Susan R. Salka pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*
32.2	Certification by Brian M. Scott pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*
101.INS	XBRL Instance Document.*
101.SCH	XBRL Taxonomy Extension Schema Document.*
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document.*
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document.*
101.LAB	XBRL Taxonomy Extension Label Linkbase Document.*
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document.*

*	Filed herewith.
**	Incorporated by reference to the applicable exhibit of the Registrant’s Current Report on Form 8-K dated April 12, 2006, filed with the SEC on April 14, 2006.
***	Incorporated by reference to the applicable exhibit of the Registrant’s Current Report on Form 8-K dated February 12, 2008, filed with the SEC on February 12, 2008.

64

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

AMN HEALTHCARE SERVICES, INC.

/S/    SUSAN R. SALKA

Susan R. Salka

President and Chief Executive Officer

Date: February 24, 2015

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated and on February 24, 2015.

/S/    SUSAN R. SALKA

Susan R. Salka

Director, President and Chief Executive Officer

(Principal Executive Officer)

/S/    BRIAN M. SCOTT

Brian M. Scott

Chief Accounting Officer,

Chief Financial Officer and Treasurer

(Principal Accounting and Financial Officer)

/S/    DOUGLAS D. WHEAT

Douglas D. Wheat

Director and Chairman of the Board

/S/    MARK G. FOLETTA

Mark G. Foletta

Director

/S/    R. JEFFREY HARRIS

R. Jeffrey Harris

Director

/S/    MICHAEL M.E. JOHNS

Michael M.E. Johns

Director

/S/    MARTHA H. MARSH

Martha H. Marsh

Director

/S/    ANDREW M. STERN

Andrew M. Stern

Director

/S/    PAUL E. WEAVER

Paul E. Weaver

Director

65

EX-21.1

Exhibit 21.1

Subsidiaries of the Registrant, as of December 31, 2014

Subsidiary	Jurisdiction of Organization
AMN Allied Services, LLC	Delaware
AMN Healthcare Allied, Inc.	Texas
AMN Healthcare, Inc.	Nevada
AMN Services, LLC	North Carolina
AMN Staffing Services, LLC	Delaware
Avantas, LLC	Nebraska
Linde Health Care Staffing, Inc.	Missouri
Merritt, Hawkins & Associates, LLC	California
Nursefinders, LLC	Texas
O’Grady-Peyton International (Europe) Limited	United Kingdom
O’Grady Peyton International (India) Private Limited	India
O’Grady Peyton International Recruitment U.K.  Limited	United Kingdom
O’Grady-Peyton International (SA) (Proprietary)  Limited	South Africa
O’Grady-Peyton International (USA), Inc.	Massachusetts
Rx Pro Health, LLC	Colorado
ShiftWise, Inc.	Oregon
Spectrum Insurance Company, Inc.	Hawaii
Staff Care, Inc.	Delaware

EX-23.1

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

The Board of Directors

AMN Healthcare Services, Inc.:

We consent to the incorporation by reference in the registration statements (No. 333-73482, No. 333-117695, No. 333-133227, No. 333-133305, No. 333-142187, No. 333-158523, No. 333-180856, No. 333-180857, and No. 333-194484) on Form S-8 of AMN Healthcare Services, Inc. (the Company) of our reports dated February 24, 2015, with respect to the consolidated balance sheets of the Company and subsidiaries, as of December 31, 2014 and 2013, and the related consolidated statements of comprehensive income, stockholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2014, and the effectiveness of internal control over financial reporting as of December 31, 2014, which reports appear in the December 31, 2014 Annual Report on Form 10-K of AMN Healthcare Services, Inc.

/s/ KPMG LLP

San Diego, California

February 24, 2015

EX-31.1

Exhibit 31.1

Certification Pursuant To

Rule 13a-14(a) of the Securities Exchange Act of 1934

I, Susan R. Salka, certify that:

1. I have reviewed this report on Form 10-K of AMN Healthcare Services, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

/S/    SUSAN R. SALKA

Susan R. Salka

Director, President and Chief Executive Officer

(Principal Executive Officer)

Date: February 24, 2015

EX-31.2

Exhibit 31.2

Certification Pursuant To

Rule 13a-14(a) of the Securities Exchange Act of 1934

I, Brian M. Scott, certify that:

1. I have reviewed this report on Form 10-K of AMN Healthcare Services, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

/S/    BRIAN M. SCOTT

Brian M. Scott

Chief Accounting Officer,

Chief Financial Officer and Treasurer

(Principal Accounting and Financial Officer)

Date: February 24, 2015

EX-32.1

Exhibit 32.1

AMN Healthcare Services, Inc.

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of AMN Healthcare Services, Inc. (the “Company”) on Form 10-K for the period ended December 31, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Susan R. Salka, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/S/    SUSAN R. SALKA

Susan R. Salka

President and Chief Executive Officer

Date: February 24, 2015

EX-32.2

Exhibit 32.2

AMN Healthcare Services, Inc.

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of AMN Healthcare Services, Inc. (the “Company”) on Form 10-K for the period ended December 31, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Brian M. Scott, Chief Accounting Officer, Chief Financial Officer and Treasurer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/S/    BRIAN M. SCOTT

Brian M. Scott

Chief Accounting Officer,

Chief Financial Officer and Treasurer

Date: February 24, 2015

XML

Summary of Significant Accounting Policies - Segment (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended								12 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014 segment	Dec. 31, 2013	Dec. 31, 2012
Accounting Policies [Abstract]
Reportable business segments									4
Segment Reporting Information, Profit (Loss) [Abstract]
Revenue	$ 279,649	$ 264,584	$ 250,913	$ 240,881	$ 248,658	$ 257,095	$ 253,943	$ 252,120	$ 1,036,027	$ 1,011,816	$ 953,951
Operating income									67,903	65,502	53,342
Depreciation and amortization									15,993	13,545	14,151
Share-based compensation									7,157	6,125	6,221
Interest expense, net (including loss on debt extinguishment of $3,113, $434, and $9,815 for the years ended December 31, 2014, 2013 and 2012, respectively), and other									9,237	9,665	26,019
Income from continuing operations before income taxes									58,666	55,837	27,323
Loss on debt extinguishment									3,113	434	9,815
Operating Segments
Segment Reporting Information, Profit (Loss) [Abstract]
Revenue									1,036,027	1,011,816	953,951
Operating income									128,049	116,099	105,388
Operating Segments | Nurse and Allied Healthcare Staffing
Segment Reporting Information, Profit (Loss) [Abstract]
Revenue									695,206	681,979	653,829
Operating income									87,246	82,458	75,907
Operating Segments | Locum Tenens Staffing
Segment Reporting Information, Profit (Loss) [Abstract]
Revenue									296,166	287,484	261,431
Operating income									30,985	24,712	21,613
Operating Segments | Physician Permanent Placement Services
Segment Reporting Information, Profit (Loss) [Abstract]
Revenue									44,655	42,353	38,691
Operating income									9,818	8,929	7,868
Corporate, Non-Segment
Segment Reporting Information, Profit (Loss) [Abstract]
Unallocated corporate overhead									$ 36,996	$ 30,927	$ 31,674

XML

Notes Payable and Related Credit Agreement - Maturities (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2014
Maturities of Long-term Debt [Abstract]
Year ending December 31, 2015	$ 7,500
Year ending December 31, 2016	7,500
Year ending December 31, 2017	7,500
Year ending December 31, 2018	7,500
Thereafter	114,375
Total credit agreement debt	$ 144,375

XML

Income Taxes - Provision (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Current income taxes:
Federal	$ 10,787	$ 17,268	$ 3,334
State	2,883	2,605	727
Foreign	0	0	(2)
Total	13,670	19,873	4,059
Deferred income taxes:
Federal	10,430	1,693	5,663
State	1,349	1,338	1,288
Total	11,779	3,031	6,951
Income tax expense from continuing operations	$ 25,449	$ 22,904	$ 11,010

XML

Retirement Plans - 401(k) Retirement Savings Plan (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Compensation and Retirement Disclosure [Abstract]
Employer contributions, net of forfeitures	$ 553	$ 165	$ 0

XML

Goodwill and Identifiable Intangible Assets - Changes in the Carrying Amount of Goodwill (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 22, 2014
Goodwill [Roll Forward]
Beginning Balance			$ 123,324
Ending Balance	154,387	144,642	123,324
Accumulated impairment loss	214,939	214,939
Nurse and Allied Healthcare Staffing
Goodwill [Roll Forward]
Beginning Balance			76,493
Ending Balance	107,556	97,811	76,493
Accumulated impairment loss	154,444	154,444
Locum Tenens Staffing
Goodwill [Roll Forward]
Beginning Balance			14,502
Ending Balance	14,502	14,502	14,502
Accumulated impairment loss	53,940	53,940
Physician Permanent Placement Services
Goodwill [Roll Forward]
Beginning Balance			32,329
Ending Balance	32,329	32,329	32,329
Accumulated impairment loss	6,555	6,555
Shiftwise Acquisition
Goodwill [Roll Forward]
Goodwill adjustment for ShiftWise acquisition	(5)
Goodwill acquired from acquisition		21,318
Shiftwise Acquisition | Nurse and Allied Healthcare Staffing
Goodwill [Roll Forward]
Goodwill adjustment for ShiftWise acquisition	(5)
Goodwill acquired from acquisition		21,318
Shiftwise Acquisition | Locum Tenens Staffing
Goodwill [Roll Forward]
Goodwill adjustment for ShiftWise acquisition	0
Goodwill acquired from acquisition		0
Shiftwise Acquisition | Physician Permanent Placement Services
Goodwill [Roll Forward]
Goodwill adjustment for ShiftWise acquisition	0
Goodwill acquired from acquisition		0
Avantas Acquisition
Goodwill [Roll Forward]
Beginning Balance				9,750
Goodwill acquired from acquisition	9,750
Ending Balance				9,750
Avantas Acquisition | Nurse and Allied Healthcare Staffing
Goodwill [Roll Forward]
Goodwill acquired from acquisition	9,750
Avantas Acquisition | Locum Tenens Staffing
Goodwill [Roll Forward]
Goodwill acquired from acquisition	0
Avantas Acquisition | Physician Permanent Placement Services
Goodwill [Roll Forward]
Goodwill acquired from acquisition	$ 0

XML

Quarterly Financial Data (Unaudited) (Tables)

12 Months Ended

Dec. 31, 2014

Quarterly Financial Information Disclosure [Abstract]

Schedule of Quarterly Financial Information

	Year Ended December 31, 2014
	First Quarter		Second Quarter		Third Quarter		Fourth Quarter		Total Year
	(In thousands, except per share data)
Revenue	$	240,881	$	250,913	$	264,584	$	279,649	$	1,036,027
Gross profit	$	73,956	$	77,159	$	80,306	$	84,696	$	316,117
Net income	$	7,630	$	7,193	$	8,499	$	9,895	$	33,217
Net income per share from:
Basic	$	0.16	$	0.15	$	0.18	$	0.21	$	0.71
Diluted	$	0.16	$	0.15	$	0.18	$	0.20	$	0.69

	Year Ended December 31, 2013
	First Quarter		Second Quarter		Third Quarter		Fourth Quarter		Total Year
	(In thousands, except per share data)
Revenue	$	252,120	$	253,943	$	257,095	$	248,658	$	1,011,816
Gross profit	$	73,007	$	74,413	$	75,667	$	74,193	$	297,280
Net income	$	7,563	$	8,399	$	8,615	$	8,356	$	32,933
Net income per share from:
Basic	$	0.17	$	0.18	$	0.19	$	0.18	$	0.72
Diluted	$	0.16	$	0.18	$	0.18	$	0.17	$	0.69

XML

Capital Stock (Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Jun. 30, 2013
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Preferred stock total shares including Series A	10,000	10,000
Preferred stock, par value	$ 0.01	$ 0.01
Preferred Stock, Shares Outstanding	0	0
Treasury Stock, Number of Shares and Restriction Disclosures [Abstract]
Stock In Escrow For Indemnification Claims			457
Common Stock Released From Escrow				457
Treasury Stock, Shares		204		204
Holdback settlement in equity from prior acquisition	$ 0	$ 3,046	$ 0
Common Stock Returned To Former Acquired Company's Selling Shareholders				253

XML

Discontinued Operations (Tables)

12 Months Ended

Dec. 31, 2014

Discontinued Operation, Income (Loss) from Discontinued Operation Disclosures [Abstract]

Components of discontinued operations, net of tax

The following table represents the revenue and the components of discontinued operations, net of tax:

	Year Ended December 31, 2012
Revenue	$	3,885
Loss before income taxes	$	(547	)
Income tax benefit	183
Loss from discontinued operations	$	(364	)
Gain on sale of discontinued operations, before income taxes	$	3,825
Income tax expense	(2,638		)
Gain on sale of discontinued operations	$	1,187
Total income from discontinued operations	$	823

XML

Income Taxes - Deferred Tax Assets and Liabilities (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Deferred Tax Assets, Net [Abstract]
Stock compensation	$ 11,217	$ 11,998
Deferred revenue	573	1,003
Allowance for doubtful accounts	1,467	1,552
Deferred compensation	8,142	7,116
Accrued expenses, net	20,475	23,078
Deferred rent	3,420	3,209
Net operating losses	14,354	19,841
State taxes	1,346	446
Other	2,265	1,803
Total deferred tax assets	63,259	70,046
Deferred tax liabilities:
Intangibles	(57,316)	(56,121)
Fixed assets	(8,453)	(4,289)
Prepaid expenses	(1,427)	(1,259)
Total deferred tax liabilities	(67,196)	(61,669)
Valuation allowance	(1,224)	(1,205)
Net deferred tax assets (liabilities)	$ (5,161)	$ 7,172

XML

Fair Value Measurement - Financial Assets and Liabilities (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2014 tier	Dec. 31, 2013	Dec. 22, 2014
Schedule of financial assets and liabilities measured at fair value on recurring basis
Total financial assets measured at fair value	7,026	$ 18,176
Quoted Prices in Active Markets for Identical Assets (Level 1)
Schedule of financial assets and liabilities measured at fair value on recurring basis
Total financial assets measured at fair value	5,626	18,176
Significant Other Observable Inputs (Level 2)
Schedule of financial assets and liabilities measured at fair value on recurring basis
Total financial assets measured at fair value	0	0
Significant Unobservable Inputs (Level 3)
Schedule of financial assets and liabilities measured at fair value on recurring basis
Total financial assets measured at fair value	1,400	0
Avantas Acquisition
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent earn-out based on future operating performance			8,500
Securities (Assets) | US Treasury securities
Schedule of financial assets and liabilities measured at fair value on recurring basis
Total financial assets measured at fair value	5,291	17,817
Securities (Assets) | Money market funds
Schedule of financial assets and liabilities measured at fair value on recurring basis
Total financial assets measured at fair value	335	359
Securities (Assets) | Quoted Prices in Active Markets for Identical Assets (Level 1) | US Treasury securities
Schedule of financial assets and liabilities measured at fair value on recurring basis
Total financial assets measured at fair value	5,291	17,817
Securities (Assets) | Quoted Prices in Active Markets for Identical Assets (Level 1) | Money market funds
Schedule of financial assets and liabilities measured at fair value on recurring basis
Total financial assets measured at fair value	335	359
Securities (Assets) | Significant Other Observable Inputs (Level 2) | US Treasury securities
Schedule of financial assets and liabilities measured at fair value on recurring basis
Total financial assets measured at fair value	0	0
Securities (Assets) | Significant Other Observable Inputs (Level 2) | Money market funds
Schedule of financial assets and liabilities measured at fair value on recurring basis
Total financial assets measured at fair value	0	0
Securities (Assets) | Significant Unobservable Inputs (Level 3) | US Treasury securities
Schedule of financial assets and liabilities measured at fair value on recurring basis
Total financial assets measured at fair value	0	0
Securities (Assets) | Significant Unobservable Inputs (Level 3) | Money market funds
Schedule of financial assets and liabilities measured at fair value on recurring basis
Total financial assets measured at fair value	0	0
Contingent Consideration
Schedule of financial assets and liabilities measured at fair value on recurring basis
Total financial assets measured at fair value	1,400
Contingent Consideration | Quoted Prices in Active Markets for Identical Assets (Level 1)
Schedule of financial assets and liabilities measured at fair value on recurring basis
Total financial assets measured at fair value	0
Contingent Consideration | Significant Other Observable Inputs (Level 2)
Schedule of financial assets and liabilities measured at fair value on recurring basis
Total financial assets measured at fair value	0
Contingent Consideration | Significant Unobservable Inputs (Level 3)
Schedule of financial assets and liabilities measured at fair value on recurring basis
Total financial assets measured at fair value	1,400
Contingent Consideration | Avantas Acquisition | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Number of earn-out tiers	5
Earn-out Tier 1 | Contingent Consideration | Avantas Acquisition | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent earn-out based on future operating performance	0
Earn-out Tier 2 | Contingent Consideration | Avantas Acquisition | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent earn-out based on future operating performance	1,500
Earn-out Tier 3 | Contingent Consideration | Avantas Acquisition | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent earn-out based on future operating performance	3,500
Earn-out Tier 4 | Contingent Consideration | Avantas Acquisition | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent earn-out based on future operating performance	5,500
Earn-out Tier 5 | Contingent Consideration | Avantas Acquisition | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent earn-out based on future operating performance	8,500

XML

Summary of Significant Accounting Policies - Share-Based Compensation (Details)	12 Months Ended
	Dec. 31, 2014
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years
Performance Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Period for relative and absolute shareholder return	3 years
Minimum | Performance Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percent of target amount granted to be issued	0.00%
Maximum | Performance Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percent of target amount granted to be issued	175.00%
Vesting Period, Thirteen Month Aniversary of Grant Date | Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	33.00%
Vesting Period, Second Anniversary of Grant Date | Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	34.00%

XML

Income Taxes - Unrecognized Tax Benefits (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Income Tax Disclosure [Abstract]
Unrecognized tax benefits that would affect the effective tax rate	$ 25,056
Accrued interest and penalties related to uncertain tax positions	5,815	4,605	3,178
Interest and penalties recognized	1,211	1,427	468
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Beginning balance of unrecognized tax benefits	22,573	21,415	21,221
Additions based on tax positions related to the current year	0	809	1,096
Additions based on tax positions of prior years	317	349	0
Reductions due to lapse of applicable statute of limitation	0	0	(902)
Ending balance of unrecognized tax benefits	$ 22,890	$ 22,573	$ 21,415

XML

Share-Based Compensation - Share Based Compensation Expense (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Share-based employee compensation, before tax	$ 7,157	$ 6,125	$ 6,224
Related income tax benefits	(2,783)	(2,383)	(2,403)
Share-based employee compensation, net of tax	$ 4,374	$ 3,742	$ 3,821

XML

Balance Sheet Details (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Prepaids and other current assets:
Prepaid expenses	$ 10,350	$ 8,128
Restricted cash	9,054	8,325
Income taxes receivable	3,503	3,084
Other current assets	4,643	7,094
Prepaids and other current assets	27,550	26,631
Fixed assets:
Furniture and equipment	17,761	16,413
Software	78,593	62,471
Leasehold improvements	5,340	5,305
Fixed Assets, Gross	101,694	84,189
Accumulated depreciation and amortization	(68,814)	(63,031)
Fixed assets, net	32,880	21,158
Accounts payable and accrued expenses:
Trade accounts payable	30,039	37,288
Subcontractor payable	33,474	22,051
Professional liability reserve	7,380	10,158
Overdraft	6,338	233
Other	1,762	1,584
Accounts payable and accrued expenses	78,993	71,314
Accrued compensation and benefits:
Accrued payroll	21,857	17,216
Accrued bonuses	15,196	11,359
Accrued travel expense	2,413	2,203
Accrued health insurance reserve	1,871	2,021
Accrued workers compensation reserve	5,830	5,313
Deferred compensation	20,729	17,731
Other	99	106
Accrued compensation and benefits	67,995	55,949
Other long-term liabilities:
Workers compensation reserve	13,855	13,086
Professional liability reserve	30,722	27,414
Deferred rent	8,122	6,625
Unrecognized tax benefits	21,706	27,178
Other	3,269	2,717
Other long-term liabilities	$ 77,674	$ 77,020

XML

Summary of Significant Accounting Policies (Notes)

12 Months Ended

Dec. 31, 2014

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Summary of Significant Accounting Policies

(a) General

AMN Healthcare Services, Inc. was incorporated in Delaware on November 10, 1997. AMN Healthcare Services, Inc. and its subsidiaries (collectively, the “Company”) provide healthcare workforce solutions and staffing services at acute and sub-acute care hospitals and other healthcare facilities throughout the United States.

(b) Principles of Consolidation

The accompanying consolidated financial statements include the accounts of AMN Healthcare Services, Inc. and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

(c) Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. On an ongoing basis, the Company evaluates its estimates, including those related to asset impairment, accruals for self-insurance and compensation and related benefits, accounts receivable, contingencies and litigation, and income taxes. The Company bases these estimates on the information that is currently available and on various other assumptions that it believes are reasonable under the circumstances. Actual results could differ from those estimates under different assumptions or conditions.

(d) Cash and Cash Equivalents

The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents include currency on hand, deposits with financial institutions and highly liquid investments.

(e) Restricted Cash, Cash Equivalents and Investments

Restricted cash, cash equivalents and investments primarily represent the cash and U.S. Treasury securities on deposit with financial institutions that serve as collateral for the Company’s outstanding letters of credit and captive insurance subsidiary claim payments. The original maturity terms for the U.S. Treasury securities were between 3-months and 12-months. See Note (4), “Fair Value Measurement” and Note (8), “Notes Payable and Credit Agreement” for additional information.

(f) Fixed Assets

The Company records furniture, equipment, leasehold improvements and internal-use software at cost less accumulated amortization and depreciation. The Company records equipment acquired under capital leases at the present value of the future minimum lease payments. The Company capitalizes major additions and improvements, and expenses maintenance and repairs when incurred. The Company calculates depreciation on furniture, equipment and software using the straight-line method based on the estimated useful lives of the related assets (three to seven years). The Company amortizes leasehold improvements and equipment obtained under capital leases over the shorter of the term of the lease or their estimated useful lives. The Company includes amortization of equipment obtained under capital leases with depreciation expense in the accompanying consolidated financial statements.

The Company capitalizes costs it incurs to develop internal-use software during the application development stage. Application development stage costs generally include costs associated with internal-use software configuration, coding, installation and testing. The Company also capitalizes costs of significant upgrades and enhancements that result in additional functionality, whereas it expenses as incurred costs for maintenance and minor upgrades and enhancements. The Company amortizes capitalized costs using the straight-line method over three to seven years once the software is ready for its intended use.

The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset group to the future undiscounted net cash flows that are expected to be generated by the asset group. If such asset group is considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset group exceeds the fair value of the asset group. The Company reports assets to be disposed of at the lower of the carrying amount or fair value less costs to sell.

(g) Goodwill

The Company records as goodwill the portion of the purchase price that exceeds the fair value of net assets of entities acquired. The Company evaluates goodwill annually for impairment at the reporting unit level and whenever circumstances occur indicating that goodwill may be impaired. The Company may first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, after assessing the totality of events and circumstances, the Company determines that it is more likely than not that the fair value of the reporting unit is greater than its carrying amount, the quantitative impairment test is unnecessary. The performance of the quantitative impairment test involves a two-step process. The first step of the test involves comparing the fair value of the Company’s reporting units with the reporting unit’s carrying amount, including goodwill. The Company generally determines the fair value of its reporting units using a combination of the income approach (using discounted future cash flows) and the market valuation approach. If the carrying amount of the Company’s reporting units exceeds the reporting unit’s fair value, the Company performs the second step of the test to determine the amount of impairment loss. The second step of the test involves comparing the implied fair value of the Company’s reporting unit’s goodwill with the carrying amount of that goodwill. The amount by which the carrying value of the goodwill exceeds its implied fair value, if any, is recognized as an impairment loss.

(h) Intangible Assets

Intangible assets consist of identifiable intangible assets acquired through acquisitions. Identifiable intangible assets include tradenames and trademarks, customer relationships, non-compete agreements, staffing databases, acquired technology and online courses. The Company amortizes intangible assets, other than tradenames and trademarks with an indefinite life, using the straight-line method over their useful lives. The Company amortizes non-compete covenants using the straight-line method over the lives of the related agreements. The Company reviews for impairment intangible assets with estimable useful lives whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.

The Company does not amortize indefinite-lived tradenames and trademarks and instead reviews them for impairment annually. The Company may first perform a qualitative assessment to determine whether it is more likely than not that an indefinite-lived intangible asset is impaired. If, after assessing the totality of events and circumstances, the Company determines that it is more likely than not that the indefinite-lived intangible asset is not impaired, no quantitative fair value measurement is necessary. If a quantitative fair value measurement calculation is required for the indefinite-lived intangible assets, the Company compares the fair value of the Company’s indefinite-lived intangibles with their carrying amount. If the carrying amount exceeds the fair value, the Company records the excess as an impairment loss.

(i) Insurance Reserves

The Company maintains an accrual for professional liability that is included in accounts payable and accrued expenses and other long-term liabilities in the consolidated balance sheets. The expense is included in the selling, general and administrative expenses in the consolidated statement of comprehensive income. The Company determines the adequacy of this accrual by evaluating its historical experience and trends, loss reserves established by the Company’s insurance carriers, management and third-party administrators, and its independent actuarial studies. The Company obtains actuarial studies on a semi-annual basis that use the Company’s actual claims data and industry data to assist the Company in determining the adequacy of its reserves each year. For periods between the actuarial studies, the Company records its accruals based on loss rates provided in the most recent actuarial study and management's review of loss history. In November 2012, the Company established a captive insurance subsidiary, which provides coverage, on an occurrence basis, for professional liability within its nurse and allied healthcare staffing segment. Liabilities include provisions for estimated losses incurred but not yet reported (“IBNR”), as well as provisions for known claims. IBNR reserve estimates involve the use of assumptions and are primarily based upon historical loss experience, industry data and other actuarial assumptions. The Company maintains excess insurance coverage through a commercial carrier for losses above the per occurrence retention.

The Company maintains an accrual for workers compensation, which is included in accrued compensation and benefits and other long-term liabilities in the consolidated balance sheets. The Company determines the adequacy of this accrual by evaluating its historical experience and trends, loss reserves established by the Company’s insurance carriers and third-party administrators, and its independent actuarial studies. The Company obtains actuarial studies on a semi-annual basis that use the Company’s payroll and historical claims data, as well as industry data, to determine the appropriate reserve for both reported claims and IBNR claims for each policy year. For periods between the actuarial studies, the Company records its accruals based on loss rates provided in the most recent actuarial study.

(j) Revenue Recognition

Revenue consists of fees earned from the permanent and temporary placement of healthcare professionals. Revenue is recognized when earned and realizable. The Company has entered into certain contracts with healthcare organizations to provide managed services programs. Under these contract arrangements, the Company uses its healthcare professionals along with those of third-party subcontractors to fulfill client orders. If the Company uses subcontractors, it records revenue net of related subcontractors expense. The resulting net revenue represents the administrative fee the Company charges for its vendor management services. The Company is liable to the subcontractor after it receives payment from the client. The Company includes payables to subcontractors in accounts payable and accrued expenses in the consolidated balance sheets.

(k) Accounts Receivable

The Company records accounts receivable at the invoiced amount. Accounts receivable are non-interest bearing. The Company maintains an allowance for doubtful accounts for estimated credit losses resulting from collection risk, including the inability of customers to make required payments under contractual agreements. The allowance for doubtful accounts is reported as a reduction of accounts receivable in the consolidated balance sheets. The Company determines the adequacy of this allowance by evaluating historical delinquency and write-off trends, the financial condition and credit risk and history of each customer, historical payment trends as well as current economic conditions and the impact of such conditions on the customers’ liquidity and overall financial condition. The Company also maintains a sales allowance to reserve for potential credits issued to customers. The Company determines the amount of the reserve based on historical credits issued.

(l) Concentration of Credit Risk

The majority of the Company’s business activity is with hospitals located throughout the United States. Credit is extended based on the evaluation of each entity’s financial condition, and collateral is generally not required. Credit losses have been within management’s expectations. Other than one healthcare system, which comprised approximately 10% of the consolidated revenue of the Company for the fiscal year ended December 31, 2014, no client healthcare system exceeded 10% of consolidated revenue for the years ended December 31, 2014, 2013 or 2012. As of each of December 31, 2014 and 2013, accounts receivable from the Company’s top five clients represented approximately 12% of the net accounts receivable balance, excluding amounts due to subcontractors.

The Company’s cash and cash equivalents and restricted cash, cash equivalents and investments accounts are also financial instruments that are exposed to concentration of credit risk. The Company maintains its cash balances with high-credit quality and federally insured institutions. Cash balances may be invested in a non-federally insured money market account. As of December 31, 2014 and 2013, there were $19,567 and $23,115, respectively, of restricted cash, cash equivalents and investments primarily invested in a non-federally insured U.S. Treasury security account.

(m) Income Taxes

The Company records income taxes using the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period the changes are enacted. In assessing the realizability of deferred tax assets, the Company considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. The Company considers the scheduled reversal of deferred tax liabilities (including the impact of available carryback and carryforward periods), projected future taxable income, and tax-planning strategies in making this assessment. The Company recognizes the effect of income tax positions only if it is more likely than not that such positions will be sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company records interest and penalties related to unrecognized tax benefits in income tax expense.

(n) Fair Value of Financial Instruments

The carrying amounts of the Company’s cash equivalents and restricted cash equivalents approximate their respective fair values due to the short-term nature and liquidity of these financial instruments. The carrying amount of the Company’s notes payable approximates its fair value as the Company refinanced its credit facilities in 2014 and the instrument’s interest rates are variable (significant other observable inputs - level 2). See Note (8), “Notes Payable and Credit Agreement,” for additional information. The fair value of the long-term portion of the Company’s insurance accruals cannot be estimated as the Company cannot reasonably determine the timing of future payments.

(o) Share-Based Compensation

The Company accounts for its share-based employee compensation plans by expensing the estimated fair value of share-based awards on a straight-line basis over the requisite employee service period, which is the vesting period. Restricted stock units (“RSUs”) granted under the Equity Plan (as defined in Note (11), “Share-Based Compensation”) typically vest at the end of a three-year vesting period, however, 33% of the awards may vest on the 13th month anniversary of the grant date, and 34% on the second anniversary of the grant date, if certain performance targets are met. Share-based compensation cost of RSUs is measured by the market value of the Company’s common stock on the date of grant. Performance restricted stock units (“PRSUs”) granted under the Equity Plan typically consist of 1) PRSUs that contain a market condition with the ultimate realizable number of PRSUs dependent on relative and absolute total shareholder return over a three-year period, up to a maximum amount to be issued under the award of 175% of the original grant (“TSR PRSUs”), the fair values of which are estimated using the Monte-Carlo simulation valuation model and will not be adjusted for the achievement, or lack thereof, of the performance conditions; and 2) PRSUs that contain a performance condition, with the ultimate realizable number of PRSUs dependent on the adjusted EBITDA margin performance of the Company during a certain annual performance period, with a range of 0% to 175% of the target amount granted to be issued under the award. Share-based compensation cost for EBITDA margin PRSUs is measured by the market value of the Company’s common stock on the date of grant, and will be adjusted for estimated achievement of the performance conditions. Stock options and stock appreciation rights granted are measured on the date of grant using the Black-Scholes valuation model, which includes assumptions such as expected term of the award, stock price volatility, dividend rate and risk free interest rate. The Company also estimates the forfeiture rate and records share-based compensation expense only for those awards that are expected to vest.

(p) Net Income per Common Share

Securities that are entitled to participate in dividends with common stock, such as the Company’s Series A Conditional Convertible Preferred Stock (the “Preferred Stock”), are considered to be participating securities and the two-class method is used for purposes of calculating basic net income per share. Under the two-class method, a portion of net income is allocated to participating securities and excluded from the calculation of basic net income per common share. On December 21, 2012, all outstanding shares of Preferred Stock were converted into common stock; accordingly, for the two-class method calculation, the net income was allocated between common stock and Preferred Stock on a proportionate basis using a systematic and reasonable basis (based on number of days outstanding) for purpose of calculating the basic net income per share for the year ended December 31, 2012.

Share-based awards to purchase 298, 308 and 1,902 shares of common stock for the years ended December 31, 2014, 2013 and 2012, respectively, were not included in the calculation of diluted net income per common share because the effect of these instruments was anti-dilutive.

The following table sets forth the computation of basic and diluted net income per common share for the years ended December 31, 2014, 2013 and 2012, respectively:

	Years Ended December 31,
	2014		2013		2012
Income from continuing operations	$	33,217	$	32,933	$	16,313
Income from discontinued operations, net of tax	—		—		823
Net income	$	33,217	$	32,933	$	17,136
Less: Allocation to participating securities from continuing operations	—		—		(1,249		)
Allocation to participating securities from discontinued operations	—		—		(65		)
Total allocation to participating securities	—		—		(1,314		)
Net income attributable to common stockholders - basic	$	33,217	$	32,933	$	15,822
Basic income per common share from:
Continuing operations	$	0.71	$	0.72	$	0.36
Discontinued operations	—		—		0.02
Net income	$	0.71	$	0.72	$	0.38
Diluted income per common share from:
Continuing operations	$	0.69	$	0.69	$	0.35
Discontinued operations	—		—		0.02
Net income	$	0.69	$	0.69	$	0.37
Weighted average common shares outstanding—basic	46,504		45,963		41,632
Plus dilutive effect of potential common shares	1,582		1,824		5,077
Weighted average common shares outstanding—diluted	48,086		47,787		46,709

(q) Discontinued Operations

The results of operations of a disposal group held for sale or disposed is presented as discontinued operations when the underlying operations and cash flows of the disposal group will be, or have been, eliminated from the Company’s continuing operations and the Company no longer has the ability to influence the operating and/or financial policies of the disposal group. This assessment is made at the time the disposal group is classified as held for sale and for a one-year period after the sale of the disposal group. See Note (2), “Discontinued Operations,” for further information regarding the Company’s discontinued operations.

(r) Segment Information

Historically, the Company had four reportable segments: nurse and allied healthcare staffing, locum tenens staffing, physician permanent placement services and home healthcare services. During the fourth quarter of 2011, the Company announced the expected divestiture of its home healthcare services segment, which was completed in January 2012. As a result, the home healthcare services segment was classified as disposal group held for sale as of December 31, 2011, and its results of operations have been classified as discontinued operations for the year ended December 31, 2012.

The Company’s management relies on internal management reporting processes that provide revenue and operating income by reportable segment for making financial decisions and allocating resources. Segment operating income represents income before income taxes plus depreciation, amortization of intangible assets, share-based compensation expense, interest expense (net) and other, and unallocated corporate overhead. The Company’s management does not evaluate, manage or measure performance of segments using asset information; accordingly, asset information by segment is not prepared or disclosed.

The following table provides a reconciliation of revenue and segment operating income by reportable segment to consolidated results and was derived from each segment’s internal financial information as used for corporate management purposes:

	Years Ended December 31,
	2014		2013		2012
Revenue
Nurse and allied healthcare staffing	$	695,206	$	681,979	$	653,829
Locum tenens staffing	296,166		287,484		261,431
Physician permanent placement services	44,655		42,353		38,691
	$	1,036,027	$	1,011,816	$	953,951
Segment operating income
Nurse and allied healthcare staffing	$	87,246	$	82,458	$	75,907
Locum tenens staffing	30,985		24,712		21,613
Physician permanent placement services	9,818		8,929		7,868
	128,049		116,099		105,388
Unallocated corporate overhead	36,996		30,927		31,674
Depreciation and amortization	15,993		13,545		14,151
Share-based compensation	7,157		6,125		6,221
Interest expense, net (including loss on debt extinguishment of $3,113, $434, and $9,815 for the years ended December 31, 2014, 2013 and 2012, respectively), and other	9,237		9,665		26,019
Income from continuing operations before income taxes	$	58,666	$	55,837	$	27,323

(s) Reclassifications

Certain reclassifications have been made to certain of the prior years’ consolidated financial statements to conform to the current year presentation. Specifically, 1) payments made into the Company’s life insurance policies to assist in funding the deferred compensation plan were reclassified from cash flows from operating activities to cash flows from investing activities; and 2) changes in book overdraft were reclassified from cash flows from financing activities to changes in accounts payable and accrued expenses within cash flows from operating activities in the consolidated statement of cash flows for both the year ended December 31, 2013 and 2012. In addition, the Company reclassified expected insurance recoveries under its professional liability and workers compensation policies in the consolidated balance sheet for the year ended December 31, 2013 to conform to the current year presentation. Professional liability and workers compensation liabilities were previously presented net of insurance recoveries. For the fiscal year ended December 31, 2014, expected insurance recoveries are presented on a gross basis, with the short-term insurance receivable portion included within “Prepaid and other current assets” and the long-term portion included within “Other assets” on the consolidated balance sheet.

XML

Commitments and Contingencies - Capital and Operating Leases (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended			0 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Jan. 26, 2015
Subsequent Event [Line Items]
Total minimum lease payments	$ 155,666
Operating Leases
2015	13,215
2016	13,786
2017	12,271
2018	11,662
2019	11,783
Thereafter	92,949
Total minimum lease payments	155,666
Rent expense under operating leases for continuing operations	14,136	14,205	15,187
Subsequent Event
Subsequent Event [Line Items]
Operating lease agreement term				10 years
Total minimum lease payments				23,956
Operating Leases
Total minimum lease payments				$ 23,956

XML

Fair Value Measurement - Non-financial Assets and Liabilities (Details) (USD $)	0 Months Ended
	Oct. 31, 2014	Oct. 31, 2013	Oct. 31, 2012
Fair Value Disclosures [Abstract]
Impairment charges	$ 0	$ 0	$ 0
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)	$ 0	$ 0	$ 0

XML

Income Taxes (Tables)

12 Months Ended

Dec. 31, 2014

Income Tax Disclosure [Abstract]

Schedule of provision for income taxes from continuing operations

The provision for income taxes from continuing operations for the years ended December 31, 2014, 2013 and 2012 consists of the following:

	Years Ended December 31,
	2014		2013		2012
Current income taxes:
Federal	$	10,787	$	17,268	$	3,334
State	2,883		2,605		727
Foreign	—		—		(2		)
Total	13,670		19,873		4,059
Deferred income taxes:
Federal	10,430		1,693		5,663
State	1,349		1,338		1,288
Total	11,779		3,031		6,951
Provision for income taxes from continuing operations	$	25,449	$	22,904	$	11,010

Schedule of income tax reconciliation

The Company’s income tax expense differs from the amount that would have resulted from applying the federal statutory rate of 35% to pretax income from continuing operations because of the effect of the following items during the years ended December 31, 2014, 2013 and 2012:

	Years Ended December 31,
	2014			2013			2012
Tax expense at federal statutory rate	$	20,533		$	19,543		$	9,563
State taxes, net of federal benefit	2,551			2,302			1,263
Non-deductible expenses	1,816			—			—
Unrecognized tax benefit	971			1,952			742
Other, net	(422		)	(893		)	(558		)
Income tax expense from continuing operations	$	25,449		$	22,904		$	11,010

Schedule of deferred tax assets and liabilities

The tax effects of temporary differences that give rise to significant portions of deferred tax assets and deferred tax liabilities are presented below as of December 31, 2014 and 2013:

	Years Ended December 31,
	2014			2013
Deferred tax assets:
Stock compensation	$	11,217		$	11,998
Deferred revenue	573			1,003
Allowance for doubtful accounts	1,467			1,552
Deferred compensation	8,142			7,116
Accrued expenses, net	20,475			23,078
Deferred rent	3,420			3,209
Net operating losses	14,354			19,841
State taxes	1,346			446
Other	2,265			1,803
Total deferred tax assets	$	63,259		$	70,046
Deferred tax liabilities:
Intangibles	$	(57,316	)	$	(56,121	)
Fixed assets	(8,453		)	(4,289		)
Prepaid expenses	(1,427		)	(1,259		)
Total deferred tax liabilities	$	(67,196	)	$	(61,669	)
Valuation allowance	$	(1,224	)	$	(1,205	)
Net deferred tax assets (liabilities)	$	(5,161	)	$	7,172

Schedule of unrecognized tax benefits

A summary of the changes in the amount of unrecognized tax benefits (excluding interest and penalties) for 2014, 2013 and 2012 is as follows:

	2014		2013		2012
Beginning balance of unrecognized tax benefits	$	22,573	$	21,415	$	21,221
Additions based on tax positions related to the current year	—		809		1,096
Additions based on tax positions of prior years	317		349		—
Reductions due to lapse of applicable statute of limitation	—		—		(902		)
Ending balance of unrecognized tax benefits	$	22,890	$	22,573	$	21,415

XML

Balance Sheet Details (Tables)

12 Months Ended

Dec. 31, 2014

Balance Sheet Related Disclosures [Abstract]

Consolidated balance sheets detail

The consolidated balance sheets detail is as follows as of December 31, 2014 and 2013:

	As of December 31,
	2014			2013
Prepaids and other current assets:
Prepaid expenses	$	10,350		$	8,128
Restricted cash	9,054			8,325
Income taxes receivable	3,503			3,084
Other current assets	4,643			7,094
Prepaids and other current assets	$	27,550		$	26,631
Fixed assets:
Furniture and equipment	$	17,761		$	16,413
Software	78,593			62,471
Leasehold improvements	5,340			5,305
	101,694			84,189
Accumulated depreciation and amortization	(68,814		)	(63,031		)
Fixed assets, net	$	32,880		$	21,158
Accounts payable and accrued expenses:
Trade accounts payable	$	30,039		$	37,288
Subcontractor payable	33,474			22,051
Professional liability reserve	7,380			10,158
Overdraft	6,338			233
Other	1,762			1,584
Accounts payable and accrued expenses	$	78,993		$	71,314
Accrued compensation and benefits:
Accrued payroll	$	21,857		$	17,216
Accrued bonuses	15,196			11,359
Accrued travel expense	2,413			2,203
Accrued health insurance reserve	1,871			2,021
Accrued workers compensation reserve	5,830			5,313
Deferred compensation	20,729			17,731
Other	99			106
Accrued compensation and benefits	$	67,995		$	55,949
Other long-term liabilities:
Workers compensation reserve	$	13,855		$	13,086
Professional liability reserve	30,722			27,414
Deferred rent	8,122			6,625
Unrecognized tax benefits	21,706			27,178
Other	3,269			2,717
Other long-term liabilities	$	77,674		$	77,020

XML

Retirement Plans - Deferred Compensation Plan(Details) (Key Executives and Key Employees, USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Key Executives and Key Employees
Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]
Maximum Percent of Vested RSUs Deferrable	100.00%
Maximum Percent of Bonus Deferrable	90.00%
Maximum Percent of Base Salary Deferrable	80.00%
Service vesting period	5 years
Employer contributions	$ 595	$ 384	$ 343

XML

Goodwill and Identifiable Intangible Assets - Acquired Intangible Assets (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Schedule of Acquired Intangible Assets By Major Class [Line Items]
Gross Carrying Amount	$ 105,080	$ 103,236
Accumulated Amortization	(41,963)	(42,439)
Net Carrying Amount	63,117	60,797
Intangible assets excluding goodwill	152,517	150,197
Trade Names and Trademarks
Schedule of Acquired Intangible Assets By Major Class [Line Items]
Intangible assets not subject to amortization: tradenames and trademarks	89,400	89,400
Staffing Databases
Schedule of Acquired Intangible Assets By Major Class [Line Items]
Gross Carrying Amount	3,020	5,450
Accumulated Amortization	(2,618)	(4,444)
Net Carrying Amount	402	1,006
Customer Relationships
Schedule of Acquired Intangible Assets By Major Class [Line Items]
Gross Carrying Amount	77,300	72,990
Accumulated Amortization	(32,971)	(29,363)
Net Carrying Amount	44,329	43,627
Trade Names and Trademarks
Schedule of Acquired Intangible Assets By Major Class [Line Items]
Gross Carrying Amount	17,540	16,871
Accumulated Amortization	(5,436)	(6,203)
Net Carrying Amount	12,104	10,668
Non-compete Agreements
Schedule of Acquired Intangible Assets By Major Class [Line Items]
Gross Carrying Amount	190	1,666
Accumulated Amortization	(72)	(1,484)
Net Carrying Amount	118	182
Acquired Technology
Schedule of Acquired Intangible Assets By Major Class [Line Items]
Gross Carrying Amount	7,030	6,200
Accumulated Amortization	(866)	(886)
Net Carrying Amount	6,164	5,314
Online Courses
Schedule of Acquired Intangible Assets By Major Class [Line Items]
Gross Carrying Amount	0	59
Accumulated Amortization	0	(59)
Net Carrying Amount	$ 0	$ 0

XML

Notes Payable and Related Credit Agreement (Tables)

12 Months Ended

Dec. 31, 2014

Debt Disclosure [Abstract]

Schedule of annual principal maturities

Annual principal maturities of the Term Loan are as follows:

Year ending December 31, 2015	$	7,500
Year ending December 31, 2016	7,500
Year ending December 31, 2017	7,500
Year ending December 31, 2018	7,500
Thereafter	114,375
	$	144,375

XML

Share-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2014

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of stock option and SAR activity

A summary of stock option and SAR activity under the Stock Option Plan and the Equity Plan and Other Plans are as follows:

	Stock Option Plan				Equity Plan and Other Plans
	Number Outstanding		Weighted- Average Exercise Price per Share		Number Outstanding		Weighted- Average Exercise Price per Share
Outstanding at December 31, 2011	781		$	14.06	1,500		$	10.10
Granted	—		$	—	—		$	—
Exercised	(55	)	$	9.68	(143	)	$	8.10
Canceled/forfeited/expired	(28	)	$	15.63	(116	)	$	7.55
Outstanding at December 31, 2012	698		$	14.34	1,241		$	10.57
Granted	—		$	—	—		$	—
Exercised	(109	)	$	11.23	(132	)	$	8.31
Canceled/forfeited/expired	—		$	—	(13	)	$	15.19
Outstanding at December 31, 2013	589		$	14.92	1,096		$	10.78
Granted	—		$	—	—		$	—
Exercised	(117	)	$	14.86	(142	)	$	11.53
Canceled/forfeited/expired	(227	)	$	14.94	(6	)	$	19.69
Outstanding at December 31, 2014	245		$	14.93	948		$	10.61
Vested and expected to vest at December 31, 2014	245		$	14.93	948		$	10.61
Exercisable at December 31, 2014	245		$	14.93	948		$	10.61

Schedule of RSU activity for non-vested awards

The following table summarizes RSU and PRSU activity for non-vested awards for the years ended December 31, 2014, 2013 and 2012:

	Number of Shares		Weighted Average Grant Date Fair Value per Share
Unvested at January 1, 2012	1,529		$	7.74
Granted—RSUs	459		$	6.70
Granted—PRSUs	465		$	8.15
Vested	(716	)	$	7.95
Canceled/forfeited/expired	(78	)	$	6.66
Unvested at December 31, 2012	1,659		$	7.53
Granted—RSUs	285		$	12.86
Granted—PRSUs	291		$	13.86
Vested	(588	)	$	7.02
Canceled/forfeited/expired	(10	)	$	13.06
Unvested at December 31, 2013	1,637		$	9.73
Granted—RSUs	361		$	13.76
Granted—PRSUs	535		$	14.97
Vested	(838	)	$	8.63
Canceled/forfeited/expired	(120	)	$	12.16
Unvested at December 31, 2014	1,575		$	11.95

Schedule of share-based compensation expense

Total share-based compensation expense for the years ended December 31, 2014, 2013 and 2012 was as follows:

	Years Ended December 31,
	2014			2013			2012
Share-based employee compensation, before tax	$	7,157		$	6,125		$	6,224
Related income tax benefits	(2,783		)	(2,383		)	(2,403		)
Share-based employee compensation, net of tax	$	4,374		$	3,742		$	3,821

XML

Consolidated Statements of Cash Flows (Parenthetical) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Interest capitalized	$ 123	$ 63	$ 27

XML

Commitments and Contingencies (Tables)

12 Months Ended

Dec. 31, 2014

Commitments and Contingencies Disclosure [Abstract]

Schedule of Future Minimum Lease Payments

Future minimum lease payments under noncancelable operating leases (with initial or remaining lease terms in excess of one year) as of December 31, 2014 are as follows:

	Operating Leases
Years ending December 31,
2015	$	13,215
2016	13,786
2017	12,271
2018	11,662
2019	11,783
Thereafter	92,949
Total minimum lease payments	$	155,666

XML

Discontinued Operations Revenues and Components of Discontinued Operations (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Gain on sale of discontinued operations	$ 0	$ 0	$ 1,187
Total income from discontinued operations	0	0	823
Home Healthcare Services Segment
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenue			3,885
Loss before income taxes			(547)
Income tax benefit			183
Loss from discontinued operations			(364)
Gain on sale of discontinued operations, before income taxes			3,825
Income tax expense			(2,638)
Gain on sale of discontinued operations			1,187
Total income from discontinued operations			$ 823

XML

Notes Payable and Related Credit Agreement (Details) (USD $)	12 Months Ended	0 Months Ended
	Dec. 31, 2014	Apr. 18, 2014 credit_facility	Dec. 31, 2013
Line of Credit Facility [Line Items]
Long-term debt due in next 12 months	$ 7,500,000
Fees paid to lenders and other third parties	3,488,000
Write off of unamortized financing fees and original issue discount	3,113,000
Standby Letters of Credit
Line of Credit Facility [Line Items]
Letters of credit, amount outstanding	15,006,000		27,691,000
Debt Instrument, Collateral Amount	5,626,000
Line of Credit
Line of Credit Facility [Line Items]
Number of credit facilities		2
Credit facility, available		125,000,000
Line of Credit | Revolving Credit Facility
Line of Credit Facility [Line Items]
Credit facility, available		225,000,000
Interest rate	4.00%
Line of Credit | Revolving Credit Facility | Maximum
Line of Credit Facility [Line Items]
Unused fee, percent		0.35%
Letter of credit fee		2.25%
Line of Credit | Revolving Credit Facility | Minimum
Line of Credit Facility [Line Items]
Unused fee, percent		0.25%
Letter of credit fee		1.50%
Line of Credit | Term Loan
Line of Credit Facility [Line Items]
Long-term debt due in next 12 months	7,500,000
Credit facility, available		150,000,000
Amortization rate		5.00%
Annual principal payment		7,500,000
Interest rate	1.90%
Line of Credit | Letter of Credit
Line of Credit Facility [Line Items]
Credit facility, available		40,000,000
Debt Instrument, Collateral Amount	9,380,000
Line of Credit Facility, Remaining Borrowing Capacity	197,620,000
Line of Credit | Revolving Credit Facility, Swing Line Loan
Line of Credit Facility [Line Items]
Credit facility, available		20,000,000
Line of Credit | London Interbank Offered Rate (LIBOR) | Revolving Credit Facility | Maximum
Line of Credit Facility [Line Items]
Interest rates spread over LIBOR and Base rate		2.25%
Line of Credit | London Interbank Offered Rate (LIBOR) | Revolving Credit Facility | Minimum
Line of Credit Facility [Line Items]
Interest rates spread over LIBOR and Base rate		1.50%
Line of Credit | London Interbank Offered Rate (LIBOR) | Term Loan | Maximum
Line of Credit Facility [Line Items]
Interest rates spread over LIBOR and Base rate		2.25%
Line of Credit | London Interbank Offered Rate (LIBOR) | Term Loan | Minimum
Line of Credit Facility [Line Items]
Interest rates spread over LIBOR and Base rate		1.50%
Line of Credit | Base Rate | Revolving Credit Facility | Maximum
Line of Credit Facility [Line Items]
Interest rates spread over LIBOR and Base rate		1.25%
Line of Credit | Base Rate | Revolving Credit Facility | Minimum
Line of Credit Facility [Line Items]
Interest rates spread over LIBOR and Base rate		0.50%
Line of Credit | Base Rate | Term Loan | Maximum
Line of Credit Facility [Line Items]
Interest rates spread over LIBOR and Base rate		1.25%
Line of Credit | Base Rate | Term Loan | Minimum
Line of Credit Facility [Line Items]
Interest rates spread over LIBOR and Base rate		0.50%
Term Loan Due April 2019 [Member] | Line of Credit | Term Loan
Line of Credit Facility [Line Items]
Long-term Debt, Gross	144,375,000
Revolver Facility Due April 2019 | Line of Credit | Revolving Credit Facility
Line of Credit Facility [Line Items]
Long-term Debt, Gross	$ 18,000,000
Credit Agreement
Line of Credit Facility [Line Items]
Initial maximum consolidated leverage ratio	4.00
Stepped-down maximum consolidated leverage ratio	3.50
Minimum consolidated interest coverage ratio	2.50

XML

Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Current assets:
Cash and cash equivalents	$ 13,073	$ 15,580
Accounts receivable, net of allowances of $4,515 and $5,118 at December 31, 2014 and 2013, respectively	186,274	147,477
Accounts receivable, subcontractor	28,443	18,271
Deferred income taxes, net	27,330	24,938
Prepaid and other current assets	27,550	26,631
Total current assets	282,670	232,897
Restricted cash, cash equivalents and investments	19,567	23,115
Fixed assets, net of accumulated depreciation of $68,814 and $63,031 at December 31, 2014 and 2013, respectively	32,880	21,158
Other assets	39,895	32,279
Goodwill	154,387	144,642
Intangible assets, net of accumulated amortization of $41,963 and $42,439 at December 31, 2014 and 2013, respectively	152,517	150,197
Total assets	681,916	604,288
Current liabilities:
Accounts payable and accrued expenses	78,993	71,314
Accrued compensation and benefits	67,995	55,949
Revolving credit facility	18,000	10,000
Current portion of notes payable	7,500	0
Deferred revenue	3,177	1,373
Other current liabilities	2,630	4,454
Total current liabilities	178,295	143,090
Notes payable, net of discount	136,875	148,672
Deferred income taxes, net	32,491	17,764
Other long-term liabilities	77,674	77,020
Total liabilities	425,335	386,546
Commitments and contingencies and subsequent events
Stockholders’ equity:
Preferred stock, $0.01 par value; 10,000 shares authorized; none issued and outstanding at December 31, 2014 and 2013	0	0
Common stock, $0.01 par value; 200,000 shares authorized; 46,639 and 46,011 shares issued and outstanding at December 31, 2014 and 2013, respectively	466	460
Additional paid-in capital	434,529	429,055
Accumulated deficit	(178,058)	(211,275)
Accumulated other comprehensive loss	(356)	(498)
Total stockholders’ equity	256,581	217,742
Total liabilities and stockholders’ equity	$ 681,916	$ 604,288

XML

Goodwill and Identifiable Intangible Assets - Estimated Amortization Expense (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Goodwill and Intangible Assets Disclosure [Abstract]
Aggregate amortization expense, intangible assets	$ 7,639	$ 6,503
Year ending December 31, 2015	8,202
Year ending December 31, 2016	7,734
Year ending December 31, 2017	7,517
Year ending December 31, 2018	7,315
Year ending December 31, 2019	6,911
Thereafter	25,438
Net Carrying Amount	$ 63,117	$ 60,797

XML

Consolidated Statement of Stockholders' Equity (USD $) In Thousands, unless otherwise specified	Total	Common Stock	Additional Paid-in Capital	Treasury Stock	Accumulated Deficit	Accumulated Other Comprehensive Gain (Loss)
Balance at Dec. 31, 2011	$ 135,659	$ 405	$ 394,958	$ 0	$ (259,331)	$ (373)
Balance, Shares at Dec. 31, 2011		40,454		0
Statement of Stockholders' Equity [Roll Forward]
Equity awards vested and issued and exercised, shares		486
Equity awards vested and issued and exercised, net of shares withheld for payroll taxes	(545)	5	(550)
Preferred Stock converted to common stock, shares		4,751
Preferred Stock converted to common stock	24,039	47	23,992
Preferred Stock retirement	37		37
Income tax shortfall from equity awards vested and exercised	(369)		(369)
Share-based compensation	6,224		6,224
Comprehensive income	17,066				17,136	(70)
Balance at Dec. 31, 2012	182,111	457	424,292	0	(242,195)	(443)
Balance, Shares at Dec. 31, 2012		45,691		0
Statement of Stockholders' Equity [Roll Forward]
Equity awards vested and issued and exercised, shares		524
Equity awards vested and issued and exercised, net of shares withheld for payroll taxes	(1,493)	5	(1,498)
Settlement of acquisition share holdback	(3,046)			(3,046)
Treasury stock retirement, shares		(204)		0
Treasury stock retirement	0	(2)	(1,031)	3,046	(2,013)
Income tax benefit from equity awards vested and exercised	1,167		1,167
Share-based compensation	6,125		6,125
Comprehensive income	32,878				32,933	(55)
Balance at Dec. 31, 2013	217,742	460	429,055	0	(211,275)	(498)
Balance, Shares at Dec. 31, 2013		46,011		0
Statement of Stockholders' Equity [Roll Forward]
Equity awards vested and issued and exercised, shares		628
Equity awards vested and issued and exercised, net of shares withheld for payroll taxes	(2,655)	6	(2,661)
Income tax benefit from equity awards vested and exercised	978		978
Share-based compensation	7,157		7,157
Comprehensive income	33,359				33,217	142
Balance at Dec. 31, 2014	$ 256,581	$ 466	$ 434,529	$ 0	$ (178,058)	$ (356)
Balance, Shares at Dec. 31, 2014		46,639		0

XML

Share-Based Compensation - Restricted Stock Units (Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Number of Shares
Unvested Shares, Beginning Balance	1,637	1,659	1,529
Vested shares	(838)	(588)	(716)
Canceled/forfeited/expired shares	(120)	(10)	(78)
Unvested Shares, Ending Balance	1,575	1,637	1,659
Weighted Average Grant Date Fair Value (usd per share) per Share
Unvested weighted average fair value per share, Beginning Balance	$ 9.73	$ 7.53	$ 7.74
Vested weighted average fair value per share	$ 8.63	$ 7.02	$ 7.95
Canceled/forfeited/expired weighted average fair value per share	$ 12.16	$ 13.06	$ 6.66
Unvested weighted average fair value per share, Ending Balance	$ 11.95	$ 9.73	$ 7.53
Restricted Stock Units (RSUs)
Number of Shares
Granted shares	361	285	459
Weighted Average Grant Date Fair Value (usd per share) per Share
Granted weighted average fair value per share	$ 13.76	$ 12.86	$ 6.70
Performance Restricted Stock Units
Number of Shares
Granted shares	535	291	465
Weighted Average Grant Date Fair Value (usd per share) per Share
Granted weighted average fair value per share	$ 14.97	$ 13.86	$ 8.15

XML

Summary of Significant Accounting Policies - Fixed Assets (Details)	12 Months Ended
	Dec. 31, 2014
Furniture, Equipment and Software | Minimum
Property, Plant and Equipment [Line Items]
Fixed Assets, Useful Life	3 years
Furniture, Equipment and Software | Maximum
Property, Plant and Equipment [Line Items]
Fixed Assets, Useful Life	7 years
Software Development | Minimum
Property, Plant and Equipment [Line Items]
Fixed Assets, Useful Life	3 years
Software Development | Maximum
Property, Plant and Equipment [Line Items]
Fixed Assets, Useful Life	7 years

XML

Subsequent Events (Notes)

12 Months Ended

Dec. 31, 2014

Subsequent Events [Abstract]

Subsequent Events

Subsequent Events

Onward Healthcare, Locum Leaders and Medefis Acquisition

On January 7, 2015, the Company completed its acquisition of Onward Healthcare, Locum Leaders and Medefis from OGH, LLC for $82,500 in cash. Onward Healthcare is a national nurse and allied healthcare staffing firm, Locum Leaders is a national locum tenens provider, and Medefis is a leading provider of a SaaS-based vendor management system for healthcare facilities.

XML

Summary of Significant Accounting Policies - Concentration of Credit Risk (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Concentration Risk [Line Items]
Restricted cash, cash equivalents and investments	19,567	23,115
Healthcare System | Consolidated Revenue | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk, number of customers	1
Concentration risk percentage	10.00%
Major Customers, Top Five Clients | Accounts Receivable | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk percentage	12.00%	12.00%

XML

Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2014

Accounting Policies [Abstract]

Computation of basic and diluted net income (loss) per common share

The following table sets forth the computation of basic and diluted net income per common share for the years ended December 31, 2014, 2013 and 2012, respectively:

	Years Ended December 31,
	2014		2013		2012
Income from continuing operations	$	33,217	$	32,933	$	16,313
Income from discontinued operations, net of tax	—		—		823
Net income	$	33,217	$	32,933	$	17,136
Less: Allocation to participating securities from continuing operations	—		—		(1,249		)
Allocation to participating securities from discontinued operations	—		—		(65		)
Total allocation to participating securities	—		—		(1,314		)
Net income attributable to common stockholders - basic	$	33,217	$	32,933	$	15,822
Basic income per common share from:
Continuing operations	$	0.71	$	0.72	$	0.36
Discontinued operations	—		—		0.02
Net income	$	0.71	$	0.72	$	0.38
Diluted income per common share from:
Continuing operations	$	0.69	$	0.69	$	0.35
Discontinued operations	—		—		0.02
Net income	$	0.69	$	0.69	$	0.37
Weighted average common shares outstanding—basic	46,504		45,963		41,632
Plus dilutive effect of potential common shares	1,582		1,824		5,077
Weighted average common shares outstanding—diluted	48,086		47,787		46,709

Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results

The following table provides a reconciliation of revenue and segment operating income by reportable segment to consolidated results and was derived from each segment’s internal financial information as used for corporate management purposes:

	Years Ended December 31,
	2014		2013		2012
Revenue
Nurse and allied healthcare staffing	$	695,206	$	681,979	$	653,829
Locum tenens staffing	296,166		287,484		261,431
Physician permanent placement services	44,655		42,353		38,691
	$	1,036,027	$	1,011,816	$	953,951
Segment operating income
Nurse and allied healthcare staffing	$	87,246	$	82,458	$	75,907
Locum tenens staffing	30,985		24,712		21,613
Physician permanent placement services	9,818		8,929		7,868
	128,049		116,099		105,388
Unallocated corporate overhead	36,996		30,927		31,674
Depreciation and amortization	15,993		13,545		14,151
Share-based compensation	7,157		6,125		6,221
Interest expense, net (including loss on debt extinguishment of $3,113, $434, and $9,815 for the years ended December 31, 2014, 2013 and 2012, respectively), and other	9,237		9,665		26,019
Income from continuing operations before income taxes	$	58,666	$	55,837	$	27,323

XML

Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Cash flows from operating activities:
Net income	$ 33,217	$ 32,933	$ 17,136
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	15,993	13,545	14,151
Non-cash interest expense and other	1,392	1,336	2,921
Increase in allowances for doubtful accounts and sales credits	4,393	4,628	6,786
Provision for deferred income taxes	11,779	3,031	6,951
Share-based compensation	7,157	6,125	6,224
Excess tax benefit from share-based compensation	(1,819)	(1,521)	(44)
Holdback settlement in equity from prior acquisition	0	(3,046)	0
Gain on sale of discontinued operations	0	0	(1,187)
Loss on disposal or sale of fixed assets	60	14	32
Loss on debt extinguishment	3,113	434	9,815
Changes in assets and liabilities, net of effects from acquisition and divestiture:
Accounts receivable	(41,958)	(8,644)	(2,642)
Accounts receivable, subcontractor	(10,172)	196	4,030
Income taxes receivable	768	(1,572)	3,035
Prepaid expenses and other current assets	(13)	3,226	(8,684)
Other assets	(268)	(11,865)	(1,537)
Accounts payable and accrued expenses	6,125	6,244	(680)
Accrued compensation and benefits	11,515	6,367	5,794
Other liabilities	(4,488)	13,129	(3,029)
Deferred Revenue	(114)	(90)	(692)
Restricted cash, cash equivalents and investments balance	(9,002)	(4,301)	0
Net cash provided by operating activities	27,678	60,169	58,380
Cash flows from investing activities:
Purchase and development of fixed assets	(19,134)	(9,047)	(5,472)
Change in restricted cash, cash equivalents and investments balance	12,550	47	(617)
Equity method investment	(5,000)	0	0
Payments to fund deferred compensation plan	(2,174)	(1,298)	(1,383)
Cash paid for acquisitions, net of cash received	(14,470)	(39,500)	0
Proceeds from sales of assets held for sale	0	600	9,050
Net cash provided by (used in) investing activities	(28,228)	(49,198)	1,578
Cash flows from financing activities:
Capital lease repayments	(529)	(681)	(650)
Payments on term loan	(155,245)	(10,000)	(246,880)
Proceeds from term loan	150,000	0	198,000
Payments on revolving credit facility	(39,500)	(16,000)	(3,000)
Proceeds from revolving credit facility	47,500	26,000	0
Prepayment penalty associated with the prior credit facilities	0	0	(1,200)
Payment of financing costs	(3,488)	(364)	(3,938)
Proceeds from exercise of equity awards	1,792	1,177	530
Cash paid for shares withheld for taxes	(4,448)	(2,670)	(1,075)
Excess tax benefit from share-based compensation	1,819	1,521	44
Net cash used in financing activities	(2,099)	(1,017)	(58,169)
Effect of exchange rate changes on cash	142	(55)	(70)
Net change in cash and cash equivalents	(2,507)	9,899	1,719
Cash and cash equivalents at beginning of year	15,580	5,681	3,962
Cash and cash equivalents at end of year	13,073	15,580	5,681
Supplemental disclosures of cash flow information:
Cash paid for interest (net of $123, $63 and $27 capitalized in 2014, 2013 and 2012, respectively)	4,599	7,405	13,698
Cash paid for income taxes	17,880	18,865	1,860
Acquisitions:
Fair value of tangible assets acquired in acquisitions, net of cash received	1,631	9,899	0
Goodwill	9,750	21,318	0
Intangible assets	9,960	19,790	0
Liabilities and deferred revenue assumed	(3,821)	(11,507)	0
Holdback provision	(1,650)	0	0
Earn-out liabilities	(1,400)	0	0
Net cash paid for acquisitions	14,470	39,500	0
Supplemental disclosures of non-cash investing and financing activities:
Purchase of fixed assets recorded in accounts payable and accrued expenses	$ 4,618	$ 3,727	$ 282

XML

Consolidated Balance Sheets (Parenthetical) (USD $) In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Accounts receivable, allowance	$ 4,515	$ 5,118
Accumulated depreciation	68,814	63,031
Accumulated amortization	$ 41,963	$ 42,439
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, shares authorized	10,000	10,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	200,000	200,000
Common stock, shares issued	46,639	46,011
Common stock, shares outstanding	46,639	46,011

XML

Retirement Plans (Notes)

12 Months Ended

Dec. 31, 2014

Compensation and Retirement Disclosure [Abstract]

Retirement Plans

Retirement Plans

The Company maintains the AMN Services 401(k) Retirement Savings Plan (the “AMN Plan”), which the Company believes complies with the IRC Section 401(k) provisions. The AMN Plan covers all employees that meet certain age and other eligibility requirements. An annual discretionary matching contribution is determined by the Compensation and Stock Plan Committee of the Board of Directors each year. Employer contributions under the AMN Plan were $553, $165 and $0 for the years ended December 31, 2014, 2013 and 2012, respectively.

The Company has a deferred compensation plan for certain executives and key employees (the “Plan”). The Plan is not intended to be tax qualified and is an unfunded plan. The Plan is composed of deferred compensation and all related income and losses attributable thereto. Discretionary matching contributions to the Plan are made that vest incrementally so that the employee is fully vested in the match following five years of employment with the Company. Under the Plan, participants can defer up to 80% of their base salary, 90% of their bonus and 100% of their vested RSUs or vested PRSUs. An annual discretionary matching contribution is determined by the Compensation and Stock Plan Committee of the Board of Directors each year. Employer contributions under the Plan were $595, $384 and $343 for the years ended December 31, 2014, 2013 and 2012, respectively.

XML

Document and Entity Information (USD $)	12 Months Ended
	Dec. 31, 2014	Feb. 20, 2015	Jun. 30, 2014
Document and Entity Information [Abstract]
Entity Registrant Name	AMN HEALTHCARE SERVICES INC
Entity Central Index Key	0001142750
Document Type	10-K
Document Period End Date	Dec. 31, 2014
Amendment Flag	false
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	FY
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		47,110,127
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Public Float			$ 354,980,891

XML

Capital Stock (Notes)

12 Months Ended

Dec. 31, 2014

Equity [Abstract]

Capital Stock

Capital Stock

(a) Preferred Stock

The Company has 10,000 shares of preferred stock authorized for issuance in one or more series (including preferred stock designated as Series A Conditional Convertible Preferred Stock), at a par value of $0.01 per share.At December 31, 2014 and 2013, no shares of preferred stock were outstanding.

(b) Treasury Stock

In connection with the 2010 acquisition of NFI, 457 shares of the Company’s common stock remained in escrow as of December 31, 2012 for potential Company indemnification claims. During the second quarter of 2013, the Company and former NFI selling shareholders agreed to release all 457 shares in escrow as follows: 1) 204 shares were returned to the Company for settlement of certain indemnification claims, which were recorded as treasury stock and a $3,046 reduction to selling, general and administrative expenses for the year ended December 31, 2013; and 2) the remaining 253 shares were released from escrow to the former NFI selling shareholders. During 2013, the Company cancelled and retired all 204 shares of treasury stock. Upon cancellation and retirement, these shares were returned to the status of authorized and unissued.

XML

Consolidated Statements of Comprehensive Income (Loss) (USD $) In Thousands, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Revenue	$ 1,036,027	$ 1,011,816	$ 953,951
Cost of revenue	719,910	714,536	683,554
Gross profit	316,117	297,280	270,397
Operating expenses:
Selling, general and administrative	232,221	218,233	202,904
Depreciation and amortization	15,993	13,545	14,151
Total operating expenses	248,214	231,778	217,055
Income from operations	67,903	65,502	53,342
Interest expense, net (including loss on debt extinguishment of $3,113, $434, and $9,815 for the years ended December 31, 2014, 2013, and 2012, respectively), and other	9,237	9,665	26,019
Income from continuing operations before income taxes	58,666	55,837	27,323
Income tax expense	25,449	22,904	11,010
Income from continuing operations	33,217	32,933	16,313
Income from discontinued operations, net of tax	0	0	823
Net income	33,217	32,933	17,136
Other comprehensive income (loss) - foreign currency translation	142	(55)	(70)
Comprehensive income	$ 33,359	$ 32,878	$ 17,066
Basic income per common share from:
Continuing operations (in dollars per share)	$ 0.71	$ 0.72	$ 0.36
Discontinued operations (in dollars per share)	$ 0.00	$ 0.00	$ 0.02
Net income (in dollars per share)	$ 0.71	$ 0.72	$ 0.38
Diluted income per common share from:
Continuing operations (in dollars per share)	$ 0.69	$ 0.69	$ 0.35
Discontinued operations (in dollars per share)	$ 0.00	$ 0.00	$ 0.02
Net income (in dollars per share)	$ 0.69	$ 0.69	$ 0.37
Weighted average common shares outstanding:
Basic (in dollars per share)	46,504	45,963	41,632
Diluted (in dollars per share)	48,086	47,787	46,709

XML

Fair Value Measurement (Notes)

12 Months Ended

Dec. 31, 2014

Fair Value Disclosures [Abstract]

Fair Value Measurement

Fair Value Measurement

Fair value represents the price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. When determining fair value, the Company considers the principal or most advantageous market in which the Company would conduct a transaction, in addition to the assumptions that market participants would use when pricing the related assets or liabilities, including non-performance risk.

A three-level hierarchy prioritizes the inputs to valuation techniques used to measure fair value and requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The three levels of the fair value hierarchy are as follows:

Level 1—Quoted prices in active markets for identical assets or liabilities.

Level 2—Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

Assets and Liabilities Measured on a Recurring Basis

The Company’s assets that are measured at fair value on a recurring basis include restricted cash equivalents and investments.

In addition, with the recent acquisition of Avantas, the Company has an obligation to pay earn-out consideration of up to $8,500 in cash, to the former selling shareholders, if certain future financial metrics are met by Avantas. The earn-out payment is expected to be determined in the second half of 2016. Expected cash flows are determined using the probability-weighted average of possible outcomes that would occur should certain financial metrics be reached. There is no market data available to use in valuing the contingent consideration, therefore, the Company developed its own assumptions related to the future financial performance of Avantas to evaluate the fair value of this liability. As such, the contingent consideration is classified within Level 3.

In connection with estimating the fair value of the contingent consideration, the Company estimates the weighted probability of Avantas earningeach of the five specified tiered earn-out amountsof $0, $1,500, $3,500, $5,500 and $8,500, whichareeach tied to the financial performance of Avantasduring the year ending June 30, 2016. An increase or decrease in the probability of achievement of an earn-out tierwill result in an increase or decrease to the estimated fair value of the contingent consideration.The Company will reassess the fair value each reporting period and adjust the liability to its then fair value.

The following tables present information about these assets and liabilities and indicate the fair value hierarchy of the valuation techniques utilized to determine such fair value:

	Fair Value Measurements as of December 31, 2014
	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
U.S. Treasury securities	$	5,291	$	5,291	$	—	$	—
Money market funds	335		335		—		—
Acquisition contingent consideration earn-out liability	1,400		—		—		1,400
Total financial assets measured at fair value	$	7,026	$	5,626	$	—	$	1,400

	Fair Value Measurements as of December 31, 2013
	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
U.S. Treasury securities	$	17,817	$	17,817	$	—	$	—
Money market funds	359		359		—		—
Total financial assets measured at fair value	$	18,176	$	18,176	$	—	$	—

The Company’s restricted cash equivalents and investments typically consist of U.S. Treasury securities and money market funds on deposit with financial institutions that serve as collateral for the Company’s outstanding letters of credit.

Assets Measured on a Non-Recurring Basis

The Company applies fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to its goodwill, indefinite-lived intangible assets, long-lived assets and equity method investment.

The Company evaluates goodwill at the reporting unit level and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. The Company determines the fair value of its reporting units based on a combination of inputs including the market capitalization of the Company as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. The Company determined the fair value of its indefinite-lived intangible assets using the income approach (relief-from-royalty method) based on Level 3 inputs.

The Company performed its annual impairment testing at each of October 31, 2014, 2013 and 2012, and determined there was no impairment of goodwill or its indefinite-lived intangibles. See Note (5), “Goodwill and Identifiable Intangible Assets” for additional information.

XML

Business Combinations and Equity Investment (Notes)

12 Months Ended

Dec. 31, 2014

Business Combinations [Abstract]

Business Combinations and Equity Investment

Business Combinations and Equity Investment

Avantas Acquisition

On December 22, 2014, the Company completed its acquisition of Avantas, a leading provider of clinical labor management services, including workforce consulting, data analytics, predictive modeling and SaaS-based scheduling technology. The acquisition is intended to help enable the Company to provide a level of workforce predictability to clients that can be integrated with its workforce and staffing solutions. The acquisition is not considered a material business combination and, accordingly, pro forma information is not provided. The acquisition was funded through cash-on-hand and borrowings under the Company’s Revolver (as defined in Note (8), “Notes Payable and Credit Agreement”). The Company did not incur any material acquisition-related costs.

The Company accounted for the acquisition using the acquisition method of accounting and, accordingly, it recorded the tangible and intangible assets acquired and liabilities assumed at their estimated fair values as of the date of the acquisition. The total purchase price of $17,520 included $14,470 cash consideration paid, $1,650 cash holdback for potential claims indemnified by the Avantas shareholders and contingent earn-out with a fair value of $1,400. The acquisition agreement provides for a contingent earn-out payment of up to $8,500 to be paid in 2016 based on future operating performance. As of the date of this Annual Report on Form 10-K, the Company is still finalizing the allocation of the purchase price. The provisional items pending finalization are primarily related to tax matters, which the Company expects to complete during 2015.

The preliminary allocation of the purchase price consisted of $1,631 of fair value of tangible assets acquired, $3,821 of liabilities and deferred revenue assumed, $9,750 of goodwill and $9,960 of identified intangible assets. The intangible assets include the fair value of tradenames and trademarks, customer relationships and acquired technologies. The weighted average useful life of the acquired intangible assets subject to amortization is approximately 14 years. All goodwill recognized from this acquisition is deductible for tax purposes.

The results of operations of Avantas are included in the nurse and allied healthcare staffing segment in the Company’s consolidated financial statements since the date of acquisition.

ShiftWise Acquisition

On November 20, 2013, the Company completed its acquisition of ShiftWise, a leading national provider of web-based healthcare workforce solutions, including its VMS technology utilized by hospitals and other healthcare systems. The acquisition is not considered a material business combination and, accordingly, pro forma information is not provided. The acquisition was funded through cash-on-hand and the Company did not incur any material acquisition-related costs.

The Company accounted for the acquisition using the acquisition method of accounting and, accordingly, it recorded the tangible and intangible assets acquired and liabilities assumed at their estimated fair values as of the date of the acquisition. The purchase price of the acquisition totaled $39,500, of which $6,000 was deposited in escrow to satisfy any indemnification claims by the Company with respect to, among other customary items, breaches of representations, warranties and covenants by ShiftWise and post-closing purchase price adjustments. The $6,000 deposited in escrow is scheduled to be disbursed to the selling shareholders in three years following the closing date at $2,000 per annum minus any indemnification claims. In November 2014, $132 cash was released from escrow to the Company, and $1,568 cash was released from escrow to the former Shiftwise shareholders, under the terms of the acquisition agreement.

The allocation of the purchase price consisted of $9,899 of fair value of tangible assets acquired, $11,502 of liabilities assumed (including $2,701 of deferred tax liabilities), $21,313 of goodwill and $19,790 of identified intangible assets. The intangible assets include the fair value of tradenames and trademarks, customer relationships, non-compete agreements and acquired technologies. The weighted average useful life of the acquired intangible assets subject to amortization is approximately 8 years. There is no goodwill recognized as part of this acquisition that is deductible for tax purposes.

The results of operations of ShiftWise are included in the nurse and allied healthcare staffing segment in the Company’s consolidated financial statements since the date of acquisition.

Pipeline Equity Investment

In March 2014, the Company entered into an agreement (the “Pipeline Agreement”) under which it made an initial $2,000 investment in Pipeline Health Holdings LLC (“Pipeline”), a telepharmacy and pharmacy technology solutions provider. The Company’s ownership percentage in Pipeline at March 31, 2014 was approximately 9%. Under the Pipeline Agreement, the Company committed to invest up to an additional $3,000 contingent upon Pipeline reaching two milestone commitments within a year. In April and September 2014, the Company made the milestone investments of $1,000 and $2,000, respectively, which together with the initial investment represents an ownership percentage in Pipeline of approximately 18% as of December 31, 2014. The investment is accounted for under the equity method of accounting. The Company’s share of Pipeline’s results is included within “Interest expense, net, and other” in the accompanying audited consolidated statement of comprehensive income for the year ended December 31, 2014.

XML

Summary of Significant Accounting Policies (Policies)

12 Months Ended

Dec. 31, 2014

Accounting Policies [Abstract]

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of AMN Healthcare Services, Inc. and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. On an ongoing basis, the Company evaluates its estimates, including those related to asset impairment, accruals for self-insurance and compensation and related benefits, accounts receivable, contingencies and litigation, and income taxes. The Company bases these estimates on the information that is currently available and on various other assumptions that it believes are reasonable under the circumstances. Actual results could differ from those estimates under different assumptions or conditions.

Cash and Cash Equivalents

The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents include currency on hand, deposits with financial institutions and highly liquid investments.

Restricted Cash, Cash Equivalents and Investments

Restricted cash, cash equivalents and investments primarily represent the cash and U.S. Treasury securities on deposit with financial institutions that serve as collateral for the Company’s outstanding letters of credit and captive insurance subsidiary claim payments. The original maturity terms for the U.S. Treasury securities were between 3-months and 12-months.

Fixed Assets

The Company records furniture, equipment, leasehold improvements and internal-use software at cost less accumulated amortization and depreciation. The Company records equipment acquired under capital leases at the present value of the future minimum lease payments. The Company capitalizes major additions and improvements, and expenses maintenance and repairs when incurred. The Company calculates depreciation on furniture, equipment and software using the straight-line method based on the estimated useful lives of the related assets (three to seven years). The Company amortizes leasehold improvements and equipment obtained under capital leases over the shorter of the term of the lease or their estimated useful lives. The Company includes amortization of equipment obtained under capital leases with depreciation expense in the accompanying consolidated financial statements.

The Company capitalizes costs it incurs to develop internal-use software during the application development stage. Application development stage costs generally include costs associated with internal-use software configuration, coding, installation and testing. The Company also capitalizes costs of significant upgrades and enhancements that result in additional functionality, whereas it expenses as incurred costs for maintenance and minor upgrades and enhancements. The Company amortizes capitalized costs using the straight-line method over three to seven years once the software is ready for its intended use.

The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset group to the future undiscounted net cash flows that are expected to be generated by the asset group. If such asset group is considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset group exceeds the fair value of the asset group. The Company reports assets to be disposed of at the lower of the carrying amount or fair value less costs to sell.

Goodwill

The Company records as goodwill the portion of the purchase price that exceeds the fair value of net assets of entities acquired. The Company evaluates goodwill annually for impairment at the reporting unit level and whenever circumstances occur indicating that goodwill may be impaired. The Company may first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, after assessing the totality of events and circumstances, the Company determines that it is more likely than not that the fair value of the reporting unit is greater than its carrying amount, the quantitative impairment test is unnecessary. The performance of the quantitative impairment test involves a two-step process. The first step of the test involves comparing the fair value of the Company’s reporting units with the reporting unit’s carrying amount, including goodwill. The Company generally determines the fair value of its reporting units using a combination of the income approach (using discounted future cash flows) and the market valuation approach. If the carrying amount of the Company’s reporting units exceeds the reporting unit’s fair value, the Company performs the second step of the test to determine the amount of impairment loss. The second step of the test involves comparing the implied fair value of the Company’s reporting unit’s goodwill with the carrying amount of that goodwill. The amount by which the carrying value of the goodwill exceeds its implied fair value, if any, is recognized as an impairment loss.

Intangible Assets

Intangible assets consist of identifiable intangible assets acquired through acquisitions. Identifiable intangible assets include tradenames and trademarks, customer relationships, non-compete agreements, staffing databases, acquired technology and online courses. The Company amortizes intangible assets, other than tradenames and trademarks with an indefinite life, using the straight-line method over their useful lives. The Company amortizes non-compete covenants using the straight-line method over the lives of the related agreements. The Company reviews for impairment intangible assets with estimable useful lives whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.

The Company does not amortize indefinite-lived tradenames and trademarks and instead reviews them for impairment annually. The Company may first perform a qualitative assessment to determine whether it is more likely than not that an indefinite-lived intangible asset is impaired. If, after assessing the totality of events and circumstances, the Company determines that it is more likely than not that the indefinite-lived intangible asset is not impaired, no quantitative fair value measurement is necessary. If a quantitative fair value measurement calculation is required for the indefinite-lived intangible assets, the Company compares the fair value of the Company’s indefinite-lived intangibles with their carrying amount. If the carrying amount exceeds the fair value, the Company records the excess as an impairment loss.

Insurance Reserves

The Company maintains an accrual for professional liability that is included in accounts payable and accrued expenses and other long-term liabilities in the consolidated balance sheets. The expense is included in the selling, general and administrative expenses in the consolidated statement of comprehensive income. The Company determines the adequacy of this accrual by evaluating its historical experience and trends, loss reserves established by the Company’s insurance carriers, management and third-party administrators, and its independent actuarial studies. The Company obtains actuarial studies on a semi-annual basis that use the Company’s actual claims data and industry data to assist the Company in determining the adequacy of its reserves each year. For periods between the actuarial studies, the Company records its accruals based on loss rates provided in the most recent actuarial study and management's review of loss history. In November 2012, the Company established a captive insurance subsidiary, which provides coverage, on an occurrence basis, for professional liability within its nurse and allied healthcare staffing segment. Liabilities include provisions for estimated losses incurred but not yet reported (“IBNR”), as well as provisions for known claims. IBNR reserve estimates involve the use of assumptions and are primarily based upon historical loss experience, industry data and other actuarial assumptions. The Company maintains excess insurance coverage through a commercial carrier for losses above the per occurrence retention.

The Company maintains an accrual for workers compensation, which is included in accrued compensation and benefits and other long-term liabilities in the consolidated balance sheets. The Company determines the adequacy of this accrual by evaluating its historical experience and trends, loss reserves established by the Company’s insurance carriers and third-party administrators, and its independent actuarial studies. The Company obtains actuarial studies on a semi-annual basis that use the Company’s payroll and historical claims data, as well as industry data, to determine the appropriate reserve for both reported claims and IBNR claims for each policy year. For periods between the actuarial studies, the Company records its accruals based on loss rates provided in the most recent actuarial study.

Revenue Recognition

Revenue consists of fees earned from the permanent and temporary placement of healthcare professionals. Revenue is recognized when earned and realizable. The Company has entered into certain contracts with healthcare organizations to provide managed services programs. Under these contract arrangements, the Company uses its healthcare professionals along with those of third-party subcontractors to fulfill client orders. If the Company uses subcontractors, it records revenue net of related subcontractors expense. The resulting net revenue represents the administrative fee the Company charges for its vendor management services. The Company is liable to the subcontractor after it receives payment from the client.

Accounts Receivable

The Company records accounts receivable at the invoiced amount. Accounts receivable are non-interest bearing. The Company maintains an allowance for doubtful accounts for estimated credit losses resulting from collection risk, including the inability of customers to make required payments under contractual agreements. The allowance for doubtful accounts is reported as a reduction of accounts receivable in the consolidated balance sheets. The Company determines the adequacy of this allowance by evaluating historical delinquency and write-off trends, the financial condition and credit risk and history of each customer, historical payment trends as well as current economic conditions and the impact of such conditions on the customers’ liquidity and overall financial condition. The Company also maintains a sales allowance to reserve for potential credits issued to customers. The Company determines the amount of the reserve based on historical credits issued.

Concentration of Credit Risk

The Company’s cash and cash equivalents and restricted cash, cash equivalents and investments accounts are also financial instruments that are exposed to concentration of credit risk. The Company maintains its cash balances with high-credit quality and federally insured institutions. Cash balances may be invested in a non-federally insured money market account.

The majority of the Company’s business activity is with hospitals located throughout the United States. Credit is extended based on the evaluation of each entity’s financial condition, and collateral is generally not required. Credit losses have been within management’s expectations.

Income Taxes

The Company records income taxes using the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period the changes are enacted. In assessing the realizability of deferred tax assets, the Company considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. The Company considers the scheduled reversal of deferred tax liabilities (including the impact of available carryback and carryforward periods), projected future taxable income, and tax-planning strategies in making this assessment. The Company recognizes the effect of income tax positions only if it is more likely than not that such positions will be sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company records interest and penalties related to unrecognized tax benefits in income tax expense.

Fair Value of Financial Instruments

The carrying amounts of the Company’s cash equivalents and restricted cash equivalents approximate their respective fair values due to the short-term nature and liquidity of these financial instruments. The carrying amount of the Company’s notes payable approximates its fair value as the Company refinanced its credit facilities in 2014 and the instrument’s interest rates are variable (significant other observable inputs - level 2). See Note (8), “Notes Payable and Credit Agreement,” for additional information. The fair value of the long-term portion of the Company’s insurance accruals cannot be estimated as the Company cannot reasonably determine the timing of future payments.

Share-Based Compensation

The Company accounts for its share-based employee compensation plans by expensing the estimated fair value of share-based awards on a straight-line basis over the requisite employee service period, which is the vesting period. Restricted stock units (“RSUs”) granted under the Equity Plan (as defined in Note (11), “Share-Based Compensation”) typically vest at the end of a three-year vesting period, however, 33% of the awards may vest on the 13th month anniversary of the grant date, and 34% on the second anniversary of the grant date, if certain performance targets are met. Share-based compensation cost of RSUs is measured by the market value of the Company’s common stock on the date of grant. Performance restricted stock units (“PRSUs”) granted under the Equity Plan typically consist of 1) PRSUs that contain a market condition with the ultimate realizable number of PRSUs dependent on relative and absolute total shareholder return over a three-year period, up to a maximum amount to be issued under the award of 175% of the original grant (“TSR PRSUs”), the fair values of which are estimated using the Monte-Carlo simulation valuation model and will not be adjusted for the achievement, or lack thereof, of the performance conditions; and 2) PRSUs that contain a performance condition, with the ultimate realizable number of PRSUs dependent on the adjusted EBITDA margin performance of the Company during a certain annual performance period, with a range of 0% to 175% of the target amount granted to be issued under the award. Share-based compensation cost for EBITDA margin PRSUs is measured by the market value of the Company’s common stock on the date of grant, and will be adjusted for estimated achievement of the performance conditions. Stock options and stock appreciation rights granted are measured on the date of grant using the Black-Scholes valuation model, which includes assumptions such as expected term of the award, stock price volatility, dividend rate and risk free interest rate. The Company also estimates the forfeiture rate and records share-based compensation expense only for those awards that are expected to vest.

Net Income (loss) per Common Share

Securities that are entitled to participate in dividends with common stock, such as the Company’s Series A Conditional Convertible Preferred Stock (the “Preferred Stock”), are considered to be participating securities and the two-class method is used for purposes of calculating basic net income per share. Under the two-class method, a portion of net income is allocated to participating securities and excluded from the calculation of basic net income per common share. On December 21, 2012, all outstanding shares of Preferred Stock were converted into common stock; accordingly, for the two-class method calculation, the net income was allocated between common stock and Preferred Stock on a proportionate basis using a systematic and reasonable basis (based on number of days outstanding) for purpose of calculating the basic net income per share for the year ended December 31, 2012.

Discontinued Operations

The results of operations of a disposal group held for sale or disposed is presented as discontinued operations when the underlying operations and cash flows of the disposal group will be, or have been, eliminated from the Company’s continuing operations and the Company no longer has the ability to influence the operating and/or financial policies of the disposal group. This assessment is made at the time the disposal group is classified as held for sale and for a one-year period after the sale of the disposal group.

Segment Information

The Company’s management relies on internal management reporting processes that provide revenue and operating income by reportable segment for making financial decisions and allocating resources. Segment operating income represents income before income taxes plus depreciation, amortization of intangible assets, share-based compensation expense, interest expense (net) and other, and unallocated corporate overhead. The Company’s management does not evaluate, manage or measure performance of segments using asset information; accordingly, asset information by segment is not prepared or disclosed.

Reclassifications

Certain reclassifications have been made to certain of the prior years’ consolidated financial statements to conform to the current year presentation. Specifically, 1) payments made into the Company’s life insurance policies to assist in funding the deferred compensation plan were reclassified from cash flows from operating activities to cash flows from investing activities; and 2) changes in book overdraft were reclassified from cash flows from financing activities to changes in accounts payable and accrued expenses within cash flows from operating activities in the consolidated statement of cash flows for both the year ended December 31, 2013 and 2012. In addition, the Company reclassified expected insurance recoveries under its professional liability and workers compensation policies in the consolidated balance sheet for the year ended December 31, 2013 to conform to the current year presentation. Professional liability and workers compensation liabilities were previously presented net of insurance recoveries. For the fiscal year ended December 31, 2014, expected insurance recoveries are presented on a gross basis, with the short-term insurance receivable portion included within “Prepaid and other current assets” and the long-term portion included within “Other assets” on the consolidated balance sheet.

XML

Share-Based Compensation (Notes)

12 Months Ended

Dec. 31, 2014

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Share-Based Compensation

Share-Based Compensation

(a) Equity Award Plans

Stock Option Plan

The Company established a stock option plan (the “Stock Option Plan”) to provide a means to attract and retain employees. 4,178 options were authorized for issuance to be granted under the Stock Option Plan. Unless otherwise provided at the time of the grant, the options vest and become exercisable in increments of 25% on each of the first four anniversaries of the date of grant. Options granted under the Stock Option Plan expire on the tenth anniversary of the grant date. On April 12, 2006, 371 shares of common stock reserved for future issuance under The Stock Option Plan were rolled into the Equity Plan, which is discussed below. There will be no further equity awards granted from the Stock Option Plan.

Equity Plan

The Company established the AMN Healthcare Equity Plan (as amended or amended and restated from time to time, the “Equity Plan”), which has been approved by the Company’s stockholders. At the time of the Equity Plan’s adoption in 2006, equity awards, based on the Company’s common stock, could be issued for a maximum of 723 shares plus the number of shares of common stock underlying any grants under the Stock Option Plan that are forfeited, canceled or terminated (other than by exercise) from and after the effective date of the Equity Plan. Pursuant to the Equity Plan, stock options and stock appreciation rights (“SARs”) granted have a maximum contractual life of ten years and exercise prices will be determined at the time of grant and will be no less than fair market value of the underlying common stock on the date of grant. Any shares to be issued under the Equity Plan will be issued by the Company from authorized but unissued common stock or shares of common stock reacquired by the Company. On April 18, 2007, April 9, 2009 and April 18, 2012, the Company amended the Equity Plan, with stockholder approval, to increase the number of shares authorized under the Equity Plan by 3,000, 1,850 and 2,400, respectively. At December 31, 2014 and 2013, respectively, 2,421 and 2,173 shares of common stock were reserved for future grants under the Equity Plan.

Other Plans

From time to time, we grant, and have granted, key employees inducement awards outside of the Equity Plan (collectively, “Other Plans”), which have consisted of SARs,options orRSUs, which generally have three-year cliff vesting with a potential for accelerated vesting based on the Company’s achievement of selected targeted financial performance. Although these awards are not made under the Equity Plan, the key terms and conditions of the grant are typically the same as equity awards made under the Equity Plan.

Additionally, in February 2014, the Company established the 2014 Employment Inducement Plan, which reserves for issuance 200 shares of common stock for prospective employees of the Company. As of December 31, 2014, 200 shares of common stock remained available for future grants under the 2014 Employment Inducement Plan.

(b) Share-Based Compensation

Restricted Stock Units

RSUs granted under the Equity Plan generally entitle the holder to receive, at the end of a vesting period, a specified number of shares of the Company’s common stock.

The following table summarizes RSU and PRSU activity for non-vested awards for the years ended December 31, 2014, 2013 and 2012:

	Number of Shares		Weighted Average Grant Date Fair Value per Share
Unvested at January 1, 2012	1,529		$	7.74
Granted—RSUs	459		$	6.70
Granted—PRSUs	465		$	8.15
Vested	(716	)	$	7.95
Canceled/forfeited/expired	(78	)	$	6.66
Unvested at December 31, 2012	1,659		$	7.53
Granted—RSUs	285		$	12.86
Granted—PRSUs	291		$	13.86
Vested	(588	)	$	7.02
Canceled/forfeited/expired	(10	)	$	13.06
Unvested at December 31, 2013	1,637		$	9.73
Granted—RSUs	361		$	13.76
Granted—PRSUs	535		$	14.97
Vested	(838	)	$	8.63
Canceled/forfeited/expired	(120	)	$	12.16
Unvested at December 31, 2014	1,575		$	11.95

As of December 31, 2014, there was $7,742 unrecognized compensation cost related to non-vested RSUs and PRSUs. The Company expects to recognize such cost over a period of 1.8 years. As of December 31, 2014 and 2013, the aggregate intrinsic value of the RSUs and PRSUs outstanding was $30,876 and $24,070, respectively.

Stock Options and SARs

Stock options entitle the holder to purchase, at the end of a vesting period, a specified number of shares of the Company’s common stock at a price per share set at the date of grant. SARs entitle the holder to receive, at the end of a vesting period, shares of the Company’s common stock equal in value to the difference between the exercise price of the SAR, which is set at the date of grant, and the fair market value of the Company’s common stock on the date of exercise.

A summary of stock option and SAR activity under the Stock Option Plan and the Equity Plan and Other Plans are as follows:

	Stock Option Plan				Equity Plan and Other Plans
	Number Outstanding		Weighted- Average Exercise Price per Share		Number Outstanding		Weighted- Average Exercise Price per Share
Outstanding at December 31, 2011	781		$	14.06	1,500		$	10.10
Granted	—		$	—	—		$	—
Exercised	(55	)	$	9.68	(143	)	$	8.10
Canceled/forfeited/expired	(28	)	$	15.63	(116	)	$	7.55
Outstanding at December 31, 2012	698		$	14.34	1,241		$	10.57
Granted	—		$	—	—		$	—
Exercised	(109	)	$	11.23	(132	)	$	8.31
Canceled/forfeited/expired	—		$	—	(13	)	$	15.19
Outstanding at December 31, 2013	589		$	14.92	1,096		$	10.78
Granted	—		$	—	—		$	—
Exercised	(117	)	$	14.86	(142	)	$	11.53
Canceled/forfeited/expired	(227	)	$	14.94	(6	)	$	19.69
Outstanding at December 31, 2014	245		$	14.93	948		$	10.61
Vested and expected to vest at December 31, 2014	245		$	14.93	948		$	10.61
Exercisable at December 31, 2014	245		$	14.93	948		$	10.61

As of December 31, 2014, all stock options and SARs were fully vested. The total intrinsic value of stock options and SARs exercised was $770, $980 and $453 for 2014, 2013 and 2012, respectively. At December 31, 2014 and 2013, the total intrinsic value of stock options and SARs outstanding and exercisable was $10,142 and $5,146, respectively.

Share-Based Compensation

Total share-based compensation expense for the years ended December 31, 2014, 2013 and 2012 was as follows:

	Years Ended December 31,
	2014			2013			2012
Share-based employee compensation, before tax	$	7,157		$	6,125		$	6,224
Related income tax benefits	(2,783		)	(2,383		)	(2,403		)
Share-based employee compensation, net of tax	$	4,374		$	3,742		$	3,821

XML

Income Taxes (Notes)

12 Months Ended

Dec. 31, 2014

Income Tax Disclosure [Abstract]

Income taxes

Income Taxes

The provision for income taxes from continuing operations for the years ended December 31, 2014, 2013 and 2012 consists of the following:

	Years Ended December 31,
	2014		2013		2012
Current income taxes:
Federal	$	10,787	$	17,268	$	3,334
State	2,883		2,605		727
Foreign	—		—		(2		)
Total	13,670		19,873		4,059
Deferred income taxes:
Federal	10,430		1,693		5,663
State	1,349		1,338		1,288
Total	11,779		3,031		6,951
Provision for income taxes from continuing operations	$	25,449	$	22,904	$	11,010

The Company’s income tax expense differs from the amount that would have resulted from applying the federal statutory rate of 35% to pretax income from continuing operations because of the effect of the following items during the years ended December 31, 2014, 2013 and 2012:

	Years Ended December 31,
	2014			2013			2012
Tax expense at federal statutory rate	$	20,533		$	19,543		$	9,563
State taxes, net of federal benefit	2,551			2,302			1,263
Non-deductible expenses	1,816			—			—
Unrecognized tax benefit	971			1,952			742
Other, net	(422		)	(893		)	(558		)
Income tax expense from continuing operations	$	25,449		$	22,904		$	11,010

The tax effects of temporary differences that give rise to significant portions of deferred tax assets and deferred tax liabilities are presented below as of December 31, 2014 and 2013:

	Years Ended December 31,
	2014			2013
Deferred tax assets:
Stock compensation	$	11,217		$	11,998
Deferred revenue	573			1,003
Allowance for doubtful accounts	1,467			1,552
Deferred compensation	8,142			7,116
Accrued expenses, net	20,475			23,078
Deferred rent	3,420			3,209
Net operating losses	14,354			19,841
State taxes	1,346			446
Other	2,265			1,803
Total deferred tax assets	$	63,259		$	70,046
Deferred tax liabilities:
Intangibles	$	(57,316	)	$	(56,121	)
Fixed assets	(8,453		)	(4,289		)
Prepaid expenses	(1,427		)	(1,259		)
Total deferred tax liabilities	$	(67,196	)	$	(61,669	)
Valuation allowance	$	(1,224	)	$	(1,205	)
Net deferred tax assets (liabilities)	$	(5,161	)	$	7,172

In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. Management believes it is more likely than not that the Company will realize the benefits of its deferred tax assets, net of the recorded valuation allowance.

The deferred tax assets related to net operating losses (“NOLs”) include NOLs from the 2010 NFI and 2013 ShiftWise acquisitions. The amount of NOL from acquired companies has been the subject of an evaluation under the NOL limitation rules of Internal Revenue Code (“IRC”) Section 382 and corresponding state authorities and the balances reflect these limitations.

The amount of federal NOL carryforward that is available for use in years subsequent to December 31, 2014 is $31,364, which is set to expire by 2029. The amount of state NOL carryforward that is available for use in years subsequent to December 31, 2014 is $47,688, which is set to expire at various dates between 2015 and 2032.

A summary of the changes in the amount of unrecognized tax benefits (excluding interest and penalties) for 2014, 2013 and 2012 is as follows:

	2014		2013		2012
Beginning balance of unrecognized tax benefits	$	22,573	$	21,415	$	21,221
Additions based on tax positions related to the current year	—		809		1,096
Additions based on tax positions of prior years	317		349		—
Reductions due to lapse of applicable statute of limitation	—		—		(902		)
Ending balance of unrecognized tax benefits	$	22,890	$	22,573	$	21,415

At December 31, 2014, if recognized, approximately $25,056 would affect the effective tax rate (including interest and penalties).

The Company recognizes interest and penalties related to unrecognized tax benefits in income tax expense. The Company has approximately $5,815, $4,605 and $3,178 of accrued interest and penalties related to unrecognized tax benefits at December 31, 2014, 2013 and 2012, respectively. The amount of interest and penalties recognized in 2014, 2013 and 2012 were $1,211, $1,427 and $468, respectively.

The Company is subject to taxation in the U.S. and various states and foreign jurisdictions. With few exceptions, as of December 31, 2014, the Company is no longer subject to U.S. federal, state, local or foreign examinations by tax authorities for years before 2005. The Internal Revenue Service (“IRS”) completed its tax audit of the Company for the years 2007, 2008, 2009 and 2010, and issued a Revenue Agent Report (“RAR”) to the Company related to its completed tax examination. The RAR seeks adjustments to the Company’s taxable income for 2007-2010 and net operating loss carryforwards from 2005-2006. The adjustments to the Company’s taxable income relate to the proposed disallowance of certain per diems paid to our healthcare professionals. Concurrent with the RAR, the Company received an Employment Tax Examination Report (“ETER”) for 2009 and 2010. The ETER adjustments propose additional Company payroll tax liabilities and penalties related to the treatment of certain non-taxable per diem allowances and travel benefits. The positions in the RAR and ETER are mutually exclusive. The RAR and ETER contain multiple tax positions, some of which are contrary to each other. The Company has filed a Protest Letter for both the RAR and ETER and intends to defend its position. The Company has held several meetings with the IRS Appeals office throughout 2014. The Company does expect resolution of these matters within the next twelve months but cannot predict with certainty the timing of such resolution or an estimated settlement amount. However, the Company believes its reserves will be adequate to cover the anticipated settlement. Notwithstanding, the Company could adjust its provision for income taxes and/or contingent tax liability based on future developments.

The IRS began a separate 2011-2012 income and payroll tax audit during November 2013 and has recently completed its field work. We are awaiting the IRS exam report but do not expect the issues to be different than the issues raised in the last exam. The Company believes its reserve for unrecognized tax benefits and contingent tax issues is adequate with respect to all open years.

XML

Share-Based Compensation - Summary of Stock Option and SAR Activity (Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Stock Option Plan | Stock Options
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Number outstanding, Beginning balance	589	698	781
Number outstanding, granted	0	0	0
Number outstanding, exercised	(117)	(109)	(55)
Number outstanding, canceled/forfeited/expired	(227)	0	(28)
Number outstanding, Ending balance	245	589	698
Vested and expected to vest	245
Exercisable	245
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]
Weighted-average exercise price per share, Beginning balance	$ 14.92	$ 14.34	$ 14.06
Weighted-average exercise price per share, granted	$ 0.00	$ 0.00	$ 0.00
Weighted-average exercise price per share, exercised	$ 14.86	$ 11.23	$ 9.68
Weighted-average exercise price per share, canceled/forfeited/expired	$ 14.94	$ 0.00	$ 15.63
Weighted-average exercise price per share, Ending balance	$ 14.93	$ 14.92	$ 14.34
Vested and expected to vest	$ 14.93
Exercisable	$ 14.93
Equity Plan and Other Plans | Stock Appreciation Rights (SARs)
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
Number outstanding, Beginning balance	1,096	1,241	1,500
Number outstanding, granted	0	0	0
Number outstanding, exercised	(142)	(132)	(143)
Number outstanding, canceled/forfeited/expired	(6)	(13)	(116)
Number outstanding, Ending balance	948	1,096	1,241
Vested and expected to vest	948
Exercisable	948
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price [Roll Forward] [Roll Forward]
Weighted-average exercise price per share, Beginning balance	$ 10.78	$ 10.57	$ 10.10
Weighted-average exercise price per share, granted	$ 0.00	$ 0.00	$ 0.00
Weighted-average exercise price per share, exercised	$ 11.53	$ 8.31	$ 8.10
Weighted-average exercise price per share, canceled/forfeited/expired	$ 19.69	$ 15.19	$ 7.55
Weighted-average exercise price per share, Ending balance	$ 10.61	$ 10.78	$ 10.57
Vested and expected to vest	$ 10.61
Exercisable	$ 10.61

XML

Goodwill and Identifiable Intangible Assets (Notes)

12 Months Ended

Dec. 31, 2014

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Identifiable Intangible Assets

Goodwill and Identifiable Intangible Assets

As of December 31, 2014 and 2013, the Company had the following acquired intangible assets:

	As of December 31, 2014							As of December 31, 2013
	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount
Intangible assets subject to amortization:
Staffing databases	$	3,020	$	(2,618	)	$	402	$	5,450	$	(4,444	)	$	1,006
Customer relationships	77,300		(32,971		)	44,329		72,990		(29,363		)	43,627
Tradenames and trademarks	17,540		(5,436		)	12,104		16,871		(6,203		)	10,668
Non-compete agreements	190		(72		)	118		1,666		(1,484		)	182
Acquired technology	7,030		(866		)	6,164		6,200		(886		)	5,314
Online courses	—		—			—		59		(59		)	—
	$	105,080	$	(41,963	)	$	63,117	$	103,236	$	(42,439	)	$	60,797
Intangible assets not subject to amortization: tradenames and trademarks						$	89,400						$	89,400
						$	152,517						$	150,197

Aggregate amortization expense for intangible assets was $7,639 and $6,503 for the years ended December 31, 2014 and 2013, respectively. Based on the current amount of intangibles subject to amortization, the estimated amortization expense as of December 31, 2014 is as follows:

	Amount
Year ending December 31, 2015	$	8,202
Year ending December 31, 2016	7,734
Year ending December 31, 2017	7,517
Year ending December 31, 2018	7,315
Year ending December 31, 2019	6,911
Thereafter	25,438
	$	63,117

The following table summarizes the activity related to the carrying value of goodwill by reportable segment:

	Nurse and Allied Healthcare Staffing			Locum Tenens Staffing		Physician Permanent Placement Services		Total
Balance, January 1, 2013	$	76,493		$	14,502	$	32,329	$	123,324
Goodwill acquired from ShiftWise acquisition	21,318			—		—		21,318
Balance, December 31, 2013	97,811			14,502		32,329		144,642
Goodwill adjustment for ShiftWise acquisition	(5		)	—		—		(5		)
Goodwill acquired from Avantas acquisition	9,750			—		—		9,750
Balance, December 31, 2014	$	107,556		$	14,502	$	32,329	$	154,387
Accumulated impairment loss as of December 31, 2013 and 2014	$	154,444		$	53,940	$	6,555	$	214,939

XML

Balance Sheet Details (Notes)

12 Months Ended

Dec. 31, 2014

Balance Sheet Related Disclosures [Abstract]

Balance Sheet Details

Balance Sheet Details

The consolidated balance sheets detail is as follows as of December 31, 2014 and 2013:

	As of December 31,
	2014			2013
Prepaids and other current assets:
Prepaid expenses	$	10,350		$	8,128
Restricted cash	9,054			8,325
Income taxes receivable	3,503			3,084
Other current assets	4,643			7,094
Prepaids and other current assets	$	27,550		$	26,631
Fixed assets:
Furniture and equipment	$	17,761		$	16,413
Software	78,593			62,471
Leasehold improvements	5,340			5,305
	101,694			84,189
Accumulated depreciation and amortization	(68,814		)	(63,031		)
Fixed assets, net	$	32,880		$	21,158
Accounts payable and accrued expenses:
Trade accounts payable	$	30,039		$	37,288
Subcontractor payable	33,474			22,051
Professional liability reserve	7,380			10,158
Overdraft	6,338			233
Other	1,762			1,584
Accounts payable and accrued expenses	$	78,993		$	71,314
Accrued compensation and benefits:
Accrued payroll	$	21,857		$	17,216
Accrued bonuses	15,196			11,359
Accrued travel expense	2,413			2,203
Accrued health insurance reserve	1,871			2,021
Accrued workers compensation reserve	5,830			5,313
Deferred compensation	20,729			17,731
Other	99			106
Accrued compensation and benefits	$	67,995		$	55,949
Other long-term liabilities:
Workers compensation reserve	$	13,855		$	13,086
Professional liability reserve	30,722			27,414
Deferred rent	8,122			6,625
Unrecognized tax benefits	21,706			27,178
Other	3,269			2,717
Other long-term liabilities	$	77,674		$	77,020

XML

Notes Payable and Related Credit Agreement (Notes)

12 Months Ended

Dec. 31, 2014

Debt Disclosure [Abstract]

Notes Payable and Credit Agreement

Notes Payable and Credit Agreement

On April 18, 2014, the Company entered into a Credit Agreement (the “Credit Agreement”) with several lenders to provide for two credit facilities (the “New Credit Facilities”) to replace its prior credit facilities, including (A) a $225,000 secured revolving credit facility (the “Revolver”) that includes a $40,000 sublimit for the issuance of letters of credit and a $20,000 sublimit for swingline loans and (B) a $150,000 secured term loan credit facility (the “Term Loan”). In addition, the Credit Agreement provides that the Company may from time to time obtain an increase in the Revolver or the Term Loan or both in an aggregate principal amount not to exceed $125,000 subject to, among other conditions, the arrangement of additional commitments with financial institutions reasonably acceptable to the Company and the administrative agent.

The Revolver carries an unused fee of 0.25% to 0.35% per annum and each standby letter of credit issued under the Revolver is subject to a letter of credit fee ranging from 1.50% to 2.25% per annum of the average daily maximum amount available to be drawn under the standby letter of credit, in each case, depending on the Company’s consolidated leverage ratio, as calculated quarterly in accordance with the Credit Agreement. The Term Loan is subject to amortization of principal of 5.00% per year of the original Term Loan amount, which is $7,500 per annum, and payable in equal quarterly installments. Borrowings under the Term Loan and Revolver bear interest at floating rates, at the Company’s option, based upon either LIBOR plus a spread of 1.50% to 2.25% or a base rate plus a spread of 0.50% to 1.25%. The applicable spread is determined quarterly based upon the Company’s consolidated leverage ratio, as calculated quarterly in accordance with the Credit Agreement. The interest rate for the outstanding Term Loan was 1.9% on a LIBOR basis and the interest rate for the outstanding Revolver was 4.0% on a base rate basis as of December 31, 2014.

The Company used the proceeds from the New Credit Facilities to repay in full all outstanding indebtedness under its prior credit facilities and to pay related transaction costs.

In connection with obtaining the New Credit Facilities, the Company incurred $3,488 in fees paid to lenders and other third parties, which were capitalized and are amortized to interest expense over the term of the New Credit Facilities. In addition, the Company wrote off $3,113 of unamortized financing fees and original issue discount, which was recorded as loss on debt extinguishment in the accompanying consolidated statement of comprehensive income for the year ended December 31, 2014.

The New Credit Facilities are available for working capital, capital expenditures, permitted acquisitions and general corporate purposes of the Company. The maturity date of the New Credit Facilities is April 18, 2019. At December 31, 2014, the outstanding balance of the Term Loan was $144,375, of which $7,500 is due in the next 12 months, and there was $18,000 outstanding under the Revolver. At December 31, 2014, with $9,380 of outstanding letters of credit collaterialized by the Revolver, there was $197,620 of available credit under the Revolver.

Annual principal maturities of the Term Loan are as follows:

Year ending December 31, 2015	$	7,500
Year ending December 31, 2016	7,500
Year ending December 31, 2017	7,500
Year ending December 31, 2018	7,500
Thereafter	114,375
	$	144,375

The Company’s outstanding debt instruments at December 31, 2014 and 2013 were secured by substantially all of the assets of the Company and the common stock or equity interests of its domestic subsidiaries.

The Credit Agreement contains various customary affirmative and negative covenants, including restrictions on assumption of additional indebtedness, declaration and payment of dividends, dispositions of assets, consolidation into another entity and allowable investments. It also contains financial covenants that require the Company (1) not to exceed a certain maximum consolidated leverage ratio, as calculated in accordance with the Credit Agreement, which is initially set at 4.00 to 1.00 but ultimately steps down to 3.50 to 1.00 beginning with the fiscal quarter ending June 30, 2016, and (2) to maintain a minimum consolidated interest coverage ratio of 2.50 to 1.00, as calculated in accordance with the Credit Agreement.

Letters of Credit

At December 31, 2014, the Company maintained outstanding standby letters of credit totaling $15,006 as collateral in relation to its professional liability insurance agreements, workers compensation insurance agreements, and a corporate office lease agreement. Of the $15,006 outstanding letters of credit, the Company has collateralized $5,626 in cash, cash equivalents and investments and the remaining amount has been collateralized by the Revolver. Outstanding standby letters of credit at December 31, 2013 totaled $27,691.

XML

Subsequent Events (Details) (Onward Healthcare, Locum Leaders and Medefis Acquisition, Subsequent Event, USD $) In Thousands, unless otherwise specified	0 Months Ended
	Jan. 07, 2015
Onward Healthcare, Locum Leaders and Medefis Acquisition | Subsequent Event
Subsequent Event [Line Items]
Cash consideration	$ 82,500

XML

Quarterly Financial Data (Unaudited) (Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended								12 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Selected Quarterly Financial Information [Abstract]
Revenue	$ 279,649	$ 264,584	$ 250,913	$ 240,881	$ 248,658	$ 257,095	$ 253,943	$ 252,120	$ 1,036,027	$ 1,011,816	$ 953,951
Gross profit	84,696	80,306	77,159	73,956	74,193	75,667	74,413	73,007	316,117	297,280	270,397
Net income	$ 9,895	$ 8,499	$ 7,193	$ 7,630	$ 8,356	$ 8,615	$ 8,399	$ 7,563	$ 33,217	$ 32,933	$ 17,136
Net income (in dollars per share)	$ 0.21	$ 0.18	$ 0.15	$ 0.16	$ 0.18	$ 0.19	$ 0.18	$ 0.17	$ 0.71	$ 0.72	$ 0.38
Net income (in dollars per share)	$ 0.20	$ 0.18	$ 0.15	$ 0.16	$ 0.17	$ 0.18	$ 0.18	$ 0.16	$ 0.69	$ 0.69	$ 0.37

XML

Summary of Significant Accounting Policies - Restricted Cash, Cash Equivalents and Investments (Details)	12 Months Ended
	Dec. 31, 2014
Minimum
Restricted Cash and Cash Equivalents Items [Line Items]
U.S. Treasury Security Maturity Term	3 months
Maximum
Restricted Cash and Cash Equivalents Items [Line Items]
U.S. Treasury Security Maturity Term	12 months

XML

Income Taxes - Operating Loss Carryforwards (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2014
Federal
Operating Loss Carryforwards
Operating loss carryforwards	$ 31,364
State
Operating Loss Carryforwards
Operating loss carryforwards	$ 47,688

XML

Quarterly Financial Data (Unaudited) (Notes)

12 Months Ended

Dec. 31, 2014

Quarterly Financial Information Disclosure [Abstract]

Quarterly Financial Information

Quarterly Financial Data (Unaudited)

	Year Ended December 31, 2014
	First Quarter		Second Quarter		Third Quarter		Fourth Quarter		Total Year
	(In thousands, except per share data)
Revenue	$	240,881	$	250,913	$	264,584	$	279,649	$	1,036,027
Gross profit	$	73,956	$	77,159	$	80,306	$	84,696	$	316,117
Net income	$	7,630	$	7,193	$	8,499	$	9,895	$	33,217
Net income per share from:
Basic	$	0.16	$	0.15	$	0.18	$	0.21	$	0.71
Diluted	$	0.16	$	0.15	$	0.18	$	0.20	$	0.69

	Year Ended December 31, 2013
	First Quarter		Second Quarter		Third Quarter		Fourth Quarter		Total Year
	(In thousands, except per share data)
Revenue	$	252,120	$	253,943	$	257,095	$	248,658	$	1,011,816
Gross profit	$	73,007	$	74,413	$	75,667	$	74,193	$	297,280
Net income	$	7,563	$	8,399	$	8,615	$	8,356	$	32,933
Net income per share from:
Basic	$	0.17	$	0.18	$	0.19	$	0.18	$	0.72
Diluted	$	0.16	$	0.18	$	0.18	$	0.17	$	0.69

XML

Fair Value Measurement (Tables)

12 Months Ended

Dec. 31, 2014

Fair Value Disclosures [Abstract]

Schedule of financial assets and liabilities measured at fair value on recurring basis

	Fair Value Measurements as of December 31, 2014
	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
U.S. Treasury securities	$	5,291	$	5,291	$	—	$	—
Money market funds	335		335		—		—
Acquisition contingent consideration earn-out liability	1,400		—		—		1,400
Total financial assets measured at fair value	$	7,026	$	5,626	$	—	$	1,400

	Fair Value Measurements as of December 31, 2013
	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
U.S. Treasury securities	$	17,817	$	17,817	$	—	$	—
Money market funds	359		359		—		—
Total financial assets measured at fair value	$	18,176	$	18,176	$	—	$	—

XML

Income Taxes - Reconciliation (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Income Tax Disclosure [Abstract]
Federal statutory tax rate	35.00%	35.00%	35.00%
Income tax reconciliation
Tax expense at federal statutory rate	$ 20,533	$ 19,543	$ 9,563
State taxes, net of federal benefit	2,551	2,302	1,263
Non-deductible expenses	1,816	0	0
Unrecognized tax benefit	971	1,952	742
Other, net	(422)	(893)	(558)
Income tax expense from continuing operations	$ 25,449	$ 22,904	$ 11,010

XML

Business Combinations and Equity Investment (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended			3 Months Ended	0 Months Ended		1 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Mar. 31, 2014 milestone_commitment	Dec. 22, 2014	Nov. 20, 2013	Nov. 30, 2014	Sep. 30, 2014	Apr. 30, 2014
Allocation of Purchase Price:
Fair value of tangible assets acquired in acquisitions, net of cash received	$ 1,631	$ 9,899	$ 0
Liabilities assumed	3,821	11,507	0
Goodwill	154,387	144,642	123,324
Goodwill	9,750	21,318	0
Intangible assets	9,960	19,790	0
Pipeline Equity Investment
Equity Method Investments and Joint Ventures [Abstract]
Equity method investment				2,000				2,000	1,000
Ownership percentage	18.00%			9.00%
Investment commitment				3,000
Number of milestone commitments				2
Avantas Acquisition
Business Combination, Description
Total purchase price of the acquisition					17,520
Cash consideration					14,470
Cash holdback for potential claims					1,650
Contingent earn-out					1,400
Contingent earn-out based on future operating performance					8,500
Allocation of Purchase Price:
Fair value of assets acquired					1,631
Liabilities assumed					3,821
Goodwill					9,750
Identified intangible assets					9,960
Intangible Assets, Net (Including Goodwill) [Abstract]
Weighted average useful life of intangible assets					14 years
Shiftwise Acquisition
Business Combination, Description
Total purchase price of the acquisition						39,500
Amount deposited into escrow						6,000
Escrow deposit disbursements						2,000
Cash released from escrow to Company							132
Cash released from escrow to former Shiftwise shareholders							1,568
Allocation of Purchase Price:
Fair value of tangible assets acquired in acquisitions, net of cash received	9,899
Liabilities assumed	11,502
Goodwill	21,313
Deferred tax liability	2,701
Intangible assets	$ 19,790
Intangible Assets, Net (Including Goodwill) [Abstract]
Weighted average useful life of intangible assets	8 years

XML

Consolidated Statements of Comprehensive Income (Loss) (Parenthetical) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Loss on debt extinguishment	$ 3,113	$ 434	$ 9,815

XML

Discontinued Operations (Notes)

12 Months Ended

Dec. 31, 2014

Discontinued Operation, Income (Loss) from Discontinued Operation Disclosures [Abstract]

Discontinued Operations

Discontinued Operations

In January 2012, the Company completed the sale of its home healthcare services segment and the related results of operations have been classified as discontinued operations for the year ended December 31, 2012.

The following table represents the revenue and the components of discontinued operations, net of tax:

	Year Ended December 31, 2012
Revenue	$	3,885
Loss before income taxes	$	(547	)
Income tax benefit	183
Loss from discontinued operations	$	(364	)
Gain on sale of discontinued operations, before income taxes	$	3,825
Income tax expense	(2,638		)
Gain on sale of discontinued operations	$	1,187
Total income from discontinued operations	$	823

XML

Share-Based Compensation - Textual (Details) (USD $) In Thousands, except Share data, unless otherwise specified	12 Months Ended			0 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Apr. 12, 2006	Apr. 18, 2012	Apr. 09, 2009	Apr. 18, 2007	Dec. 31, 2007	Feb. 28, 2014
Stock Options and Stock Appreciation Rights
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total intrinsic value of share-based payment award exercised	$ 770	$ 980	$ 453
Total intrinsic value of share-based payment award outstanding and exercisable	10,142	5,146
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years
Unrecognized compensation cost, weighted average remaining period	1 year 9 months 18 days
Total unrecognized compensation cost	7,742
Aggregate instrinsic value	$ 30,876	$ 24,070
Stock Option Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of common stock transferred between plans				371,000
Stock Option Plan | Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized for issuance	4,178,000
Stock Option Plan | Stock Options | Vesting Period, Anniversary of Grant Date
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	25.00%
Number of vesting periods	4
Stock Option Plan | Stock Options and Stock Appreciation Rights
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity awards reserved for future issuance	0
Equity Plan | Stock Options and Stock Appreciation Rights
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized for issuance								723,000
Equity awards reserved for future issuance	2,421,000	2,173,000
Contractual life of stock options and SARs	10 years
Additional number of shares authorized					2,400,000	1,850,000	3,000,000
2014 Employee Inducement Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized for issuance									200
Shares of common stock available for future grants	200

XML

Goodwill and Identifiable Intangible Assets (Tables)

12 Months Ended

Dec. 31, 2014

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Acquired Intangible Assets by Major Class

As of December 31, 2014 and 2013, the Company had the following acquired intangible assets:

	As of December 31, 2014							As of December 31, 2013
	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount
Intangible assets subject to amortization:
Staffing databases	$	3,020	$	(2,618	)	$	402	$	5,450	$	(4,444	)	$	1,006
Customer relationships	77,300		(32,971		)	44,329		72,990		(29,363		)	43,627
Tradenames and trademarks	17,540		(5,436		)	12,104		16,871		(6,203		)	10,668
Non-compete agreements	190		(72		)	118		1,666		(1,484		)	182
Acquired technology	7,030		(866		)	6,164		6,200		(886		)	5,314
Online courses	—		—			—		59		(59		)	—
	$	105,080	$	(41,963	)	$	63,117	$	103,236	$	(42,439	)	$	60,797
Intangible assets not subject to amortization: tradenames and trademarks						$	89,400						$	89,400
						$	152,517						$	150,197

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense

Based on the current amount of intangibles subject to amortization, the estimated amortization expense as of December 31, 2014 is as follows:

	Amount
Year ending December 31, 2015	$	8,202
Year ending December 31, 2016	7,734
Year ending December 31, 2017	7,517
Year ending December 31, 2018	7,315
Year ending December 31, 2019	6,911
Thereafter	25,438
	$	63,117

Schedule of Goodwill

The following table summarizes the activity related to the carrying value of goodwill by reportable segment:

	Nurse and Allied Healthcare Staffing			Locum Tenens Staffing		Physician Permanent Placement Services		Total
Balance, January 1, 2013	$	76,493		$	14,502	$	32,329	$	123,324
Goodwill acquired from ShiftWise acquisition	21,318			—		—		21,318
Balance, December 31, 2013	97,811			14,502		32,329		144,642
Goodwill adjustment for ShiftWise acquisition	(5		)	—		—		(5		)
Goodwill acquired from Avantas acquisition	9,750			—		—		9,750
Balance, December 31, 2014	$	107,556		$	14,502	$	32,329	$	154,387
Accumulated impairment loss as of December 31, 2013 and 2014	$	154,444		$	53,940	$	6,555	$	214,939

XML

Summary of Significant Accounting Policies - Net income per common share (Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended								12 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Computation of Basic and Diluted Net Income Per Common Share [Abstract]
Income from continuing operations									$ 33,217	$ 32,933	$ 16,313
Income from discontinued operations, net of tax									0	0	823
Net income	9,895	8,499	7,193	7,630	8,356	8,615	8,399	7,563	33,217	32,933	17,136
Less: Allocation to participating securities from continuing operations									0	0	(1,249)
Allocation to participating securities from discontinued operations									0	0	(65)
Total allocation to participating securities									0	0	(1,314)
Net income attributable to common stockholders - basic									$ 33,217	$ 32,933	$ 15,822
Basic income per common share from:
Continuing operations (in dollars per share)									$ 0.71	$ 0.72	$ 0.36
Discontinued operations (in dollars per share)									$ 0.00	$ 0.00	$ 0.02
Net income (in dollars per share)	$ 0.21	$ 0.18	$ 0.15	$ 0.16	$ 0.18	$ 0.19	$ 0.18	$ 0.17	$ 0.71	$ 0.72	$ 0.38
Diluted income per common share from:
Continuing operations (in dollars per share)									$ 0.69	$ 0.69	$ 0.35
Discontinued operations (in dollars per share)									$ 0.00	$ 0.00	$ 0.02
Net income (in dollars per share)	$ 0.20	$ 0.18	$ 0.15	$ 0.16	$ 0.17	$ 0.18	$ 0.18	$ 0.16	$ 0.69	$ 0.69	$ 0.37
Weighted average common shares outstanding—basic									46,504	45,963	41,632
Plus dilutive effect of potential common shares									1,582	1,824	5,077
Weighted average common shares outstanding—diluted									48,086	47,787	46,709
Stock Compensation Plan
Class of Stock [Line Items]
Common stock excluded from calculation of EPS									298	308	1,902

XML

Commitments and Contingencies (Notes)

12 Months Ended

Dec. 31, 2014

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

(a) Legal

From time to time, the Company is involved in various lawsuits, claims, investigations, and proceedings that arise in the ordinary course of business. Additionally, some of its clients may also become subject to claims, governmental inquiries and investigations and legal actions relating to services provided by the Company’s healthcare professionals. From time to time, and depending upon the particular facts and circumstances, the Company may be subject to indemnification obligations under its contracts with such clients relating to these matters. Certain of above-referenced matters may include speculative claims for substantial or indeterminate amounts of damages. The Company records a liability when management believes that it is both probable that a loss has been incurred and the amount can be reasonably estimated. Significant judgment is required to determine both probability and the estimated amount. The Company reviews these provisions at least quarterly and adjusts them accordingly to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, and updated information. During the first quarter of 2014, the Company completed the settlement of a wage and hour class action (and a related action) for an immaterial amount. With regards to outstanding loss contingencies as of December 31, 2014, the Company believes that the amount or estimable range of reasonably possible loss, will not, either individually or in the aggregate, have a material adverse effect on its business, consolidated financial position, results of operations or cash flows. However, the outcome of litigation is inherently uncertain, and therefore, if one or more of these legal matters were resolved against the Company for amounts in excess of management’s expectations, the Company’s results of operations and financial condition, including in a particular reporting period, could be materially adversely affected.

(b) Leases

The Company leases certain office facilities and equipment under various operating leases. The Company recognizes rent expense on a straight-line basis over the lease term. Future minimum lease payments under noncancelable operating leases (with initial or remaining lease terms in excess of one year) as of December 31, 2014 are as follows:

	Operating Leases
Years ending December 31,
2015	$	13,215
2016	13,786
2017	12,271
2018	11,662
2019	11,783
Thereafter	92,949
Total minimum lease payments	$	155,666

On January 26, 2015, the Company entered into a 10-year operating lease agreement for office space in Dallas, Texas that will replace its current operating lease agreement for its Irving, Texas offices, which expires in August 2015. Base rent payments under the new lease agreement will begin in September 2015 and the total estimated base rent payments will be approximately $23,956 over the life of the lease, which has been included in the above total minimum lease payments table.

Rent expense under operating leases for continuing operations was $14,136, $14,205, and $15,187 for the years ended December 31, 2014, 2013 and 2012, respectively.